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Introduction
The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB)
offers Ryan White HIV/AIDS Program (RWHAP) Part A and Part B grantees some flexibility in
determining the method used for paying subgrantees for core medical and support services.
Many Part A and Part B grantees use a traditional “cost-based reimbursement” approach, in
which subgrantees submit budgets that include personnel costs, other direct costs related to the
provision of funded services, and capped indirect costs (IDCs). Some grantees, however, have
developed alternative reimbursement models for core medical and/or support services.
This report summarizes the reimbursement approaches taken by nine RWHAP grantees.
While not an exhaustive list, the seven Part A and two Part B grantees demonstrate a range of
payment methods that might provide ideas for other grantees.
This report utilizes the following terms to describe various reimbursement concepts:

3



Cost-based reimbursement and full-time equivalent (FTE) coverage: Generally defined
as paying allowable costs incurred, up to a set limit. Most grantee staff interviewed use
“cost-based reimbursement” to refer to the “traditional” reimbursement model of paying
for line item personnel costs, including FTEs, as well as other direct costs.



Fee-for-service (FFS): A FFS approach involves paying a specific, agreed-upon amount
for each unit of service provided. As discussed in greater detail below, the fees may be
set by the grantee, negotiated based on accounting data provided by subgrantees, or
benchmarked using other fee schedules such as Medicaid or Medicare.



Unit cost reimbursement: Unit cost reimbursement can be considered a type of FFS, in
that payment is made for each “unit” of service provided. The units are clearly defined
(e.g., an x-ray conducted during a dental visit, a 15-minute unit of a face-to-face medical
case manager visit, a bag of food, or a mile driven for medical transportation); and the
“unit cost” is the aggregate cost of inputs associated with providing a given unit of
service. The cost may be calculated by dividing all subgrantee costs by the number of
units provided. A grantee could choose to calculate a standard unit cost based on the
average costs of inputs across subgrantees; build on benchmark unit cost payment
systems used by Medicaid or Medicare; or apply a blended approach.



Performance-based payment: Also sometimes known as “pay for performance” (P4P),
performance-based systems are based on a requirement that subgrantees meet certain
standards set prior to the contract period. While several grantees reported using
“performance-based” payments to describe a broad range of payment models, it appears
that of the interviewees, only LA County has already implemented a system with
payments that are linked to subgrantee performance.
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In general, there are two ways a Ryan White grantee could implement performance-based
payments: In one model, grantees could set aside a percentage of funds allocated to that
service category (a “withhold”) throughout the grant year. At the end of the grant year,
grantees would then distribute the withheld funds across subgrantees that met
performance benchmarks. Alternatively, grantees could adjust future payment rates based
on past year performance. Either way, payment levels would be linked to meeting certain
performance criteria. Enhanced payment could be based on meeting certain thresholds for
performance (e.g., testing at least X% of clients for TB in a given year) or could be scaled
based on how well a subgrantee performs beyond the threshold level. In theory, a Ryan
White grantee could also base performance-based payments on patient outcomes, such as
a certain percentage of clients having undetectable viral load.

It is important to note that GW staff found in our assessment that grantees applied
different terms for the payment models that are used. Therefore, throughout this report we
attempt to make clear both what a grantee defines as its payment system and how the system is
actually operationalized.
Because HAB refers to the recipients of grantee funding as subgrantees, that term is used
throughout this report, even where providers are technically not subgrantees but contractors.

Methodology
This analysis is based on a purposeful sample of grantees. GW staff contacted staff at
HAB and at the National Association of State and Territorial AIDS Directors (NASTAD) to
5

request a list of Part A and Part B grantees that use, or are considering, nontraditional payment
models for one or more RWHAP service categories. HAB staff recommended four Part A
grantees, while NASTAD recommended four Part B grantees. Through internal conversations,
GW staff added three additional Part A grantees to the list.
GW staff emailed contacts at each agency to request information about their payment
models. GW staff received responses from six Part A grantees and three Part B grantees. In the
course of the interviews, GW determined that one additional Part A grantee should be contacted,
and chose to include two of the three Part B grantees in the report. GW conducted phone
interviews with representatives of the nine grantees identified in Table 1.1
Table 1: RWHAP Grantees Participating in the Assessment
Part A Eligible Metropolitan Areas (EMAs)
Part B States
and Transitional Grant Areas (TGAs)
Fort Lauderdale/Broward County, FL (EMA)
New York
Los Angeles County, CA (EMA)
Washington
Miami-Dade County, FL (EMA)
New York City, NY (EMA)
Orange County, CA (TGA)
San Diego, CA (EMA)
St. Louis, MO (TGA)

Telephone interviews were guided by a semi-structured interview tool. Interviews ranged
from 30-60 minutes. All interviews were conducted with one or more staff implementing the
RWHAP in that jurisdiction. In some cases, grantee contractor staff also participated in the
interviews. Some grantees provided supplemental documentation, with a subset of materials
included in the report appendices as noted, and others are available from GW.
Staff from each grantee were asked to review their respective draft profiles for accuracy.
Edits or concurrences were received from all grantees but St. Louis.
1

GW spoke with Dawn Fukuda in Massachusetts, but did not include Massachusetts in the report at this
time.
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Key Findings
We summarize key findings in this section. Full profiles of each grantee’s payment model
can be found starting on p. 16.

RWHAP Service Categories Included in Payment Models
There is significant variation in the extent to which grantees incorporate nontraditional
payment models into their RWHAP programs (see Table 2 for details). At one end of the
spectrum, Miami-Dade County and Ft. Lauderdale/Broward County Part A grantees use FFS and
unit cost reimbursement for almost all service categories. At the other end, the Orange County
Part A grantee uses a FFS model for specialty medical care only. Los Angeles (LA) County was
the only grantee interviewed that has already implemented a performance-based payment model,
as discussed in greater detail below. The New York City (NYC) and Ft. Lauderdale/Broward
County grantees reported that they are considering adopting elements of a performance-based
model.

Fee Setting
As Table 2 summarizes, grantees use a variety of FFS approaches to reimburse
subgrantees for outpatient/ambulatory medical care (OAMC) and dental services. The most
common approach is to link fees to either Medicare or Medicaid rates, with or without an
additional rate enhancement. For example, New York State bases its FFS payments for OAMC
on the Medicaid fee schedule; Orange County negotiates specialty care reimbursement within a
range of 110-130% of Medicare rates. LA County took a different approach, developing a single
7

per-visit rate for OAMC visits, whether conducted by a physician, nurse practitioner, or
physician assistant. LA County funded a consulting firm (Mercer) to develop the rates, based on
market research, subgrantee input, and Bureau of Labor Statistics (BLS) data for the region (see
Appendix 2 for the Mercer rate study and the LA County profile for further detail).
LA County also was the only grantee interviewed that has specific plans to incorporate
performance-based elements into reimbursement within the next two years, with rate changes
and bonuses for subgrantees that meet thresholds on a specified set of performance indicators
(see Appendix 1 for a description of the incentive payment system). Ft. Lauderdale/Broward
County and NYC both reported that they are considering adding such elements in the future.
Currently in NYC, subgrantees that “over-perform” by offering more services than planned may
receive bonus payments toward the end of the grant year, if funds are available.
For unit cost reimbursement of service categories other than OAMC and dental, Ft.
Lauderdale/Broward and Miami-Dade County base their rates for unit cost reimbursement on
market research, including comparisons with other grantees. Appendix 3 summarizes MiamiDade County’s payments by service category. NYC uses FFS for a majority of services and
developed rates based on a range of calculations described in Appendix 4.
All grantees interviewed with FFS or unit cost reimbursement place some form of
monthly and/or annual caps on payment per subgrantee per service category. Reallocations
(referred to commonly as “sweeps”) among subgrantees and across service categories throughout
the grant fiscal year allow for resources to follow the needs of the clients and to be targeted to
the actual services used.

8

Table 2: Summary of Reimbursement and Fee Setting Methods Used by RWHAP Grantees
Grantee

Payment for OAMC and Dental Services

Payment for Other Services

Ft. Lauderdale/
Broward
County

FFS, based on Medicaid rate when available

Los Angeles
County

For primary medical care, single rate model for visit
with physician, NP, or PA (currently $330.12), with
plans to incorporate performance-based adjustments
in future years.

For all other service categories, unit
cost reimbursement, with price
structure based on comparison with
other local EMAs
Cost-based reimbursement

Miami-Dade
County

New York City

Orange County

Rate based on extensive consultation, BLS data, and
third party rate study
Medical: FFS fees are based on the Medicare rate,
with a 1.5 multiplier for evaluation and management
only (office visits)
Dental: multiplier applied to Medicaid dental rates
Some Part A funding supports the state’s FFS
uninsured care program (see summary below)

FFS for specialty medical care only; negotiated at
110-130% of Medicare rates

Unit cost reimbursement based on
market research for all service
categories other than outreach
(which is line-item budget
reimbursement of actual costs)
FFS for most service categories;
medical case management paid
daily and adjusted for intensity;
legal services paid hourly
Cost-based reimbursement

Dental services included under master agreement.

San Diego
County

One mental health provider is also on a FFS contract
Primary medical care: Federally Qualified Health
Centers (FQHCs) reimbursed on FFS basis at FQHC
Medicaid rate; University of California San Diego
reimbursed at rate negotiated earlier with the County
for low-income health program

Cost-based reimbursement, but
considering shift to FFS for mental
health services

Medical specialty services: FFS, rates negotiated
with subgrantees

St. Louis
New York
State
Washington
State

Dental: FFS, based on 130% of rates in an earlier
Medicaid program, but planning to switch to current
Denti-Cal rates
Primary care and dental reimbursed on FFS basis;
rates based on Medicaid
FFS for primary care, based on Medicaid fee
schedule
OAMC and dental reimbursed on FFS basis, based
on 125% (OAMC) and 133% (dental) of Medicaid
rate.
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Cost-based reimbursement
Cost-based reimbursement
Cost-based reimbursement for
medical case management and
several related service categories,
but with incorporation of
“performance-based” elements.

Staffing and Data Systems
Most grantees interviewed reported that FFS or unit cost reimbursement require staffing
and data systems that differ significantly from those needed in a more traditional payment model.

Staffing
Several grantees reported that FFS reimbursement is administratively simpler than costbased reimbursement. While subgrantees generally still must respond to an RFP or otherwise
provide documentation of eligibility for funding, reimbursement involves fairly straightforward
invoicing and payment. However, a FFS model does require fiscal staff to process claims and
track spending to ensure that funding is targeted to the right service categories and reallocated on
a timely basis as needed. In addition, grantees noted the importance of extensive desk and onsite
monitoring to ensure that client records substantiate that the claimed services were actually
provided at the levels reported.

Data Systems
Grantees using FFS or single rate systems reported that having specific claims-based data
systems is instrumental to the success of their payment models. For example, Miami-Dade
County uses CaseWatch Millennium [aka Service Delivery Information System (SDIS)], which
meets the EMA’s data management and federal reporting requirements, from Automated Case
Management Systems (ACMS). This secure data system allows authorized subgrantee staff to
enter and/or review client-level data on services provided, and maintains all program-related
client eligibility, client demographic, health assessment, plan of care, service utilization,
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adherence, and health outcome information in one centralized electronic record for each client.
Access to client information is limited to appropriate staff according to the levels or components
of the service category they work under. CaseWatch is also used to facilitate a certified referral
process, so that documentation to support client eligibility is maintained on file at the client’s
medical care management site, thereby relieving the client from having to take copies of the
same documents to each provider of service. CaseWatch is also used to facilitate the EMA’s
billing process for Part A and Minority AIDS Initiative (MAI) funding.
NYC’s FFS reimbursement system for OAMC services uses eSHARE (Electronic
System for HIV/AIDS Reporting and Evaluation), a data system developed specifically for the
grantee. Subgrantees enter client-level data, and each billable service has an associated
reimbursement rate. A “bridge” system links eSHARE to MAPS, a contract management system
developed by Public Health Solutions, the City’s RWHAP master contractor. If data entered by a
subgrantee are inconsistent with agency payment policies (such as monthly limits on a given
service per client), the system notifies the agency, and staff can contact the subgrantee to resolve
the issue. MAPS can also be used to create reports for both the agency and subgrantees.
LA County uses CaseWatch, a client-level data system. One of its features is a link to
eligibility verification, only permitting reimbursement of subgrantees that can show that a client
is ineligible for public insurance and has no private coverage.
Ft. Lauderdale/ Broward County uses Provide Enterprise (PE) client-level data system to
manage all reimbursement records, service utilization, and client demographic and eligibility
data. All FFS claims are managed in PE, with paid and denied claims recorded in the system.
Claims data are coded using Current Procedural Terminology (CPT) codes. PE interfaces with
the Medicaid enrollment data system to disallow RWHAP payment for Medicaid enrollees. Part
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A staff use PE to generate standardized expenditure, utilization, and other reports, as well as to
project under- or over-expenditure per service category and to conduct quarterly sweeps.
For its FFS payment system for OAMC, New York State uses Emdeon, a third-party
administrator.

Benefits and Challenges in Implementing Alternative Payment Models
Our interviews yielded several important considerations about the benefits and challenges
of novel RWHAP payment mechanisms for grantees and subgrantees.

Benefits
Several interviewed grantees reported that, once in place, a FFS or unit cost
reimbursement model is simpler to administer than a traditional cost-based reimbursement model
based on a line-item budget. Ft. Lauderdale/ Broward County grantee staff called FFS and unit
cost reimbursement a “cleaner process,” with common understanding and clear expectations
among the grantee and subgrantees. Ft. Lauderdale/ Broward County staff also stated that
oversight is somewhat easier, with the grantee conducting simpler, though still important, fiscal
reviews and monitoring. Miami-Dade County staff also finds unit cost reimbursement to be
simpler to administer, with less paperwork than cost-based reimbursement would entail,
particularly given the large number of clients and high service utilization in the EMA. Grantees
report that both FFS and unit cost reimbursement are easier for subgrantees, particularly medical
subgrantees that already bill other payers on a similar basis.
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A FFS or unit cost model can also be more flexible, allowing grantees to conduct
reallocations, either among subgrantees or service categories, multiple times during the grant
year to make funding follow client service utilization.
Another significant potential benefit is the incentive created for subgrantees. LA County
staff noted that under a traditional cost-based reimbursement model, subgrantees had no
incentive to increase their patient loads during a grant year, even when demand for HIV care
would rise. A single-rate model per patient visit maintains an incentive for subgrantees to see
more patients. In a related benefit, the model levels the playing field among subgrantees, which
under a cost-based reimbursement system could be paid widely divergent amounts per patient
visit. In NYC, subgrantees also have the potential to earn bonuses or increase their payment rates
based on over-performing their target number of services. In a performance-based system such
as LA County’s, providers have the potential to earn more for achieving high standards on
performance measures, with potential improvements to patient care and outcomes.
A FFS model, particularly for OAMC and dental services, also aligns RWHAP with the
payment approach used by most third-party payers. Alignment ensures simpler administration for
both grantees and subgrantees and can, in theory, allow for better integration. San Diego County
is considering shifting to a FFS basis for mental health services, in part because it would improve
integration by allowing subgrantees to have a care team that includes physical and mental health
providers and to bill for all personnel on a FFS model. LA County also noted that because most
other payers use FFS, traditional grants-based models facilitate “double dipping” or other
concerning practices on the part of subgrantees.

Challenges
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One of the most commonly cited challenges in a FFS or unit cost model is establishing
payment rates and service unit definitions. For OAMC and dental services, as discussed above, a
Medicaid or Medicare rate can be used as a benchmark. However, those rates may be
unacceptable (or insufficient) to some or all subgrantees. LA County, which set a single per-visit
rate independent of other payers’ rates, noted that an additional barrier was the reluctance of
some clinics to share “true cost” information that included Part C funding.
Outside the OAMC and dental services context, developing unit costs for other service
categories can be challenging. NYC staff noted that there is no clear consensus on setting rates,
and that it is difficult to match the rates to the real experience of all subgrantees. Additionally,
rate setting is a time consuming and resource intensive process, resulting in rates only being
updated every few years.
Relatedly, several grantees reported that paying a fixed rate for services may result in
over- or under-paying subgrantees. Subgrantees may complain if rates are not updated
frequently. For example, in Ft. Lauderdale/ Broward County, the rate for medical case managers
has not been adjusted, even for inflation, in ten years. However, grantee staff notes that a medical
case manager can still generate enough reimbursed units to exceed payroll and related budget
costs. In LA County, an initial proposed single rate payment level developed based on a detailed
analysis by Mercer (Appendix 3) was rejected by subgrantees as too low.
LA County noted that some subgrantees have been resistant to the idea of performancebased payment methods. County staff noted that ultimately, some subgrantees may leave the
program if they are unable or unwilling to meet performance goals.
In a straight FFS context, St. Louis staff cautioned that it can be relatively difficult to
implement HIV-based quality improvement (QI), compared to a grants-based system, because
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subgrantees do not receive funding for QI. Staff noted that clinics that also get RWHAP Part C
or Part D funds may be able to engage in broader HIV care QI due to an earmarked QI budget.
Subgrantees that do not get Part C or Part D funds may not.
Other grantees sounded a note of caution about the impact of new payment models on the
subgrantee-patient relationship. NYC is also considering the use of performance and quality
measures in 2015. However, staff pointed out the risk of entangling quality measures with
reimbursement in a way that could incentivize subgrantees to cherry-pick patients. In
Washington State, where medical case management is reimbursed on a traditional cost
reimbursement basis (though with required performance reporting), staff felt that a FFS model
could result in agencies trying to meet quotas at the end of each month instead of focusing on
being generally available and responsive to their clients.

Conclusion
Several payment models offer alternatives to traditional cost-based reimbursement in the
RWHAP Program. Depending on its goals, HAHSTA may want to consider assessing the
feasibility of FFS or unit cost reimbursement for one or more service categories in the EMA,
possibly eventually incorporating performance-based elements. As other grantees have done,
HAHSTA might initially develop a payment system for core medical services for which units of
service are easily defined using existing billing code systems, and for which Medicaid or
Medicare payment rates are accepted by subgrantees. Such a strategy might also promote the
transition of some core medical providers to public third-party payment systems as a growing
number of HIV+ DC residents become insured. GW staff would be happy to engage in further
research and discussions about this issue.
15

Grantee Profiles
All information in these profiles is from interviews with grantee staff, unless otherwise
indicated.

Fort Lauderdale/Broward County
Fort Lauderdale/Broward County has a long-standing practice of using FFS and unit cost
reimbursement for all medical and support services. The system is based on the model
established previously by the Miami-Dade County Part A grantee. The Palm Beach County Part
A grantee adopted the same system, resulting in a consistent payment system across South
Florida.
FFS is used by the grantee to pay for medical and dental services. Reimbursement per
procedure is generally based on Medicaid rates, where available for covered procedures. CPT
codes are used to define specific units of service. For all other service categories, reimbursement
is unit cost-based. When no Medicaid rate is available, the agency develops a price structure
based on a cost comparison with other local EMAs, such as Miami-Dade County.
All subgrantee contracts include an annual maximum reimbursement per month. Between
80-85% of subgrantees meet their monthly maximum payment threshold. There are 12
participating subgrantees, with each covering about eight service categories. Administratively,
the reimbursement system employs three contract staff and three fiscal staff. The grantee
conducts reallocations several times per year.
The grantee has considered incorporating an element of performance-based contracting
into the payment system, to “reward good subgrantees.” For example, subgrantees could receive
80-90% of their reimbursement from producing units, with the remainder predicated on meeting
16

certain performance indicators. The grantee is currently considering the feasibility of this
approach, but notes that implementation, if it occurs, would be “years down the road.”
Grantee staff reports that FFS and unit cost reimbursement are a “cleaner process” than
cost-based reimbursement was, with clear expectations and simple accountability. Oversight
responsibilities are slightly easier, although the grantee fiscal staff review all submitted claims
and track expenditures on at least a quarterly basis to ensure they are in line with projected
drawdowns. This process requires detailed claims (including service date, CPT code, name of
provider) to substantiate requests for reimbursement. Staff conduct reviews of randomly selected
clients to ensure that units billed were for services that were in fact performed.
Subgrantees may complain about inadequate reimbursement, and that the medical case
management rates in particular have not been adjusted for inflation in ten years. However, the
grantee staff noted that what a medical case manager can generate in reimbursed units will
exceed the payroll and related costs of individual medical case managers.

Los Angeles County
LA County has instituted a performance-based, FFS reimbursement approach for OAMC
services. Early in the AIDS epidemic, the grantee used a cost-based reimbursement system,
granting funds to a handful of large non-profit AIDS Service Organizations. Over time, several
subgrantees approached the grantee to report that their volume of services was increasing but
their funding was not. The grantee attempted to supplement grants as needed, but the process
was haphazard, giving subgrantees no incentive to increase patient volume. In the meantime,
other subgrantees experienced a shrinking patient population. As a result, per-visit payment to
subgrantees varied wildly, from $50 up to $600. The single rate model was developed in order to
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even the playing field and maintain an incentive for subgrantees to serve more patients if demand
exists.
The grantee conducted a series of rate studies and consulted extensively with outside
parties, including a subgrantee caucus and health economists. They specifically wanted to
determine the cost of providing a unit of service, with the unit defined as an appointment with a
physician, nurse practitioner, or physician assistant. The grantee commissioned a rate study from
Mercer, which conducted a financial review of a subset of subgrantees.
The rate that was initially developed was $167 per visit, fully loaded to reflect the costs
of clinicians, ancillary staff, staff support, administration, and indirect costs. However,
subgrantees felt that the proposed amount would be insufficient. Mercer then conducted further
review of BLS data, as well as other relevant information on rates in the region.
The grantee ultimately selected a range-based rate, from approximately $285 to
approximately $375 (this falls above Medicaid rates but below FQHC rates). The range permits
implementation of performance improvement activities (See Appendix 1 for a detailed
description of LA County’s incentive payment system). The grantee will conduct an annual
representative chart review to determine subgrantee performance for 24 indicators, such as viral
load, CD4, TB screening, cervical cancer screening, and syphilis screening for men who have
sex with men. These indicators were selected from among the HIVQUAL measures that LA
County was already collecting. Subgrantees that meet all core performance benchmarks and
reached all thresholds for compliance for supplemental measures will be eligible for rate
increases and bonus payments. Some particularly important or complex performance measures,
such as suppressed viral load, will be associated with higher bonuses than others.
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The original thinking was that each subgrantee would receive $285 per visit (regardless
of clinician type), plus bonuses. However, the grantee decided instead to pay each subgrantee the
midpoint of the range, or $330.12 per visit, for the first year, in large part due to system changes
and provider readiness issues as a result of preparation for and implementation of the Affordable
Care Act. Staff will review a year’s worth of data and conduct chart review to determine rates for
the second and third years (though staff notes that they may continue with the $330.12 rate for an
additional year).
Approximately 10,000 clients in the EMA receive OAMC services reimbursed under the
FFS model. Many are undocumented or otherwise ineligible for other health insurance coverage.
The grantee reimburses 25 subgrantees that operate a total of 41 patient-centered medical home
model sites.
LA County uses CaseWatch, a client-level data system. It is linked to eligibility
verification records, so subgrantees are only paid if they can show that a client is ineligible for
Medicaid and Medicare and doesn’t have private insurance. The grantee conducts oversight that
includes visits by contract program officers, with a sampling of charts or electronic health
records reviewed each year. Staff notes that client-level data system compliance is not always
optimal.
LA County has experienced several challenges in implementing the new payment system,
including difficulty in establishing a rate that subgrantees perceive to be fair and commensurate
with actual costs. A particular challenge that arises in this context may be subgrantee reluctance
to share true cost data. Some subgrantees were willing to share Part A-related payroll and other
related information, but would not share information on how they use Part C grants to
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supplement their overall operations. LA County staff has discussed this challenge with their
HAB project officer, as well as ways to coordinate the Part A and Part C grants.
The grantee also reported resistance among some subgrantees to the idea of performance
monitoring. Grantee staff note that a critical mass of subgrantees is needed who understand the
importance of the HAB core measures, and that some subgrantees who struggle with compliance
may not remain in the Part A program. The grantee also notes that positive competition can be
created by giving each subgrantee its own data, as well as the average rates of other subgrantees
to allow comparison.
LA County staff suggest that strong performance measures are crucial for the continued
investment of significant levels of federal RWHAP funds. In addition, they note that in a
healthcare context with multiple funding streams, most third-party payers reimburse for services
on a FFS basis. Mixing grant-based payment with FFS payers increases the risk of “double
dipping” and other inappropriate uses of public funds.

Miami-Dade
Miami-Dade County uses a unit cost/FFS payment system for nearly all local RWHAPfunded service categories. The only exception is outreach, which is funded on a cost
reimbursement basis because of challenges in identifying the appropriate “unit of service” and
ensuring appropriate service delivery.
For OAMC services, fees are based on the Medicare rate, with a 1.5 multiplier for
evaluation and management (E and M) medical office visits, and no multiplier for other
program-allowable medical services. In FY 2013, a total of 5,788 uninsured and underinsured
RWHAP clients received a combined total of 71,890 medical visits that were specifically
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reimbursed by the grantee under the Part A and Minority AIDS Initiative funding. Basing
reimbursement on the existing Medicare payment structure facilitated the billing process for the
high number of clients who received Part A/MAI- funded medical care in the EMA.
For other services, unit costs are initially developed based on market research. As
detailed in Appendix 3, unit costs vary significantly among service categories, and generally are
sufficient to cover the percentage of salaries and fringe benefits, and other direct costs and
administrative costs (up to 10% of the service category budget) charged to the Ryan White
Program, as indicated on the corresponding budget and in accordance with time and effort
reporting and fair share allocations.
Subgrantees are selected through a Request for Proposals (RFP) process every few years.
Because the unit costs are non-negotiable, applicants must describe their anticipated units
provided and how they will work within the budget corresponding to the defined units of service
and planned number of clients to be served. There are currently 14 non-profit RWHAP
subgrantees funded, each offering between 1 and 11 service categories; as well as 2 for-profit
subgrantees for data system, planning council staff support, and quality management (QM)
services.
Miami-Dade County uses CaseWatch as its centralized data system to track client
eligibility, client demographic, health assessment, service utilization, and referral information. It
also uses the system for billing service utilization analysis, and federal reporting. The CaseWatch
vendor, ACMS, is based in Los Angeles, but has a local office that houses its program support
staff and training office for Miami-Dade County operations. CaseWatch authorizes subgrantee
staff in different service categories to view only certain data about their client’s records in other
categories (for example, mental health records can be viewed by only certain authorized
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subgrantees). CaseWatch is also used to facilitate a certified referral process, so that
documentation to support client eligibility is maintained on file at the client’s medical care
management site, thereby relieving the client from having to take copies of the same documents
to each provider of service. The grantee reports that CaseWatch comes at a significant cost, but
allows for an efficient tracking of client eligibility and services, processing of claims, and
facilitation of the reporting process.
Miami-Dade County has a well-organized process for the reallocation of funds, which
occurs three to four times during the grant year, to maximize the use of available funds.
Subgrantees report unmet need to the grantee. The local planning council, the Miami-Dade
HIV/AIDS Partnership, then receives information from the grantee regarding the expenditure
rates for each service category and the unmet need by service category. The Partnership then
determines the reallocation of funds. Staff notes that their fiscal administrator is extremely
effective in overseeing this process, tracking reimbursements to the penny on a daily basis, and
determining the schedule/timing for the reallocation processes.
One reported advantage of Miami-Dade County’s unit cost reimbursement model is that
it is a quicker and more expeditious way of disbursing funds to subgrantees than grant-based
budgets. It requires far less paperwork for review by agency staff than would a grants-based
system that requires subgrantees to detail their costs in a line-item budget with backup
documentation submitted and reviewed monthly to support each line item billed to the program.
The model is also administratively simpler for subgrantees. However, grantee staff notes that
they do not conduct annual assessments of each rate, so it is possible that rates do not rise
quickly enough to sufficiently reimburse subgrantees.
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Staff recommend that other grantees considering a unit cost reimbursement model
consider several factors. The high number of clients served in Miami-Dade County makes unit
cost reimbursement much more efficient than cost reimbursement, but they note that the same
may not be true for smaller grantees. They also emphasized the importance of a well-developed
client-level data system in making reimbursement work promptly and effectively.

New York City
With approximately 17,000 PLWH receiving RWHAP services, the NYC EMA began to
implement new reimbursement models for some service categories in 2006 in an effort to better
align reimbursement with actual performance (see the New York City, “Performance-Based
Reimbursement” document in Appendix 4). The New York EMA covers the five boroughs of
NYC and three counties (Tri-County Region) north of NYC. NYC now uses per-client, per-day
payment for care coordination, a medical case management model (21% of NYC’s grant budget);
FFS payment for 41% of the grant budget, deliverables-based payments for 6% of the grant
budget, and hourly payments for 4% of the grant budget. All contracts in the Tri-County Region
(approximately 4.7% of the total grant) are paid exclusively using a traditional cost-based
reimbursement methodology.
Table 3: New York City Service Categories With Alternative Payment Systems (Either FFS,
Deliverables-Based, or Hourly)
 Legal Services (hourly)
 Early Intervention services
 Housing Placement Assistance
 Harm Reduction (Substance Abuse Services- outpatient)
 Medical Case Management
 Mental Health Services (Some Performance-Based and Some Cost-Based)
 Supportive Counseling and Family Stabilization (Psychosocial Support Services)
 Food and Nutrition Services (Food Bank/Home-delivered Meals)
“NYC Ryan White Part A Service Category Scorecards 2010-2012” in HIV Health and Human Services Planning Council of
New York and New York City Department of Health and Mental Hygiene “Needs Assessment for HIV Services: New York
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Eligible Metropolitan Area Ryan White Part A 2014 (available at
http://www.nyhiv.com/pdfs/Needs%20Assessment_Full%20Final.pdf).

For FFS payment rates, NYC initially gave applicants tools to calculate the actual cost of
their services, with the cost proposal counting toward the total bid score. In later RFPs, NYC
staff computed the rates they believe represented the costs necessary to conduct the work –
taking a cue, staff noted, from Miami-Dade County – and published them in the RFPs. For most
FFS categories, rates are based on outputs such as counseling sessions or meals served. Others
are based on short-term outcomes, such as housing placement or linkage to care. Payment rates
were calculated by taking into account expenses (such as salary, fringe, other than personal
services or OTPS, and administration), service time (based on certain assumptions about
productivity), and outcomes (such as linkage to care). Staff applied programmatic knowledge to
account for variance in the time and staffing required (see Appendix 4 for additional
information). Rates are intended to reflect the time required for data entry, chart notes, set-up and
breakdown for group services, and a modest allowance for client no-shows. Grantee staff
benchmark reimbursement rates when possible to ensure reasonableness.
To receive reimbursement, a subgrantee enters client-level data into eSHARE, a data
system created and supported by the grantee. Every billable service has an associated
reimbursement rate, and the system incorporates funding requirements. For example, a service
such as group counseling might only be billable if at least three RWHAP clients participate. The
system can also recognize caps on frequency of utilization per client, such as a ten service unit
per month limit on mental health services. eSHARE is linked by a “bridge” system to a contract
management system called MAPS, developed by the Part A administrative agent, Public Health
Solutions. MAPS generates reports for subgrantees and for the grantee which itemize and
summarize reported services. If the system identifies inconsistencies with billing requirements,
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grantee staff can contact subgrantees to make payment decisions and to review any problems
during fiscal monitoring site visits.
Administration of this reimbursement system required a change in staffing structure (note
that part of the administration is contracted to Public Health Solutions, a non-profit corporation).
Contract managers handle fiscal and programmatic responsibilities, including negotiation of
budgets and service targets, and fiscal and administrative monitoring. Prior to the introduction of
FFS reimbursement, Public Health Solutions assigned two staff members to each contract, one
for fiscal oversight and one for program/administrative monitoring. The contract manager
coordinates with Department of Health and Mental Hygiene (DOHMH) staff for programmatic
assistance, and also helps contractors who are struggling to reach their targets.
As noted above, some service categories (including food and nutrition, emergency rental
assistance, home care, and all 10 service categories funded in the Tri-County Region) are still
paid via a traditional cost-based reimbursement model. Medical case management is paid at a
capitated daily rate, based on the intensity of services required. Rate calculations for medical
case management are included in Appendix 5. Daily rates require compliance with program
requirements like minimum face-to-face contacts and outreach activities.
Most of the services reimbursed on a FFS basis are discrete outputs, such as counseling
sessions or lab tests. Others, like linkage to care, are based on a “culminating event.” The grantee
at one point used “milestone payments” when medical case management clients shifted from
needing more intensive to less intensive services. However, because clients shifted back and
forth between need levels (as opposed to proceeding linearly to less intensity), the grantee
stopped using this type of payment. [Please note that Appendix 5 includes information about
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these discontinued “milestone” payments as well as discontinued payments for Outpatient Bridge
Medical Care.]
NYC EMA has slightly over 190 contracts, with 109 different subgrantees. Most
subgrantees are multiply funded across service categories, with the largest numbers of
subgrantees providing HIV testing and medical case management.
The grantee conducts a review of spending several times per year, and imposes contract
takedowns when necessary for subgrantees that are not on track to spend their awards.
“Takedown” funds are returned to the pool to redistribute. An appeals process for the takedown
process is available for subgrantees. The grantee determines eligibility for enhancement funding
(i.e. specific criteria for strong year-to-date spending contract awards, programmatic
compliance). The local Planning Council has given the grantee the flexibility to reprogram
original funding allocations for each service category. Toward the end of the grant year, the
grantee determines which subgrantees have outperformed their targets and are, therefore, eligible
for additional funds. Payment beyond initial targets is not guaranteed to subgrantees and is
contingent on the availability of funds to due to underspending by other subgrantees. However,
the subgrantee staff noted that the possibility of contract enhancement operates as a meaningful
incentive for performance of a high volume of services.
In 2015, the grantee plans to increase the use of performance and quality measures. Staff
stated that they are trying to avoid incentivizing subgrantees to look for clients likely to lead to
“better” outcomes.
One challenge that NYC staff described is adjusting reimbursement rates in response to
real experience of subgrantees. Rates are modified every few years, but there is no clear
consensus on how to set rates, and the grantee tries to acknowledge the full costs of the program.
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For example, there is a modest allowance made for clients who do not keep their appointments.
While some rates have been increased, others have been decreased.

Orange County
The Orange County (California) TGA uses a FFS system for specialty medical care and
with one mental health provider. Rates are negotiated and are generally set at 110% of the
Medicare rate; they do not exceed 130%. In the past, RWHAP specialty medical care was
provided by a single hospital subgrantee and reimbursed on a FFS basis. About eight or nine
years ago, the grantee retained the FFS model, but shifted to a master agreement system in which
subgrantees could apply to provide specialty services. Currently, at least 14 subgrantees have
signed the master service agreement. Dental services are also included under the master
agreement.
Participating Part A clients are generally uninsured. In 2013, 389 RWHAP clients used
specialty medical services, compared to 765 in 2012. Staff attributes the decline to early
implementation of the ACA in California, during which approximately one-half of their RWHAP
patients became eligible for Medi-Cal (the California Medicaid program). Staff notes that the
current patient pool is primarily people without legal residency status. The staff predicts that the
number of clients will remain relatively stable, apart from newly identified HIV infections in
people ineligible for other coverage.
Administrative staff includes one contract administrator (who only spends a portion of
her time on contracts, including annual re-signing of the master agreement with each
subgrantee). The sub grantee also has one specialty coordinator. The staff works with a thirdparty billing administrator to process reimbursement.
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In a recent RFP for services categories other than specialty medical care, the grantee gave
applicants the option of traditional cost-based reimbursement or proposing a FFS payment. For
primary medical care, the grantee was curious about how the proposed rates would compare to
those paid by Medicare. However, almost all subgrantees outside specialty medical care chose to
continue to be paid on a cost-based reimbursement basis.

San Diego
The San Diego EMA uses a pooled services model, with FFS reimbursement for primary
and specialty medical care and for primary and specialty dental care. Subgrantees join the “pool”
by signing a master purchase agreement. This model was originally established by San Diego
County to purchase healthcare for low-income people in general, and RWHAP was added later.
Any willing and qualified subgrantee can sign the agreement and bill the grantee for treating
RWHAP clients.
Most of the medical subgrantees are FQHCs, and they are reimbursed for OAMC at the
FQHC Medicaid rate. The University of California San Diego also serves as a subgrantee,
receiving reimbursement at a rate negotiated earlier with the County for its general low-income
health program. Medical specialty services are carved out and negotiated, because it can be
difficult to find subgrantees to provide these services. Dental fees are based on 130% of rates in
an earlier Medicaid program, but the grantee is planning to switch to current Denti-Cal rates. The
grantee uses a “not to exceed” clause to limit monthly billing per subgrantee.
Approximately 1,600 RWHAP clients are receiving OAMC, down from 2,400 before the
State’s Medi-Cal expansion took effect. Approximately 2,200 patients receive dental services,
with some overlap in these service populations.
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Mental health services are still paid on a cost reimbursement basis. However, the grantee
is considering shifting to FFS to allow better integration with other healthcare services.
Reimbursing mental health on a FFS basis would allow subgrantees to develop a team that
includes OAMC, mental health, and medical case management subgrantees, and to bill for all
services provided.
County staff notes that the FFS system for medical and dental care offers more flexibility
than a cost-based reimbursement model. For example, in a traditional grants model, a staff
member’s departure from a subgrantee organization creates savings in the grantee’s budget. In
the FFS model, a grantee only pays for services provided, and funds can be more easily shifted
where they are needed. In addition, because it receives bills as services are provided, the grantee
is aware of over or under-performance compared to targets in real time, instead of learning about
issues six or seven months into a contract year.
The system is staffed by a principal administrative analyst and a fiscal manager. They
conduct extensive forecasting based on historical data that accounts for seasonal variability, and
can seek approval from the Planning Council when significant changes such as the Medicaid
expansion occur. The grantee holds monthly meetings to review expenditures, and works with
two administrative agents to develop data reports for the grantee.

St. Louis
The St. Louis TGA uses a FFS system for OAMC and dental care. Because the TGA
spans two states, administration is somewhat complicated. At the grantee level, the program is
administered by five people, including one contract person. Funds are contracted through two
benefit/fiscal administrators, one for Missouri and one for Illinois.

29

In Missouri, the agency serving as fiscal administrator finances OAMC through FFS
subcontracts with several private subgrantees and with two clinic subgrantees (Washington
University and Saint Louis University Hope Clinic). In Illinois, the lead agency subcontracts
with one clinic (Washington University) on a FFS basis. Grantee staff reports that the rates are
based on the Medicaid fee schedule. Apart from OAMC and dental services, other categories
such as medical case management, are funded on a traditional “salary plus fringe” basis.
In both states, the directly reimbursed OAMC services are for RWHAP clients who are
uninsured. The number of uninsured clients is decreasing with implementation of the ACA,
particularly in Illinois, where close to 95% of RWHAP clients are now insured. This year, the
grantee plans to serve approximately 236 people with OAMC visits and 420 with labs tests.
Spending projections are based on the prior year’s data. When necessary, staff makes
estimates based on significant changes. For example, subsequent to implementation of the ACA,
the grantee reduced allocations for OAMC by 25%, allowing allocation of additional funds to
serve more dental clients.
Staff states that the FFS system makes it relatively difficult to implement HIV-based QI,
especially with the private subgrantees, who are only paid for specific services. The two
university clinics also receive Part C funding, which allows them to do some HIV-specific
clinical QM.

New York State
Since 1992, NY State has used a FFS system to reimburse subgrantees for OAMC
offered to uninsured and underinsured RWHAP clients. Part B funds are supplemented with Part
A funds to support a reimbursement pool.
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The program currently serves approximately 23,000 clients, who are mostly uninsured.
They are enrolled through a system integrated with the existing ADAP enrollment system. All
enrollees receive a card that effectively functions as an insurance card for use in receiving
services from enrolled primary care providers (subgrantees). In turn, the providers bill the State
for reimbursement. Rates are based on Medicaid fee schedules.
For enrollees who are insured, the grantee determines whether the insurance is adequate
and cost effective, and if the cost of the premium is a barrier to care. If the plan is adequate and
cost effective but the premium is a barrier to care, the grantee pays the premium. Staff also
determine if cost sharing would exceed 2% of the enrollee’s gross income by analyzing cost
sharing within the plan, assuming an average cost of care (including medications). If cost
sharing would exceed that threshold, the client is enrolled in the state’s program as underinsured.
For covered primary care services, the grantee uses a “pay and chase” model in which it
directly reimburses primary care providers (subgrantees) for services, and then bills the client’s
insurer for reimbursement. This approach results in clients having no out-of-pocket costs for
covered services.
Approximately 300 hospitals and clinics, 200 private clinicians and over 50 stand-alone
laboratories participate as subgrantees. Staff report that subgrantees like the system because they
are adequately reimbursed, it is administratively simple, and it assures reimbursement for
services provided to uninsured individuals, helping to support the HIV service delivery
infrastructure. Staff operate the HIV Uninsured Care Programs as part of the system for
providing quality HIV care for uninsured and underinsured individuals living with HIV in New
York State. For Primary care claims, the program uses a third-party administrator (Emdeon) to
process most claims.
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Washington State
Washington State reimburses OAMC and dental services on a FFS basis, both for
uninsured and underinsured clients, and for insured clients who have yet to meet their
deductibles. Their payment rate is set at 125% of the Medicaid rate for each CPT code, and at
133% of the Medicaid rate for dental services.
Washington State uses an FTE reimbursement model for medical case management
services, but incorporates “performance-based payment” elements with extensive reporting and
monitoring required. The grantee contracts with 14 agencies, all of which provide medical case
management services. Some subgrantees provide additional services from four service
categories, including food and transportation. Subgrantees are required to submit invoices with
their FTEs allocated to provision of funded services, and must report quarterly on quality
measures related to a statewide set of performance requirements for the service category. The
grantee conducts monthly desk audits, as well as a quarterly review of clients served, and
quarterly review of the QM and QI reporting. Subgrantees cannot receive reimbursement if they
do not submit all required reports.
Five staff administer the program, including one field monitor, one contract coordinator,
and one data person. Grantee staff conduct annual QM site visits at which they review 50% of
charts for RWHAP patients who are not on Medicaid and 100% of charts for Medicaid patients.
If a subgrantee has fewer than 50 RWHAP clients, the grantee reviews all RWHAP client charts,
regardless of insurance status. Staff report that these site visits are staff intensive and time
consuming but very important to the program.
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At the end of each grant year, the grantee compiles data from each subgrantee and
calculates a cost per service unit and cost per client. This information allows the grantee to
compare agencies’ services and performance, and to identify any problematic discrepancies. The
grantee also provides each subgrantee with its own performance reports and with an average of
other subgrantees’ performance rates to allow de-identified comparisons and incentives for
improvement. The grantee also sets aside some funding each year for situations such as
unexpectedly high transportation costs in rural counties.
Grantee staff notes that in using FTE rather than a FFS approach, they are really paying
for the medical case managers to be available to their RWHAP clients. One staff person
previously worked in a state that used FFS for case managers (Iowa). She found that it created an
incentive for medical case managers to make a lot of calls at the end of the month to meet their
targets. Washington State staff believes that the FTE model for medical case management allows
a more collaborative approach with the subgrantees, who they report are more patient-centered
than they might be under a FFS model.
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LA County: Fee-for-Service and Additional Reimbursement Incentives Guidelines
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ATTACHMENT 5
FEE-FOR-SERVICE AND ADDITIONAL REIMBURSEMENT INCENTIVES GUIDELINES
Payment for services provided shall be subject to the Fee-For-Service Reimbursement and
Additional Reimbursement Incentives provisions described below.
HIV/AIDS Medical Outpatient Services Fee-For-Service (FFS) Reimbursement
The fee-for-service reimbursement guidelines support quality of care and efficiency of services
performed. To achieve this, payments are structured around providers meeting pre-established
benchmarks for a combination of process and outcome measures. Reimbursement ranges from
the base rate of $284.86 per patient visit up to a maximum rate of $375.22 for providers who
meet or exceed the established benchmarks.
To assist providers in meeting performance targets and resource demands, the reimbursement
rate for FFS Year 1 and Year 2 only is set at the rate of $330.12 per patient per visit. This rate
is mid-way between the base reimbursement rate of $284.86 and the maximum rate of $375.22.
In Year 3, providers will receive a base payment rate of $284.86 but may be eligible for a
payment rate as high as $375.22 based on their performance during Year 2.
This base rate will be paid with the expectation that the provider meets established benchmarks
with a core set of eleven (11) clinical and performance measures, listed in Table 1.
Table 1. Core Measures
Measure
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10
1.11

Benchmark

ART for pregnant women
ART for CD4 <500
PCP prophylaxis
Adherence assessment and counseling
Cervical cancer screen
Hepatitis C screen
HIV risk counseling
Syphilis screen
Tuberculosis screen
Patient satisfaction survey response
Data validation (Casewatch)

100%
95%
95%
95%
90%
90%
95%
90%
75%
100%
75%

Providers will qualify for additional reimbursement incentives only if performance on each of the
eleven (11) core measures meets or exceeds the established benchmark during the
measurement year. Providers, who meet the established benchmarks on all eleven (11) core
measures, will be eligible to obtain additional reimbursement for a total of nine (9) Part A
supplemental measures, listed in Table 2A and two (2) Part B supplemental measures listed in
Table 2B.
Table 2A. Part A Supplemental Measures

2.1
2.2

Measure

Service
Score

Reimbursement per Measure
($3.03 x service score)

Benchmark

Chlamydia screen
Gonorrhea screen

1
1

$3.03
$3.03

90%
90%
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Measure
2.3
2.4
2.5
2.6
2.7
2.8
2.9

Service
Score

Reimbursement per Measure
($3.03 x service score)

Benchmark

1
1
2
3
3
3
3

$3.03
$3.03
$6.06
$9.09
$9.09
$9.09
$9.09

85%
75%
90%
90%
90%
90%
90%

Pneumococcal vaccination
Influenza vaccination
Hepatitis B screen
Substance abuse assessment
Mental health assessment
Hepatitis B vaccination
Tobacco cessation counseling

Part A supplemental measures include a total of nine (9) measures. Each of the nine (9) Part A
supplemental measures has been assigned a service score that reflects the level of complexity
and time required to complete the measure. Service scores for each of the supplemental
measures are given a rating from one (1) to three (3). A rating of one (1) indicates a measure
requiring minimal effort and resources to complete or a low complexity measure. A rating of two
(2) indicates a measure requiring moderate effort and resources to complete or a moderate
complexity measure. A rating of three (3) indicates a measure requiring significant effort and
resources to complete or a significant complexity measure.
The provider’s rate of Part A supplemental reimbursement per patient is based on the number of
Part A supplemental measures that meets or exceeds the established benchmark for the clinic
population. To calculate this rate, the service score for each Part A performance measure is
multiplied by $3.03, and then added to the base rate of $284.86. Providers will be paid at an
increased rate per patient visit for each additional Part A supplemental measure for which
performance meets or exceeds the established benchmark.
Table 2B. Part B Supplemental Measures
2.10
2.11

Measure
Medical visits
Viral load suppression <200 copies/mL
when on ART

Reimbursement
$18.00

Benchmark
90%

$18.00

80%

Part B supplemental measures include a total of two (2) outcome measures reimbursed at
$18.00 each when the established benchmarks are met. Providers will qualify for additional
Part B supplemental reimbursement only if performance on each of the eleven (11) core
measures meets or exceeds the established benchmark during the measurement year.
The provider’s total amount of Part A and B supplemental reimbursement per patient visit is
based on the number of Part A and B supplemental measures that meet or exceed the
established benchmark. This amount is added to the base rate of $284.86. If all eleven (11)
supplemental performance measure benchmarks are met, reimbursement will be at the
maximum rate of $375.40 per patient visit.

Performance Review and Rate Determination
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Provider performance during the preceding calendar year will be reviewed to determine
payment rate. The first performance review, which will occur between February and June 2014,
will examine calendar year 2013 data. Performance on the review will determine performancebased rates for Year 3. Going forward, rates will be determined based on annual performance
review for the preceding calendar year and be effective on July 1st (Figure 1).
Figure 1.Performance Monitoring and Payment Determination Timeline
Calendar Year

2012
2013
2014
2015
Nov-Dec Jan-Feb Mar-Apr May-Jun Jul-Aug Sept-Oct Nov-Dec Jan-Feb Mar-Apr May-JuneJul-Aug Sept-Oct Nov-Dec Jan-Feb Mar-Apr May-JunJuly-Aug Sept-..
Contract Year
Year 1
Year 2
Year 3
Year 4
Monitoring Time
CY 2013 Review
CY 2014 Review
Payment Rate
$330.12
Varies based on Performance in CY 2013
Varies- CY 2014

Sampling for Performance Measures
Patients with two (2) or more visits in the measurement year will be eligible for inclusion in the
sampling for for all performance measures except for the following: patient satisfaction survey
response, medical visits and viral load suppression. The two (2)-visit minimum is used to
ensure that providers have the opportunity to perform the necessary screens, vaccination and
counseling that would be difficult or impossible to complete for patients with only a single visit.
Healthy Way LA and Ryan White Program patients will be used in the sample.
A standardized sampling methodology developed by the National HIVQUAL Project will be used
to determine the number of patient records to be sampled at the Division of HIV and STD
Programs (DHSP) on site reviews. It is expected that all providers enter patient level data on
performance measures into DHSP’s data system as described below.
Patient Satisfaction Survey (Core)
Patient satisfaction surveys are an essential tool to shaping patient centered care. Surveys
allow for the quick identification of problems that patients experience and create a space for
dialogue with patients, letting them know that their feedback is critical to providing effective and
efficient care. The purpose of this measure is to determine whether the agency has
implemented a process to routinely administer patient satisfaction surveys to its clinic
population. This measure also determines the response rate of patients who received a patient
satisfaction survey during the measurement year, which is important in considering the
generalizability of the findings.
Table 4 below can be used to identify the number of completed surveys needed for various
clinic sizes. The clinic size is determined by the number of providers (MD, DO, PA, or NP) who
are seeing patients in the clinic regardless of the provider’s FTE or the number of patients they
see. The designated number of completed patient surveys determined in Table 4, must be
obtained for every provider who practices in the clinic.

Table 4. Sampling by Clinic
Number of Providers in the Clinic
<5
5-9
=/> 10
Number of Completed
Surveys Per Provider Per
Year
Updated: 11/08/2012
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15

10
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For example: a clinic with 8 providers would need to obtain a minimum of 10 completed patient
surveys for each of the 8 providers per measurement year. If the clinic has fewer than 5
providers, a minimum of 15 returned/completed surveys per provider are needed for every
provider in the clinic.
The eligible population for survey includes all clinic patients with at least 1 medical visit during
the measurement year and is not limited to Ryan White Program patients. Providers with a
smaller patient population should administer enough surveys during the measurement year to
obtain no less than the required number of completed surveys per provider indicated in the
above table.
Data Validation (Core)
The purpose of this measure is to determine the percentage of medical records reviewed during
the measurement period that demonstrate consistency between DHSP’s data system and the
client’s medical record (chart or electronic) with regard to the following twelve (12) data
elements.
1. Age
2. Ethnicity
3. Gender
4. ART for pregnant women
5. ART for CD4<500
6. PCP prophylaxis
7. Adherence assessment and counseling
8. Cervical cancer screenin
9. Hepatitis C screen
10. HIV risk counseling
11. Syphilis screen
12. Tuberculosis screen
Providers will ensure that the above data elements are entered into DHSP’s data system either
manually or through an electronic data interface. Data validation will be performed through a
medical records review of these elements and comparing that documentation to data in DHSP’s
data system. The eligible population for survey includes Ryan White Program patients with at
least two (2) medical visits during the measurement year. The threshold for compliance is set at
seventy-five percent (75%) which means that at least seventy-five percent (75%) of medical
records reviewed will have all twelve (12) data elements reflected in each patient’s medical
record and in DHSP’s data system.
Utilization of Medical Visits and Reimbursement of Additional Visits
Providers will furnish medical visits to the minimum number of clients to be served as stipulated
in this contract. To ensure the appropriate utilization of medical visits, a maximum of ten (10)
visits per patient per year is established. The ten (10)-visit per patient per year threshold only
applies to Ryan White Program patients.
Each clinic will routinely track the number of medical visits per patient per year, as well as the
clinic’s overall total number of visits for the entire clinic patient population based on the total
number of patients to be served.
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Tracking medical visit utilization is essential in providing patients with access to needed clinical
and medical care and follow-up while ensuring that providers adhere to their established
budgeted allocations. Given that there are conditions and special circumstances where some
patients may need more medical visits than the established ten (10)-visit per year threshold;
providers will follow the DHSP review and approval process outlined in the protocol below in
order to ensure reimbursement for those additional visits.
The DHSP review process will be retrospective to ensure that patient care is not compromised.
The provider will not be able to bill any more visits over the ten (10)-visit threshold without
DHSP’s approval. Within this process, providers will have the option to request up to three (3)
additional visits for patients that have reached the ten (10)-visit threshold, by providing
appropriate justification following the protocol outlined below.
There are two scenarios for patients exceeding their ten (10)-visit per year threshold. Each
scenario requires action as follows:
Scenario 1
A patient exceeds the ten (10)-visit per year threshold but overall total number of visits for the
clinic’s Ryan White Program patients remains under the maximum allowed total visits per the
approved budget.
Provider will request for a retrospective (or prospective, if preferred) review of the visit(s) in
question and approval for those visits and future additional visits up to three (3) visits. DHSP
will review each patient’s case and render its decision to approve visits incurred over the ten
(10)-visit threshold and may authorize up to three (3) additional future visits or disapprove the
visit(s) in question. Visits over the ten (10)-visit threshold that are not approved by DHSP
pursuant to its review, will not be reimbursed.
Scenario 2
A patient exceeds the ten (10)-visit per year threshold and the clinic exceeds overall total
number of Ryan White Program patient visits allowed per the approved budget.
In this scenario, provider will request for a retrospective review of the additional visit(s) in
question and approval for those visits and future additional visits up to three (3) visits. In this
scenario, the provider will not be able to bill any additional visits for these patients, without
DHSP’s approval. DHSP will review each patient’s case and render its decision to approve the
visits in question and may authorize up to three (3) additional future visits or disapprove the
additional visit(s) in question. Additional visits over the ten (10)-visit threshold that are not
approved by DHSP will not be reimbursed.
Protocol for DHSP Case Review, Decision and Appeals Process for Medical Visits
Exceeding the ten (10)-Visit Per Year Threshold
Providers should routinely track the number of medical visits per patient per year, as well as the
clinic’s overall total number of visits for the entire clinic patient population based on the total
number of patients to be served. When a patient exceeds the 10-visit threshold per patient per
year, the following steps will be followed:
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1. Provider completes the Ryan White Program Medical Outpatient Utilization Initial
Request Form (URF01) and submits this form to DHSP for approval. Provider
documents the medical justification for the visit(s) in question and requests any
additional future visit up to three (3) visits. Request is submitted to DHSP via:
a. Mail:

DHSP
Attention: DHSP Office of the Medical Director
600 S. Commonwealth Avenue, 10th Floor
Los Angeles, CA 9005

b. Secure Fax: (213) 252-4506
c. Email: dhsp-urqm@ph.lacounty.gov
2. DHSP will review the request/justification to determine if the documentation provided
supports the level of service requested requiring the additional medical visit(s). DHSP’s
decision will be based on a review of information provided on the request form and when
necessary, consultation with the provider and/or a site visit to review the patient’s
medical records.
3. DHSP will render a decision to approve or disapprove the request.
a. Approved Requests. DHSP has determined that documentation received
contains the required justifications for the level of service requested. DHSP
will approve the visit(s) in question. Up to three (3) additional future visits will
also be approved per request and will be reimbursed under the specific
provisions outlined in case scenarios one (1) and two (2) above.
Disapproved Requests. DHSP has determined that documentation received
is insufficient to approve the past visit(s) in question and the additional visit(s)
requested. DHSP will return the initial request form and document the
specific reason(s) for denying the initial request.
4. The provider accepts DHSP’s decision or files an appeal in response to DHSP’s denial
of the initial request by completing form URF01. Provider sends the appeal to DHSP by
mail, secure fax, or email as indicated above.
5. DHSP will review the appeal. If the appeal is denied, DHSP will send a final denial letter
to the provider that will include the specific reasons for the denial.
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.1: Antiretroviral therapy (ART) for pregnant women
Description: Percentage of HIV-infected pregnant women who are prescribed ART in the
measurement year.
Number of HIV-infected pregnant women who were prescribed ART during
Numerator:
the second and third trimester in the measurement year.
Number of HIV-infected pregnant women who had a medical visit with a
Denominator:
provider with prescribing privileges,1 at least twice in the measurement year.
1. Patients2 whose pregnancy is terminated by spontaneous or induced
abortion.
2. Pregnant patients who are in the first trimester and newly enrolled in
Patient
care during last three months of the measurement year.
Exclusions:
3. Patients with documented referral to another perinatal HIV care
program.
4. Patients with documented refusal of ART offered by provider.
1. Is the patient HIV-infected? (Y/N)
a. If yes, is the patient female? (Y/N)
i. If yes, was she pregnant during the reporting period? (Y/N)
Data Element:
1. If yes, was she on ART during this reporting period?
(Y/N)
• Ryan White Program Data Report, Section 5, Item 53 may provide
data useful in establishing a baseline for this performance measure
•
Electronic Medical Record/Electronic Health Record
Data Sources:
• CAREWare, Lab Tracker, or other electronic data base
• Medical record data abstraction by grantee of a sample of records
National Goals,
Targets, or
No national benchmarks available at this time.
Benchmarks
DHSP Benchmark = 100%
for
Comparison:
o Rate of perinatal transmission in the measurement year
Outcome
o Number of events of perinatal transmission in the measurement year
Measures for
Consideration:
Basis for Selection:
Treatment recommendations for pregnant women infected with HIV-1 have been based on the
belief that therapies of known benefit to women should not be withheld during pregnancy unless
there are known adverse effects on the mother, fetus, or infant and unless these adverse effects
outweigh the benefit to the woman. ART can reduce perinatal HIV-1 transmission by nearly
70%.3
Measure reflects important aspect of care that significantly impacts survival, mortality, and
hinders transmission. Data collection is currently feasible and measure has a strong evidence
Updated: 11/08/2012
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base supporting the use.
U.S. Public Health Service Guidelines:
Health care providers considering the use of antiretroviral agents for HIV-1 infected women
during pregnancy must take into account two separate but related issues:
• Antiretroviral treatment of maternal HIV-1 infection, and
• Antiretroviral chemoprophylaxis to reduce the risk for perinatal HIV-1 transmission
The benefits of ART for a pregnant woman must be weighed against the risk of adverse events to
the woman, fetus, and newborn. Although ZDV chemoprophylaxis alone has substantially
reduced the risk for perinatal transmission, antiretroviral monotherapy is now considered
suboptimal for treatment of HIV-1 infection, and combination drug regimens are considered the
standard of care for therapy. Initial evaluation of an infected pregnant woman should include an
assessment of HIV-1 disease status and recommendations regarding antiretroviral treatment or
alteration of her current antiretroviral regimen.3
References/Notes:
1
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
2
“Patients” include all patients aged 13 years or older.
3
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for
Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States.
September 14, 2011. www.aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf.
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.2: ART for CD4 <500
Description: Percentage of patients1 with HIV infection and CD4 T-cell counts <500 cells/mm3
who are prescribed ART in the measurement year.
Number of HIV-infected patients with CD4 T-cell counts <500 cells/mm3or
an AIDS-defining condition who were prescribed an ART regimen2 within the
Numerator:
measurement year.
Number of HIV-infected patients who have:
• A CD4 T-cell count < 500 cells/mm3 or an AIDS-defining condition,2
and
Denominator:
• At least two medical visits with a provider with prescribing
privileges,3 in the measurement year
1. Patients newly enrolled in care during last three months of the
Patient
measurement year.
Exclusions:
2. Patients with documented refusal to take ART in medical record.
1. Is the patient HIV-infected (Y/N)
a. If yes, is the patient diagnosed with CDC-defined AIDS? (Y/N)
i. If yes, was the patient prescribed ART during the reporting
period? (Y/N)
Data Element:
ii. If no, does the patient have two or more CD4 counts <500
cells/mm3? (Y/N)
a. If yes, was the patient prescribed ART during the
reporting period? (Y/N)
• Ryan White Program Data Report, Section 2, Items 26 and 31 may
provide data useful in establishing a baseline for this performance
measure
• Electronic Medical Record/Electronic Health Record
Data Sources:
• CAREWare, Lab Tracker, or other electronic data base
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 95%
CDC and HIVRN data consistent that 80% of those in care “eligible for
4,5,6
National Goals, ART’s”
National HIVQUAL-US Data:6,7
Targets, or
2003
2004
2005
2006
Benchmarks
Top 10% 100% 100%
100% 100%
for
Comparison
Top 25% 100% 100%
100% 100%
Median* 100% 88.9% 95.7% 100%
*from HAB data base
o Rate of opportunistic infections in the measurement year
Outcome
o Rate of HIV-related hospitalizations in the measurement year
Measures for
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Consideration:

o Mortality rates

Basis for Selection:
Randomized clinical trials provide strong evidence of improved survival and reduced disease
progression by treating patients with AIDS-defining conditions and patients with CD4 T-cells
between350 and 500 cells/mm3.2
Measure reflects important aspect of care that significantly impacts survival, mortality, and
transmission. Data collection is currently feasible and measure has a strong evidence base
supporting the use.
U.S. Public Health Service Guidelines:
“Antiretroviral therapy should be initiated in patients with a history of an AIDS-defining illness
or with a CD4 T-cell count between350 and 500 cells/mm3.”2
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
“Randomized controlled trials provide evidence supporting the benefit of ART in patients with
CD4 counts <350cells/mm3. However, such evidence showing benefit for patients with higher
CD4 cell counts is not yet available. Based on cumulative observational cohort data
demonstrating benefits of ART in reducing AIDS- and non-AIDS associated morbidity and
mortality, the Panel now recommends ART for patients with CD4 count between 350 and 500
cells/mm3. For patients with CD4 count >500 cells/mm3, panel members are evenly divided:
50% favor starting ART at earlier stages of HIV disease; 50% view initiating therapy at this
stage as optional. Panel members favoring earlier initiation of therapy base their
recommendation on several recent developments: (1) report from at least one recent cohort study
demonstrating survival benefit with initiation of ART at CD4 count >500 cells/mm3; (2)
growing awareness that untreated HIV infection may be associated with development of many
non-AIDS-defining diseases, including cardiovascular disease, kidney disease, liver disease, and
malignancy; (3) availability of ARV regimens that are more effective, more convenient, and
better tolerated than ARV combinations no longer in use; and (4) increasing evidence that
effective ART reduces HIV transmission. The other 50% of the Panel members feel that current
evidence does not definitively demonstrate clear benefit of ART in all patients with CD4 count
>500 cells/mm3. They also feel that risks of short- or long-term drug-related complications, nonadherence to lifelong therapy in asymptomatic patients, and potential for development of drug
resistance may offset possible benefits of earlier initiation of therapy. Thus, pending more
definitive supporting evidence, these Panel members recommend that therapy in this setting
should be optional and considered on a case-by case basis.Panel on Antiretroviral Guidelines for
Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected
Adults and Adolescents. Department of Health and Human Services. October 14, 2011;.
Available at aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
Gebo, JAIDS January 2005, vol. 38, pp. 96-103.
5
Teshale Abstract #167, CROI 2005.
6
The National HIVQUAL data may not be directly comparable due to varying exclusions.
Indicator definitions can be accessed at http://www.hivguidelines.org/Content.aspx?PageID=53.
7
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.3: Pneumocystis pneumonia (PCP) prophylaxis
Description: Percentage of patients1 with HIV infection and a CD4 T-cell count < 200
cells/mm3 who were prescribed PCP prophylaxis in the measurement year.
Number of HIV-infected patients with CD4 T-cell count < 200 cells/mm3 who
Numerator:
were prescribed PCP prophylaxis2,3 in the measurement year.
Number of HIV-infected patients who:
• had a medical visit with a provider with prescribing privileges,4 at
Denominator:
least twice in the measurement year, and
• had a CD4 T-cell count < 200 cells/mm3
1. Patients with subsequent CD4 T-cell count < 200 cells/mm3 repeated
within three months which rose above 200 cells/mm3
2. Patients newly enrolled in care during last three months of the
Patient
measurement year.
Exclusions:
3. Patients with documented refusal to take PCP prophylaxis in medical
record.
1. Is the patient HIV-infected? (Y/N)
a. If yes, was the CD4 T-cell count <200 cells/mm3? (Y/N)
i. If yes, was PCP prophylaxis prescribed? (Y/N)
1. If no, was the CD4 count repeated within three months?
Data Element:
(Y/N)
A. If yes, did it remain < 200 cells/mm3? (Y/N)
I.
If yes, was PCP prophylaxis prescribed? (Y/N)
• Electronic Medical Record/Electronic Health Record
• HIVQUAL reports on this measure for grantee under review
Data Sources:
• CAREWare, Lab Tracker, or other electronic data base
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 95%
IHI Goal: 95%5
National Goals, National HIVQUAL-US Data: 6
Targets, or
2003
2004
2005
2006
Benchmarks
Top 10% 100% 100%
100% 100%
for
Top 25% 100% 100%
100% 100%
Comparison:
Median* 93.3% 90.9% 92.3% 94.4%
*from HAB data base
o Rate of PCP in the measurement year
Outcome
o Mortality rates
Measures for
o Cost effectiveness
Consideration:
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Basis for Selection:
PCP is the most common opportunistic infection in people with HIV. Without treatment, over
85% of people with HIV would eventually develop PCP. It is a major cause of mortality among
persons with HIV-infection, yet is almost entirely preventable and treatable. Pneumocystis
almost always affects the lungs, causing a form of pneumonia. People with CD4 T-cell counts <
200 cells/mm3are at greatest risk of developing PCP.2
Before the widespread use of primary PCP prophylaxis and effective ART, PCP occurred in
70%-80% of patients with AIDS.7 The course of treated PCP was associated with a mortality
rate of between 20% and 40% in persons with profound immunosuppression. Approximately
90% of cases occurred among patients with CD4 T-cell counts <200 cells/mm3.8,9 Measure
reflects important aspect of care that significantly impacts survival and mortality. Data collection
is currently feasible and measure has a strong evidence base supporting the use.
U.S. Public Health Service Guidelines:
HIV-infected adults and adolescents, including pregnant women and those on ART, should
receive chemoprophylaxis against PCP if they have a CD4 T-cell count <200 cells/mm3 or a
history of oropharyngeal candidiasis .2
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR. March 24, 2009. Volume 58.
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4.
3
PCP prophylactic recommended in US PHS guidelines: TMP-SMX (preferred regimen at 1 DS
QD, however tolerability may improve with 1 SS QD, 1 DS 3x a week), alternative regimens (in
case of TMP-SMX intolerability) include: 1) dapsone + pyrimethamine + leukovorin; 2)
atovaquone; 3) aerosolized pentamadine; 4) oral pyrimethamine + sulfaxodoxine (if sulfonamide
hypersensitivity).
4
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP..
5
IHI Measure reads, “Percent of Patients with a CD4 Cell Count Below 200 cells/mm3 receiving
Pneumocystis Carinii Pneumonia (PCP) Prophylaxis”
6
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.
7
Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men
infected with human immunodeﬁciency virus type 1. Multicenter AIDS Cohort Study Group. N
Engl J Med 1990;322:161–5.
8
Kaplan JE, Hanson DL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii
pneumonia in human immunodeﬁciency virus- infected adolescents and adults in the United
States: reassessment of indications for chemoprophylaxis. J Infect Dis 1998;178:1126–32.
9
Kaplan JE, Hanson DL, Jones JL, Dworkin MS. Viral load as an independent risk factor for
opportunistic infections in HIV-infected adults and adolescents. AIDS 2001;15:1831–6.
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.4: Adherence assessment and counseling
Description: Percentage of patients1 with HIV infection on ART who were assessed for
adherence (and counseled if suboptimal adherence) two or more times in the measurement year.
Number of HIV-infected patients, as part of their primary care, who were
2,3
Numerator:
assessed for adherence and counseled
two or more times in the
measurement year.
Number of HIV-infected patients on ART who had a medical visit with a
Denominator:
4
provider with prescribing privileges at least twice in the measurement year
1. Patients newly enrolled in care during the last six months of the
Patient
measurement year.
Exclusions:
2. Patients who are not on ART.
1. Is the patient HIV-infected? (Y/N)
a. If yes, was the patient on ART? (Y/N)
i. If yes, did he/she receive adherence counseling at least twice
Data Element:
during the measurement year? (Y/N)
1. If yes, list the dates of these visits
• Electronic Medical Record/Electronic Health Record
• HIVQUAL reports on this measure for grantee under review
Data Sources:
• CAREWare, Lab Tracker, or other electronic data base
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 95%
5
IHI Goal: 90%
National Goals,
6
National HIVQUAL-US Performance Data:
Targets, or
2003
2004
2005
2006
Benchmarks
Top 10% 95.8% 92.0% 97.5% 98.4%
for
Top 25% 82.7% 79.2% 88.3% 91.6%
Comparison:
Median* 57.5% 39.7% 46.8% 55.7%
*from HAB data base
o Percent of undetectable viral loads among patients on ART in the
measurement year
o Percent of patients with ART-resistance developed during therapy in
Outcome
the measurement year
Measures for
o Mortality rates
Consideration:
o Incidence of HIV-related hospitalizations in the clinic population
o Incidence of patients with progression to AIDS in the clinic
population
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Basis for Selection:
Adherence is a key determinant in the degree and duration of virologic suppression. Among
studies reporting on the association between suboptimal adherence and virologic failure, nonadherence among patients on ART was the strongest predictor for failure to achieve viral
suppression below the level of detection. HIV viral suppression, reduced rates of resistance, and
improved survival have been correlated with high rates of adherence to ART.7
Prior to writing the first prescriptions, clinicians need to assess the patient’s readiness to take
medication. Patients need to understand that the first regimen is the best chance for long-term
success. Resources need to be identified to assist in success. Interventions can also assist with
7
identifying adherence education needs and strategies for each patient.”
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on
treatment decisions that affect a sizable population. Although discussions of the importance of
adherence to ART are important to begin prior to initiation of treatment, there is no standard of
care for discussions to occur every six months for patients who may be years away from
antiretroviral treatment.
U.S. Public Health Guidelines:
7
"...adherence counseling and assessment should be done at each clinical encounter"
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Assessment of adherence includes: 1) patient reports of adherence by: a) quantifiable scales,
e.g. missed three out of ten doses; b) qualitative scale, e.g. Likert scale; or 2) quantification such
as pharmacy dispensing records, pill counts, or direct observation therapy.
3
Adherence assessment should be provided by the provider with prescribing privileges.
Adherence counseling should be performed for patients who report suboptimal adherence (less
than 100% no missed doses). Counseling can be provided by any member of the
multidisciplinary primary care team.
4
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP..
5
IHI Measure reads, “Percent of Patients/Patients Assessed for Adherence to Antiretroviral
(ARV) Therapy in the Past 4 Months.”
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientsPatien
tsAssessedforAdherencetoAntiretroviralARVTherapyinthePast4Months.htm.
6
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.
7
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
October 14, 2011. Available at
http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.5: Cervical cancer screening
Description: Percentage of women with HIV infection who have a PAP screen in the
measurement year.
Number of HIV-infected female patients1 who had PAP screen results
Numerator:
documented in the measurement year.
Number of HIV-infected female patients who:
2
• were >18 years old in the measurement year or reported having a
history of sexual activity, and
Denominator:
3
• had a medical visit with a provider with prescribing privileges at
least twice in the measurement year
1. Patients who were < 18 years old and denied history of sexual
activity.
2. Patients who have had a hysterectomy for non-dysplasia/nonmalignant indications.
Patient
3. Patients with documented refusal of PAP screen in medical record.
Exclusions:
4. Patients newly enrolled in care during last three months of the
measurement year.

Data Element:

Data Sources:

1. Is the patient HIV-infected? (Y/N)
a. If yes, is the patient female? (Y/N)
i. If yes, is she > 18 years or reports having a history of sexual
activity? (Y/N)
2. If yes, was the PAP screening completed during the
measurement year?
• Ryan White Program Data Report, Section 5, Items 42 and 52 may
provide data useful in establishing a baseline for this performance
measure
• Electronic Medical Record/Electronic Health Record
• CAREWare, Lab Tracker, or other electronic data base
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records

DHSP Benchmark: 90%
4
IHI Goal: 90%
5
National Goals,
National HIVQUAL-US Data:
Targets, or
Percent of female patients who received a pelvic examination.
Benchmarks
2003
2004
2005
2006
2007
for
Top
10%
100%
100%
100%
100%
100%
Comparison
Top 25% 84.3% 86.7% 87.0% 89.2%
n/a
Median* 70.5% 67.7% 71.8% 73.3% 70.0%
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Bottom 10%
*from HAB data base

45.5%

33.3%

Percent of female patients who received a pelvic examination and Pap test
2007
2009
Top 10%
100%
90.9%
Median
67.1%
62.1%
Bottom 10%
43.5%
31.6%
Outcome
Measures for
Consideration

o Incidence of cervical cancer in HIV-positive women in clinic
population

Basis for Selection:
Human Papillomavirus (HPV) is a common infection in the general population. Current
evidence suggests that over 50% of sexually active adults have been infected with one or more
HPV types. According to population-based prospective studies, HPV precedes the development
6
of cervical cancer.
‘The American College of Obstetricians and Gynecologists (ACOG) identifies additional risk
factors that might justify annual screening, including a history of cervical neoplasia, infection
with HPV or other sexually transmitted diseases (STDs), or high-risk sexual behavior, but data
are limited to determine the benefits of these strategies.7
Cervical cancer may be the most common AIDS-related malignancy in women. Although not a
common diagnosis in women in the general population, according to New York City AIDS
Surveillance data from 1990 to 1995, the observed cervical cancer cases in HIV-positive
,8
women were two to three times higher than the expected number of cases. Findings such as
these resulted in the inclusion of cervical cancer in the Centers for Disease Control and
9
Prevention (CDC) expanded definition of AIDS.
When compared with HIV-negative women, HIV-positive women with invasive cervical cancer
present at more advanced stages and with cancer metastasizing to unusual locations. HIVpositive women have poorer responses to standard therapy and have higher recurrences and
10,11
death rates, as well as shorter intervals to recurrence or death.
The CDC currently recommends that HIV-positive women have a complete gynecologic
evaluation, including a PAP smear, as part of their initial HIV evaluations, or upon entry to
prenatal care, and another PAP smear six months later. If both PAP smears are negative, annual
screening is recommended thereafter in asymptomatic women. The CDC further recommends
more frequent screenings (every six months) for women with symptomatic HIV-infection, prior
12,13
abnormal PAP smears, or signs of HPV infection.
Cervical cancer can often be prevented or detected in its earliest stages through effective
screening with a PAP smear and avoidance of known risk factors. This accentuates the
importance of routine gynecological care, which includes PAP smears for HIV-infected
14
women. Measure reflects important aspect of care that impacts HIV-related morbidity and
focuses on treatment decisions that affect a sizable population. Measure has a strong evidence
base supporting the use.
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U.S. Public Health Guidelines:
“The Pap test should be obtained twice during the ﬁrst year after diagnosis of HIV-infection
and, if the results are normal, annually thereafter (AII). If the results of the Pap test are
abnormal, care should be provided according to the Guidelines for Management of Women with
15
Abnormal Cervical Cancer Screening Tests by ASCCP.”
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Onset of sexual activity is not reliably reported or recorded. The age bracket of 18 years is
selected for performance measurement purposes only and should not be interpreted as a
recommendation about the age at which screening should begin to occur.
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
Goal: Greater than 90 percent of female patients/clients will have a documented Pap test in the
past 12 months.
http://www.ihi.org/knowledge/Pages/Measures/PercentofFemalePatientsClientswithanAnnualPa
panicolaouPapTest.aspx
5

National HIVQUAL data looked at the percent of female patients who have an annual pelvic
exam until 2007, when pelvic exam and Pap examination among female patients was added.
Data was not collect data in 2008. HIVQUAL-US Performance Data Report, Ryan White Part C
and Part D Funded Programs, Review Period: January 1, 2009 – December 31, 2009. Available
at: http://hivqualus.org/index.cfm/8418/10039
6
Davis, AT. Cervical dysplasia in women infected with the human immunodeficiency virus
(HIV): A correlation with HIV viral load and CD4 count. Gynecologic Oncology. 2001;
80(3):350–354.
7
Guide to Clinical Preventive Services, 2010-2011, Recommendations of the U.S. Preventive
Services Task Force, p 47
http://www.ahrq.gov/clinic/pocketgd1011/pocketgd1011.pdf Available at:
http://www.ahrq.gov/clinic/pocketgd.htm
8
Chiasson, MA. Declining AIDS mortality in New York City. New York City Department of
Health. Bull NY Acad. Med. 1997; 74:151–152.
9
Centers for Disease Control and Prevention (CDC). 1993. Revised classification system for
HIV-infection and expanded surveillance case definition for AIDS among adolescents and
adults. MMWR. 1992; 41(RR-17).
http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm.
10

Ibid.
U.S. Department of Health and Human Services. Anderson, JA, editor. Guide to the Clinical
Care of Women with HIV; 2005.
12 National Institutes of Allergy and Infectious Diseases. HIV Infection in Women
http://www.niaid.nih.gov/topics/hivaids/understanding/population%20specific%20information/
pages/womenhiv.aspx. Accessed 3/123/2012 13. Susan Richardson, MN, MPH, FNP-BC.
Health Care of HIV-Infected Women Through the Life Cycle, in Guide for HIV/AIDS Clinical
11

Care. U.S. Department of Health and Human Services, Health Resources and Services Administration
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HIV/AIDS Bureau, January 2011 http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/
14

Kjaer, S. Type specific persistence of high risk human papillomavirus (HPV) as indicator of
high grade cervical squamous intraepithelial lesions in young women: population based
prospective follow-up study, Brit Med J. 2002; 325: 572–578.
15
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of
Opportunistic Infections in HIV-Infected Adults and Adolescents, Recommendations from
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR 2009;58(No. RR-4)
http://aidsinfo.nih.gov/contentfiles/Adult_OI_041009.pdf
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.6: Hepatitis C (HCV) screening
Description: Percentage of patients1 for whom HCV screening was performed at least once
since the diagnosis of HIV-infection.
Number of HIV-infected patients who have HCV status documented in chart
Numerator:
2
since HIV diagnosis or initiation of care with provider
Number of HIV-infected patients who had a medical visit with a provider
Denominator:
3
with prescribing privileges at least twice in the measurement year
1. Patient refusal of test.
Patient
2. Patients newly enrolled in care during the last three months of the
Exclusions:
measurement year.
1. Is the patient HIV-infected? (Y/N)
a. If yes, is there documentation of the patient’s Hepatitis C status
Data Element:
(Hepatitis C Antibody positive or negative) in the medical record?
(Y/N)
• Ryan White Program Data Report, Section 5, Items 42 and 48 may
provide data useful in establishing a baseline for this performance
measure
• Electronic Medical Record/Electronic Health Record
Data Sources:
• CAREWare, Lab Tracker, or other electronic data base
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 90%
4
IHI Goal: 95%
5
National Goals,
National HIVQUAL-US Performance Data:
Targets, or
2003
2004
2005
2006
Benchmarks
Top 10% 100%
100%
100%
100%
for
Top 25% 94.4% 100%
100%
100%
Comparison
Median* 86.2% 88.8% 90.5% 90.9%
*from HAB data base
Outcome
o Hepatitis C- related mortality rates in the clinic population
Measures for
Consideration:
Basis for Selection:
Approximately 15% to 30% of people with HIV are estimated to be co-infected with hepatitis C
virus (HCV) in the United States, and up to 90% of those with HIV secondary to injection drug
use are co-infected. Chronic liver disease from co-infection, including cirrhosis and
hepatocellular carcinoma, leads to significant morbidity and mortality6 and HCV treatment may
7
exacerbate the side effects of some antiretroviral medications.
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on
Updated: 11/08/2012
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treatment decisions that affect a sizable population. Measure has a strong evidence base
supporting the use.
U.S. Public Health Guidelines:
8
“HIV-infected patients should be tested routinely for evidence of chronic HCV infection”
(3/29/09)
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Unless there is concern about ongoing exposure (e.g., via active injection drug use or sexual
exposure), guidelines do not consistently recommend annual re-screening.
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
IHI Measure reads, “Percent of Patients/Patients with Known Hepatitis C Status”
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientsPatien
tswithKnownHepatitisCStatus.htm.
5
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.
6
Medscape: HIV and Hepatitis C Co-infection: Guideline and Commentary, Douglas G. Fish,
MD http://www.medscape.com/viewarticle/734975
7
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human
Services. October 14, 2011; 1–167. Available at http://www.aidsinfo.nih.gov/ContentFiles/
AdultandAdolescentGL.pdf.
8
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR. March 24, 2009. Volume 58.
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4.
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.7: HIV risk counseling
2
Description: Percentage of patients1 with HIV infection who received HIV risk counseling
within the measurement year.
Number of HIV-infected patients, as part of their primary care, who received
Numerator:
HIV risk counseling within the measurement year.
Number of HIV-infected patients who had a medical visit with a provider
Denominator:
3
with prescribing privileges at least twice in the measurement year
1. Patients newly enrolled in care during last three months of the
Patient
measurement year.
Exclusions:
Data Element:

Data Sources:

1. Is the patient HIV-infected? (Y/N)
a. If yes, did the patient receive HIV risk counseling at least once
during the measurement year?(Y/N)
• Electronic Medical Record/Electronic Health Record
• CAREWare, Lab Tracker, or other electronic data base
• Medical record data abstraction by grantee of a sample of records

National Goals,
Targets, or
DHSP Benchmark: 95%
Benchmarks
None available at this time
for
Comparison:
o Incidence of new HIV-infection
Outcome
o Incidence of STD cases in clinic population
Measures for
o Rates of substance abuse counseling and referrals
Consideration:
Basis for Selection:
Reducing transmission of HIV in the United States requires new strategies, including emphasis
on prevention of transmission by HIV-infected persons. Through ongoing attention to
prevention, risky sexual and needle sharing behaviors among persons with HIV-infection can be
reduced, and transmission of HIV-infection prevented. Medical care providers can substantially
affect HIV transmission by screening their HIV-infected patients for risk behaviors;
communicating prevention messages; discussing sexual and drug-use behavior; positively
reinforcing changes to safer behavior; referring patients for services such as substance abuse
treatment; facilitating partner notification, counseling, and testing; and identifying and treating
other sexually transmitted diseases.4
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on
treatment decisions that affect a sizable population. Measure has a strong evidence base
supporting its use.
U.S. Public Health Guidelines:
"HIV-infected patients should be screened for behaviors associated with HIV transmission by
using a straightforward, nonjudgmental approach. This should be done at the initial visit and
Updated: 11/08/2012
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subsequent routine visits or periodically, as the clinician feels necessary, but at a minimum of
yearly. Any indication of risky behavior should prompt a more thorough assessment of HIV
transmission risks."4,5
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
HIV risk counseling includes assessment of risk, counseling, and as necessary, referrals.
Counseling occurs in the context of comprehensive medical care and can be provided by any
member of the multidisciplinary primary care team.
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical
care of persons living with HIV: recommendations of CDC, the Health Resources and Services
Administration, the National Institutes of Health, and the HIV Medicine Association of the
Infectious Diseases Society of America. MMWR 2003;52 (No. RR-12).
http://www.cdc.gov/mmwr/PDF/rr/rr5212.pdf or
http://aidsinfo.nih.gov/ContentFiles/HIVPreventionInMedCare_TB.pdf.
5
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
October 14, 2011 http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.8: Syphilis screening
Description: Percentage of adult patients1 with HIV infection who had a test for syphilis
performed within the measurement year.
Number of HIV-infected patients who had a serologic test for syphilis
Numerator:
performed at least once during the measurement year.
Number of HIV-infected patients who:
2
• were >18 years old in the measurement year or had a history of sexual
activity and were < 18 years old, and
Denominator:
•

Patient
Exclusions:

3

had a medical visit with a provider with prescribing privileges at least
twice in the measurement year
1. Patient refusal of test, documented in the medical record.
2. Patients who are < 18 years of age4 and deny a history of sexual
activity.
3. Patients newly enrolled in care during last three months of the
measurement year.

1. Is the patient HIV-infected? (Y/N)
a. If yes, is the patient > 18 years old or reports having a history of
sexual activity? (Y/N)
Data Element:
i. If yes, was the patient screened for syphilis with
Nontreponemal test (RPR, VDRL) during the measurement
year?
• Ryan White Program Data Report, Section 5, Items 42 and 48 may
provide data useful in establishing a baseline for this performance
measure
• Electronic Medical Record/Electronic Health Record
Data Sources:
• CAREWare, Lab Tracker, or other electronic data base
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 90%
4
IHI Goal: 90%
5
National Goals,
National HIVQUAL-US Data:
Targets, or
2003
2004
2005
2006
Benchmarks
Top 10% 99.0% 100%
100%
100%
for
Top
25%
90.4%
92.2%
95.7%
95.6%
Comparison
Median* 73.7% 78.5% 82.1% 80.0%
*from HAB data base
Outcome
o Incidence of syphilis in the clinic population
Measures for
Consideration
Updated: 11/08/2012
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Basis for Selection:
HIV-1 infection appears to alter the diagnosis, natural history, management, and outcome of T.
pallidum infection. Measure reflects important aspect of care that impacts HIV-related
morbidity and focuses on treatment decisions that affect a sizable population. Measure has a
strong evidence base supporting its use. Because the incidence of some STDs, notably syphilis, is
higher in HIV-infected persons, the use of client-centered STD counseling for HIV-infected persons has
been strongly encouraged by public health agencies and other health organizations. Consensus
guidelines issued by CDC, the Health Resources and Services Administration, the HIV Medicine
Association of the Infectious Diseases Society of America, and the National Institutes of Health
emphasize that STD/HIV risk assessment, STD screening, and client-centered risk reduction counseling
should be provided routinely to HIV-infected persons.6

Recommendations from CDC, the National Institutes of Health, and the HIV Medicine
Association of the Infectious Diseases Society of America
Routine laboratory screening for syphilis is indicated for all sexually active MSM. Screening
tests should be performed at least annually for sexually active MSM.
Serologic test for syphilis should be performed on all pregnant women at the first prenatal visit.
Because many STDs are asymptomatic, routine screening for curable STDs (e.g., syphilis) should be
performed at least annually for all sexually active, HIV-positive persons.6

The resurgence of syphilis among persons with HIV infection in the United States underscores
the importance of primary prevention of syphilis among persons with HIV infection. This
should begin with routine discussion of sexual behaviors. Providers should discuss clientcentered risk reduction messages and provide specific actions that can reduce the risk for
acquiring sexually transmitted infections and for transmitting HIV Routine serologic screening
for syphilis is recommended at least annually for all sexually active HIV-infected persons, with
more frequent screening (every 3--6 months) for those with multiple partners, unprotected
intercourse, sex in conjunction with illicit drug use, methamphetamine use, or partners who
participate in such activities. The occurrence of syphilis in an HIV-infected person is an
indication of high-risk behavior and should prompt intensified counseling messages and strong
consideration of referral for behavioral intervention. Persons undergoing screening or treatment
for syphilis also should be evaluated for all common sexually transmitted diseases (STDs)7
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years
is selected for performance measurement purposes only and should not be interpreted as a
recommendation about the age at which screening should begin to occur.
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
IHI Measure reads, “Percent of Patients with Annual Syphilis Screen”
(http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientswith
AnnualSyphilisScreen.htm)
5
(http://www.hivguidelines.org/public_html/center/quality-of-care/hivqual-project/hivqualUpdated: 11/08/2012
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workshop/03-04-natl-score-top10-25.pdf)
6
Morbidity and Mortality Weekly Report December 17, 2010 Volume 59
7

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults
and Adolescents March 24, 2009
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Clinical Performance Measures for Adult/Adolescent Patients:
Core Measures
Performance Measure 1.9: Tuberculosis screening
Description: Percentage of patients1 with HIV infection who received testing with results
documented for latent tuberculosis infection (LTBI) in the measurement year.
Number of HIV-infected patients who received documented testing for LTBI
with any approved test (tuberculin skin test [TST], interferon gamma release
Numerator:
assay [IGRA], or T-spot) for the measurement year.
Number of HIV-infected patients who:
• do not have a history of previous documented culture-positive TB
disease or previous documented positive TST or IGRA2; and
Denominator:
• had a medical visit with a provider with prescribing privileges3 at
least twice in the measurement year.
4
1. Patient refusal of TST or IGRA
Patient
2. Patients newly enrolled in care during last three months of the
Exclusions
measurement year.
1. Is the patient HIV-infected? (Y/N)
a. If yes, has the patient ever had previous documented culturepositive TB disease or previous documented positive TST or
IGRA? (Y/N)
Data Element:
i. If no, has the patient been tested for LTBI with a TST or
IGRA in the measurement year? (Y/N)
1.
If yes, are the results documented? (Y/N)
• Ryan White Program Data Report, Section 5, Item 47 may provide
data useful in establishing a baseline for this performance measure
• Electronic Medical Record/Electronic Health Record
Data Sources:
• CAREWare, Lab Tracker, or other electronic data base
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 75%
5
National Goals, National HIVQUAL-US Data:
Targets, or
2003
2004
2005
2006
Benchmarks
Top 10% 88.9% 91.7% 88.8% 92.2%
for
Top 25% 77.4% 73.5% 74.8% 78.2%
Comparison
Median* 58.8% 56.0% 57.1% 56.2%
*from HAB data base
Outcome
o Incidence of TB disease in the clinic population
Measures for
Consideration
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Basis for Selection:
HIV is the most important known risk factor for progression to TB disease from LTBI after
exposure to infectious TB patients. There is a 2% to 8% TB risk per year within five years after
6,7
LTBI for HIV-infected adults versus an 8% TB risk over 60 years for adults with LTBI but
8
not HIV. The TB risk for HIV-infected persons remains higher than for HIV-uninfected
9,10
persons, even for HIV-infected persons who are taking antiretroviral medications. TB disease
is an AIDS-defining opportunistic condition that can be deadly. McCombs found a three-times
adjusted odds of being diagnosed with TB at death and a five times adjusted odds of dying
during TB treatment for HIV-infected TB patients compared with other patients from 1993
11
through 2001.
Immunologic and virologic evidence now indicates that the host immune response to M.
tuberculosis enhances HIV replication and might accelerate the natural progression of HIV12
infection.
Providers should screen all HIV-infected patients for TB and LTBI as soon as possible after
HIV diagnosis. TB and LTBI testing should be conducted among HIV-infected persons
regardless of duration of infection since they are at increased risk for progressing to TB disease.
Thus, an HIV-infected person having a prior positive TST for which he/she did not complete
treatment is still eligible for treatment. However, early identification and treatment of TB
disease improves outcomes and reduces the risk of transmission. TB should be suspected in any
patient who has had a persistent cough for more than two to three weeks, especially if the
patient has at least one additional symptom, including fever, night sweats (sufficient to require
changing of bed clothes or sheets), weight loss, or hemoptysis (coughing up blood).
Identification of LTBI and completion of LTBI treatment reduces the risk of development of
13
TB disease by 70 to 90 percent.
Measure reflects important aspect of care that impacts HIV-related morbidity and mortality and
focuses on treatment decisions that affect a sizable population. Measure has a strong evidence
base supporting its use.
U.S. Public Health Guidelines:
Guidelines for TB services for HIV-infected persons, such as those jointly published by the
14
PHS and the Infectious Diseases Society of America or by the Centers for Disease Control and
15
Prevention (CDC) call for:
• provision of a TST or IGRA when HIV-infection is first recognized,
• annual TST or IGRA for HIV-infected persons who are initially TST-negative and
belong to groups at substantial risk for TB exposure or if they experience immune
reconstitution,
• chest radiographs and clinical evaluations to rule out active TB among those who are
TST positive (reactions ≥ 5 mm) or who have symptoms (regardless of TST result), and
• LTBI treatment (once active TB has been excluded) for those having a positive
16
TST/IGRA or for those who are recent contacts of persons with infectious active TB.
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Previous documented culture-positive TB disease or previous documented positive TST or
IGRA occurred prior to HIV diagnosis.
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3

A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
History of receiving BCG is NOT an exclusion to receiving TST. See: Targeted Tuberculin
Testing and Treatment of Latent Tuberculosis Infection. MMWR, 2000/49(RR06);1-64.
5
”PPD screening.”
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf
6
Markowitz N, Hansen NI, Hopewell PC, et al. Incidence of tuberculosis in the United States
among HIV-infected persons. Annals of Internal Medicine. 1997;126:123-32.
7
Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among
intravenous drug users with human immunodeficiency virus infection. New England Journal of
Medicine. 1989;320:545-50.
8
Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in
American Indians and Alaska Natives: A 60-year follow-up study. Journal of the American
Medical Association. 2004;291(17):2086-91.
9
The Antiretroviral therapy cohort collaboration. Incidence of tuberculosis among HIV-infected
patients receiving highly active antiretroviral therapy in Europe and North America. Clinical
Infectious Diseases. 2005;41:1772-1782.
10
Jones JL, Hanson DL, Dworkin MS, DeCock KM, and the Adult/Adolescent Spectrum of
HIV Disease Group. HIV-associated tuberculosis in the era of highly active antiretroviral
therapy. International Journal of TB and Lung Disease. 2000;4(11):1026-1031.
11
McCombs SB. Tuberculosis mortality in the United States, 1993-2001. Oral presentation at
CDC. Atlanta. December 2003.
12
Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among
patients infected with human immunodeficiency virus: Principles of therapy and revised
recommendations. MMWR 1998 Oct 30; 47(RR-20):1-58.
13
American Thoracic Society/Centers for Diseases Control and Prevention/Infectious Diseases
Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662
14
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR. March 24, 2009. Volume 58.
http://www.aidsinfo.nih.gov/Guidelines
15
Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among
patients infected with human immunodeficiency virus: Principles of therapy and revised
recommendations. MMWR 1998 Oct 30; 47(RR-20):1-58.
16
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis
Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR
December 16, 2005 / Vol. 54 / No. RR-15.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.1: Chlamydia screen
Description: Percentage of patients1 with HIV infection who had a test for Chlamydia2 within
the measurement year.
Number of HIV-infected patients who received a test for Chlamydia in the
Numerator:
measurement year.
Number of patients with HIV-infection who had a medical visit with a
Denominator:
3
provider with prescribing privileges at least twice in the measurement year
1. Patient refusal of test, documented in medical record.
2. Patients who are <18 yrs of age4 and deny a history of sexual activity.
Patient
3. Patients newly enrolled in care during last three months of the
Exclusions:
measurement year.

Data Element:

Data Sources:

1. Is the patient HIV-positive? (Y/N)
a. If yes, is the patient > 18 years or sexually active? (Y/N)
i.
If yes, was the patient tested for urethral, rectal and/or
cervical Chlamydia during the measurement period? (Y/N)
• Electronic Medical Record/Electronic Health Record
• CAREWare, Lab Tracker, or other electronic
• Medical record data abstraction by grantee of a sample of records.

National Goals,
Targets, or
DHSP Benchmark: 90%
Benchmarks
None available at this time.
for
Comparison:
Outcome
Measures for
Consideration

o Incidence of Chlamydia in the clinic population
o Incidence of pelvic inflammatory disease in the clinic population

Basis for Selection:
Early detection and treatment of STDs may reduce the risk for STD and HIV transmission.
Providers should screen for STD’s to treat infections and decrease HIV transmission to sexual
partners. Many STD’s increase the number of HIV-infected white blood cells in the genital area
5
and increase the risk of transmitting HIV-infection. STD’s can also enhance the risk of
6,7
transmitting HIV by increasing the viral burden in genital secretions.
STD infections in seronegative partners increase the risk for acquiring HIV because they
increase of the volume of white blood cells, including those that are targeted by HIV, in the
genital region, and may cause ulcerative lesions, increasing the likelihood of infection.8
Susceptibility to transmission may therefore be enhanced. Chlamydia infection in women may
often be asymptomatic but like other STD’s can also increase the risk for HIV transmission and
enhance transmission susceptibility. Providers should test women for Chlamydia infection at
least annually to treat infections and to decrease the risk of Chlamydia and HIV transmission.
Updated: 11/08/2012
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Identification and treatment of STD’s can reduce the potential for spread of these infections
7
among high-risk groups (i.e., sex or drug-using networks).
U.S. Public Health Guidelines:
“During the first visit, consider testing all patients for urogenital chlamydial infection. For
subsequent routine visits, repeated tests periodically (i.e. at least annually) for all patients who
are sexually active. More frequent periodic screening (e.g. at 3-month to 6-month intervals) may
7
be indicated for asymptomatic persons at higher risk.”
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Vaginal screening is the preferred Chlamydia test for women. Chlamydia screening for men
should be site specific using the following guidelines: (a) rectal screening test for men reporting
receptive anal sex in the past year; and (b) urine screening test for men reporting insertive only
sex in the past year The preferred method of Chlamydia testing currently is the molecular test
also known as nucleic acid amplification tests (NAAT). Other methods that may be used include
direct fluorescent antibody stain (DFA), which detects chlamydia antigens, and DNA probe,
another test that looks for chlamydia DNA but is less sensitive than NAAT. Testing for
Neisseria gonorrhoeae (gonorrhea) and Chlamydia trachomatis is generally done simultaneously
as the two organisms have similar clinical presentations.
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years
is selected for performance measurement purposes only and should not be interpreted as a
recommendation about the age at which screening should begin to occur.
5
Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis.
Lancet
1998;351(suppl 3):5--7
6
Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell
counts in HIV-infected patients with new syphilis infections. AIDS. 2004 Oct 21;18(15):2075-9
7
CDC. Recommendations and Reports: “Incorporating HIV Prevention into the Medical Care of
Persons Living with HIV”. July 18, 2003/52(RR12);1-24
8
DT Fleming and JN Wasserheit, From epidemiological synergy to public health policy and
practice: the contribution of other sexually transmitted diseases to sexual transmission of HIVinfection, Sex Transm Infect 75 (1999), pp. 3–17.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.2: Gonorrhea screen
Description: Percentage of adult patients1 with HIV infection who had a test for Gonorrhea2
within the measurement year.
Number of HIV-infected patients who received a test for Gonorrhea in the
Numerator:
measurement year.
Number of patients with HIV-infection who had a medical visit with a
Denominator:
3
provider with prescribing privileges at least twice in the measurement year
1. Patient refusal of test, documented in medical record.
2. Patients who are <18 yrs of age4 and deny a history of sexual activity.
Patient
3. Patients newly enrolled in care during last three months of the
Exclusions:
measurement year.

Data Element:

Data Sources:

1. Is the patient HIV-positive? (Y/N)
a. If yes, is the patient >18 years or sexually active? (Y/N)
i. If yes, was the patient screened for urethral, rectal, pharyngeal,
and/or cervical gonorrhea during the reporting period? (Y/N)
•
•
•

Electronic Medical Record/Electronic Health Record
CAREWare, Lab Tracker, or other electronic
Medical record data abstraction by grantee of a sample of records.

National Goals,
Targets, or
DHSP Benchmark: 90%
Benchmarks
None available at this time.
for
Comparison:
Outcome
Measures for
Consideration

o Incidence of gonorrhea in the clinic population
o Incidence of pelvic inflammatory disease in the clinic population

Basis for Selection:
Early detection and treatment of STDs may reduce the risk for STD and HIV transmission.
Providers should screen for STDs to treat infections and decrease HIV transmission to sexual
partners. Many STDs increase the number of HIV-infected white blood cells in the genital area
and increase the risk of transmitting HIV-infection.5 STDs can also enhance the risk of
transmitting HIV by increasing the viral burden in genital secretions.6
STD infections in seronegative partners increase the risk for acquiring HIV because they
increase the volume of white blood cells, including those that are targeted by HIV, in the genital
region, and may cause ulcerative lesions, increasing the likelihood of infection.6 Susceptibility to
transmission may therefore be enhanced.
Identification and treatment of STDs can reduce the potential for spread of these infections
among high-risk groups (i.e., sex or drug-using networks.7 There are currently no guidelines that
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delineate annual testing.
U.S. Public Health Guidelines:
“During the first visit, consider testing all patients for urogenital gonorrhea. For subsequent
routine visits, repeated tests periodically (i.e. at least annually) for all patients who are sexually
active. More frequent periodic screening (e.g. at 3-month to 6-month intervals) may be indicated
for asymptomatic persons at higher risk.”8
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Vaginal screening is the preferred Gonorrhea test for women. Gonorrhea screening for men
should be site specific using the following guidelines: (a) rectal screening test for men reporting
receptive anal sex in the past year; (b) urine screening test for men reporting insertive only sex
in the past year; and (c) pharyngeal screening test for men reporting receptive oral sex in the past
year. The preferred method of Gonorrhea testing currently is the molecular test also known as
nucleic acid amplification tests (NAAT). Other methods that may be used include direct
fluorescent antibody stain (DFA), which detects antigens, and DNA probe, another test that
looks for DNA but is less sensitive than NAAT. Testing for Neisseria gonorrhoeae (gonorrhea)
and Chlamydia trachomatis is generally done simultaneously as the two organisms have similar
clinical presentations.
3
Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years
is selected for performance measurement purposes only and should not be interpreted as a
recommendation about the age at which screening should begin to occur.
4
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
5
Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis.
Lancet
1998;351(suppl 3):5--7
6
Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell
counts in HIV-infected patients with new syphilis infections. AIDS. 2004 Oct 21;18(15):2075-9
7
DT Fleming and JN Wasserheit, From epidemiological synergy to public health policy and
practice: the contribution of other sexually transmitted diseases to sexual transmission of HIVinfection, Sex Transm Infect75 (1999), pp. 3–17.
8
CDC. Recommendations and Reports: “Incorporating HIV Prevention into the Medical Care of
Persons Living with HIV”. July 18, 2003/52(RR12);1-24.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.3: Pneumococcal vaccination
Description: Percentage of patients1 with HIV infection who have received a pneumococcal
vaccination within the last 5 years.
Number of HIV-infected patients who have received a pneumococcal
Numerator:
vaccination within the last 5 years.
Number of HIV-infected patients who had a medical visit with a provider
Denominator:
2
with prescribing privileges at least twice in the measurement year.
1. Patients with documented refusal of pneumococcal vaccine.
2. Patients with hypersensitivity to pneumococcal vaccine or its
components.
Patient
3. Patients newly enrolled in care during last three months of the
Exclusion:
measurement year.
1. Is the patient HIV-positive? (Y/N)
a. If yes, is there documentation in the chart that the patient received
the pneumococcal vaccine within the past five years? (Y/N)
b. Includes dated records (e.g., personal, school, physician, or
Data Element:
immunization registry) as evidence of vaccination, or
documentation of administration of pneumococcal vaccine in
medical record in past five years
• Electronic Medical Record/Electronic Health Record
• CAREWare, Lab Tracker, or other electronic data base
Data Sources:
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 90%
3
National Goals,
National HIVQUAL-US Data:
Targets, or
2003
2004
2005
Benchmarks
Top 10% 97.7% 95.8% 97.5%
for
Top 25% 92.4% 90.1% 93.0%
Comparison:
*from HAB data base
Outcome
Measures for
Consideration

o Incidence of pneumococcal infection in clinical population

Basis for Selection:
Bacterial pneumonia is a common cause of HIV-1 related morbidity. Incidence of
approximately 100 cases per 1,000 HIV-1 infected persons per year have been reported, a rate
much higher than in the non-infected population. The most consistent predictor of bacterial
4
infections is CD4 cell count.
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U.S. Public Health Guidelines:
“Adults and adolescents who have a CD4+ T-lymphocyte count of > 200 cells/uL should be
administered a single does of 23-valent polysaccharide pneumococcal vaccine (PPV) if they
have not received this vaccine during the previous five years (BII)”. Revaccination can be
considered for patients who were initially immunized when their CD4+ T-lymphocyte counts
5
were < 200 cells/uL in response to ART (CIII).
“If earlier vaccination status is unknown, patients in this group [immunocompromised,
including HIV] should be administered pneumococcal vaccine.”6
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
3
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.
4
Centers for Disease Control and Prevention. Treating opportunistic infections among HIVinfected adults and adolescents: recommendations from CDC, the National Institutes of Health,
and the HIV Medicine Association/Infectious Diseases Society of America. MMWR
2004;53(No. RR-15).
5
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR. April 10,, 2009,58.
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4.
6
Centers for Disease Control and Prevention. Prevention of Pneumococcal Disease:
Recommendations of the Advisory Committee on Immunization Practices (ACIP) – MMWR
April 4, 1997, Vol 46, No. RR-8. [Update for cochlear implants] MMWR August 8, 2003
52(31) [Update for Adults for PPSV23] MMWR September 2, 2010, 59(34) [for Children and
high risk adolescents to 18] MMWR December 10, 2010, 59; pp 13
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.4: Influenza vaccination
Description: Percentage of HIV-infected patients1 who received influenza vaccination within
the measurement year2
Number of HIV-infected patients who received influenza vaccination within
Numerator:
the measurement year.
Number of HIV-infected patients who had a medical visit with a provider
Denominator:
3
with prescribing privileges at least twice in the measurement year
1. Patient refusal of influenza vaccine documented in the chart.
2. Hypersensitivity to influenza vaccine or allergy to its components
including thimerosal, chicken protein, and egg protein.
Patient
3. Previous diagnosis of Guillain-Barre Syndrome.
Exclusions:
4. Patients newly enrolled in care during last three months of the
measurement year.

Data Element:

Data Sources:

1. Is the patient HIV-infected? (Y/N)
2. If yes, is there documentation in the chart that the patient received
influenza vaccine in the past 12 months? (Y/N)
a. Includes dated records (e.g., personal, school, physician, or
immunization registry) as evidence of vaccination, or
documentation of administration of Influenza vaccine in medical
record in measurement year
• Electronic Medical Record/Electronic Health Record
• CAREWare, Lab Tracker, or other electronic data base
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records

National Goals,
Targets, or
DHSP Benchmark: 90%
Benchmarks
None available at this time
for
Comparison:
Outcome
Measures for
Consideration

o Mortality rates from influenza and pneumonia in the clinical
population

Basis for Selection:
Influenza viruses cause disease among all age groups. While rates of infection are highest among
children, rates of serious illness and death are highest among persons aged > 65 years, children
less than two years, and persons of any age who have medical conditions that place them at
4
increased risk for complications of influenza, including HIV.
Influenza vaccination is the primary method for preventing influenza and its severe
4
complications.
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Vaccination has been demonstrated to produce substantial antibody titers against influenza
among vaccinated HIV-infected persons who have minimal AIDS-related symptoms and high
3
CD4+ T-lymphocyte cell counts.
U.S. Public Health Guidelines:
“As indicated in this report from the Advisory Committee on Immunization Practices (ACIP),
annual
influenza vaccination is now recommended for….adults and children who have required regular
medical
follow-up or hospitalization during the preceding year because of …immunodeficiency
4
(including…human immunodeficiency virus).”
“Because influenza can result in serious illness and because vaccination with inactivated
influenza vaccine might result in the production of protective antibody titers, vaccination might
benefit HIV-infected persons, including HIV-infected pregnant women. Therefore, influenza
4
vaccination is recommended.”
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Due to the unique nature of this measure and Influenza season/vaccine administration, the
measurement period runs from April 1-March 31
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
Centers for Disease Control and Prevention. Prevention and Control of Influenza:
Recommendations from the Advisory committee on Immunization Practices (ACIP).
MMWR2011; 60(33); pp 1128-1132 2010; 59(rr08); pp 1-62 59(31); pp 989-992.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.5: Hepatitis B screening
Description: Percentage of patients1 for whom Hepatitis B screening was performed at least
once since the diagnosis of HIV-infection.
Number of HIV-infected patients who have documentation of Hepatitis B
Numerator:
status2 since HIV diagnosis or initiation of care with provider.
Number of HIV-infected patients who had a medical visit with a provider
Denominator:
3
with prescribing privileges at least twice in the measurement year
1. Patient refusal of test.
2. Patients newly enrolled in care during last three months of the
Patient
measurement year.
Exclusions:

Data Element:

Data Sources:

1. Is the patient HIV-positive? (Y/N)
a. If yes, is their documentation of Hepatitis B serologic status in the
medical record? (Y/N)
o Electronic Medical Record/Electronic Health Record
o CAREWare, Lab Tracker, or other electronic data base
o Medical record data abstraction by grantee of a sample of records.

National Goals,
Targets, or
DHSP Benchmark: 90%
Benchmarks
None available at this time.
for
Comparison:
Outcome
Measures for
Consideration

o Incidence of Hepatitis B in clinic population
o Hepatitis B-related morbidity and mortality in the clinic population

Basis for Selection:
Hepatitis B virus (HBV) is the leading cause of chronic liver disease worldwide. In developed
countries, HBV is transmitted primarily through sexual contact and injection-drug use. Even
though risk factors are similar, HBV is transmitted more efficiently than HIV-1. Although up to
90% of HIV-1–infected persons have at least one serum marker of previous exposure to HBV,
only approximately 10% have chronic Hepatitis B, as evidenced by the detection of Hepatitis B
4
surface antigen (HBsAg) in the serum persisting for a minimum of six months.
HIV-1 infection is associated with an increased risk for the development of chronic Hepatitis B
after HBV exposure. Limited data indicate that co-infected patients with chronic Hepatitis B
infection have higher HBV DNA levels and are more likely to have detectable Hepatitis B e
antigen (HBeAg), accelerated loss of protective hepatitis B surface antibody (anti-HBs), and
increased risk for liver-related mortality and morbidity.4
Co-infection with HIV and HBV can complicate the care and treatment of HIV, and guide the
selection of medications for ART.
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U.S. Public Health Guidelines:
“It is not clear that treatment of hepatitis B virus (HBV) improves the course of HIV, nor is there
evidence that treatment of HIV alters the course of HBV. However several liver-associated
complications that are ascribed to flares in HBV activity or toxicity of antiretroviral agents can
affect the treatment of HIV in patients with HBV co-infection. Therefore, providers should know
the HBV status of all patients with HIV. This also will guide the choice of medications for HIV
treatment in the context of any possible HBV treatment. For patients who are HBV negative,
prophylaxis is recommended. This consists [of] 3 doses of vaccine for “all susceptible patients
4,5
(i.e., antihepatitis B core antigen-negative).”
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Serologic tests to evaluate for Hepatitis B immunity and chronic Hepatitis B include:
o Hep B Surface Antigen (+/-)
o Hep B Surface Antibody (+/-)
o Additional markers: Hep B Core Antibody (IgG or IgM), Hep B e Antigen
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR. March 24, 2009. Volume 58.
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4.
5
Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human
Services.October 14, 2011. Available at
http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.6: Substance use assessment
Description: Percentage of patients1 with HIV infection who have been assessed for substance
use (alcohol and illicit substances) in the measurement year.
2
Number of patients with HIV infection who were assessed for substance use
Numerator:
within the measurement year.
Number of patients with HIV-infection who had a medical visit with a
Denominator:
3
provider with prescribing privileges at least twice in the measurement year
1. Patients newly enrolled in care during last three months of the
Patient
measurement year.
Exclusions:
1. Is the patient HIV-positive? (Y/N)
a. If yes, was the patient assessed for substance use during the
Data Element:
reporting period with documentation in medical record? (Y/N)
o Electronic Medical Record/Electronic Health Record
o CAREWare, Lab Tracker, or other electronic data base.
Data Sources:
o HIVQUAL reports on this measure for grantee under review
o Medical record data abstraction by grantee of a sample of records.
DHSP Benchmark: 90%
4,5
IHI Goal: 90%
4
National Goals,
National HIVQUAL-US Performance Data:
Targets, or
2003
2004
2005
Benchmarks
Top
10%
100%
100%
100%
for
Top 25% 92.3% 100%
100%
Comparison:
Median* 74.4% 86.4% 92.7%
*from HAB data base
Outcome
Measures for
Consideration

o Substance use-related mortality rates
o Rate of substance use-related hospitalizations
o Rate of substance use referrals

Basis for Selection:
Patients living with HIV-infection must often cope with multiple social, psychiatric, and medical
issues. It is important to identify co-morbid illness such as substance use, which may complicate
ongoing HIV treatment.
U.S. Public Health Guidelines:
“The chronic and relapsing nature of substance abuse as a biologic and medical disease,
compounded by the high rate of mental illness, additionally complicates the relationship between
health care workers and IDU. The first step in provision of care and treatment for these
individuals is the recognition of the existence of a substance abuse problem. Whereas this is
often open and obvious, patients may hide such behaviors from clinicians. Assessment of the
patient for the presence of substance abuse should be part of routine medical history taking and
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6

should be done in a clinical, straightforward, and nonjudgmental manner”
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Substance abuse assessment: prior history of substance use and abuse, prior substance abuse
treatment, current use/abuse of substances. If patient has no history of substance abuse, annual
monitoring for changes in substance use patterns is indicated.
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
IHI Measure reads, “Percent of Patients/Patients Assessed for Substance Use and/or Tobacco
Use in the Past 12 Months.”
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientsPatien
tsAssessedforSubstanceUseandorTobaccoUseinthePast12Months.htm.
5
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.
6
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
October 14, 2011http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.7: Mental health assessment
Description: Percentage of patients1 with HIV infection who have had a mental health
assessment in the measurement year.
Number of HIV-infected patients who received a mental health assessment2 in
Numerator:
the measurement year.
Number of HIV-infected patients who had a medical visit with a provider
Denominator:
3
with prescribing privileges at least twice in the measurement year.
1. Patients newly enrolled in care during last three months of the
Patient
measurement year.
Exclusions:
1. Is the patient HIV-positive? (Y/N)
a. If yes, did the patient receive a mental health assessment during
the reporting period? (Y/N)
o Electronic Medical Record/Electronic Health Record
o CAREWare, Lab Tracker, or other electronic data base.
Data Sources:
o HIVQUAL reports on this measure for grantee under review
o Medical record data abstraction by grantee of a sample of records.
DHSP Benchmark: 90%
4
National Goals, National HIVQUAL-US Data:
Targets, or
2003
2004
2005
Benchmarks
Top 10% 100%
100% 80.6%
for
Top 25% 93.0% 89.5% 35.1%
Comparison:
Median* 72.9% 66.7%
2.2%
*from HAB data base
o Rate of mental health referrals
Outcome
o Mental health-related hospitalizations
Measures for
o Rate of suicide in the clinic population
Consideration
o Rate of mental health disorders being treated in the clinic population
Basis for Selection:
Patients living with HIV-infection must often cope with multiple social, psychiatric, and medical
issues. Mental health is an important predictor of ART adherence, and therefore may play a
substantial role in a patient’s ability to attain viral suppression on HIV medication.5
U.S. Public Health Guidelines:
“Patients living with HIV-infection must often cope with multiple social, psychiatric, and
medical
issues. Thus, the (initial) evaluation should also include assessment of substance abuse,
economic factors, social support, mental illness, co-morbidities, and other factors that are known
to impair the ability to adhere to treatment and alter outcomes. Once evaluated, these factors
6
should be managed accordingly."
Data Element:
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References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Mental health screen: documentation of prior mental illness, prior treatment of mental illness,
documentation of any current mental health symptoms. If patient has no history of prior mental
illness, annual monitoring for symptoms of mental illness (i.e. depression/anxiety) is indicated.
3
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
4
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.
The Mental Health/Substance Use Subcommittee of the National HIVQUAL Clinical Advisory
Committee include the following components for an annual Mental Health Screening for people
with HIV: Cognitive function assessment, including mental status; Depression screening;
Anxiety screening; Sleeping habits assessment; Appetite assessment; Domestic violence
screening; Post Traumatic Stress Disorder screening; Psychiatric history (optional);
Psychosocial assessment (optional)
5
Mellins CA, Havens JF, McDonnell C, et. al AIDS Care. 2009 Feb;21(2):168-77.
6
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
October 14, 2011Available at http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.8: Hepatitis B vaccination
Description: Percentage of patients1 with HIV infection who completed the vaccination series
for Hepatitis B.
Number of HIV-infected patients with documentation of having ever
Numerator:
2,3
completed the vaccination series for Hepatitis B .
Number of HIV-infected patients who had a medical visit with a provider
Denominator:
4
with prescribing privileges at least twice in the measurement year
1. Patients newly enrolled in care during the last 3 months of the
measurement year.
2. Patients with evidence of current HBV infection (Hep B Surface
Antigen, Hep B e Antigen, Hep B e Antibody, or Hep B DNA).
Patient
3. Patients with evidence of past HBV immunity (Hep B Surface
Exclusions:
Antibody).
4. Patients with documented refusal of Hepatitis B vaccine in medical
record.
1. Is the patient HIV-infected? (Y/N)
a. If yes, does the patient have documentation of Hepatitis B
immunity or HBV-infection? (Y/N)
i.
If no, is there documentation that the patient has completed the
vaccine series for Hepatitis B?(Y/N)
Data Element:
ii. Documentation includes dated records (e.g., personal, school,
physician, or immunization registry) as evidence of
vaccination, or documentation of administration of vaccine
dose(s) in medical record, or combination of outside records
and medical records to achieve three doses of vaccine
• Electronic Medical Record/Electronic Health Record
• CAREWare, Lab Tracker, or other electronic data base
Data Sources:
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 90%
National Goals, Published data from the HIV Outpatient Study (HOPS) reports 17% of
Targets, or
patients with HIV-infection who were eligible for vaccination received at
5
Benchmarks
least three doses of vaccine.
for
“Hepatitis B vaccination coverage among adults at high risk…[was] 45% in
Comparison:
6
2004.”
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Outcome
o Incidence of Hepatitis B infection in the clinic population
Measures for
Consideration:
Basis for Selection:
HBV is the leading cause of chronic liver disease worldwide. In developed countries, HBV is
transmitted primarily through sexual contact and injection-drug use. Even though risk factors are
similar, HBV is transmitted more efficiently than HIV-1. Although up to 90% of HIV-1–infected
persons have at least one serum marker of previous exposure to HBV, only approximately 10%
have chronic Hepatitis B, as evidenced by the detection of HBsAg in the serum persisting for a
3
minimum of six months.
HIV-1 infection is associated with an increased risk for the development of chronic Hepatitis B
after HBV exposure. Limited data indicate that co-infected patients with chronic Hepatitis B
infection have higher HBV DNA levels and are more likely to have detectable HBeAg,
3,7
accelerated loss of anti-HBs, and an increased risk for liver-related mortality and morbidity.
There is a protective antibody response in approximately 30% to 55% of healthy adults aged ≤40
years after the first dose of vaccine. After age 40, the proportion of persons with a protective
antibody response after a three-dose vaccination regimen declines. In addition to age, other host
factors (e.g., smoking, obesity, genetic factors, and immune suppression) contribute to decreased
vaccine response. Response to Hepatitis B vaccination also is reduced in other immunecompromised persons (e.g., HIV-infected persons, hematopoietic stem-cell transplant recipients,
and patients undergoing chemotherapy).
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on
treatment decisions that affect a sizable population. Measure has a strong evidence base
supporting its use.
U.S. Public Health Guidelines:
“Several liver-associated complications that are ascribed to flares in HBV activity or toxicity of
antiretroviral agents can affect the treatment of HIV in patients with HBV co-infection.
Therefore, providers should know the HBV status of all patients with HIV. For patients who are
HBV negative, prophylaxis is recommended. This consists [of] 3 doses of vaccine for “all
3
susceptible patients (i.e., antihepatitis B core antigen-negative).”
References/Notes:
1
“Patients” include all patients aged 13 years or older.
2
Patients in the middle of the vaccination series on 12/31/x would not be captured in the
numerator in year x. They would, if the series was completed on schedule, be captured in year
x+1.
3
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from
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CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious
Diseases Society of America. MMWR. March 24, 2009. Volume 58.
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4.
4
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
5
Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD; HIV
Outpatient Study (HOPS) Investigators. Hepatitis A and B vaccination practices for ambulatory
patients infected with HIV. Clinical Infectious Diseases. 2004 May 15;38(10):1478-84.
(http://www.journals.uchicago.edu/CID/journal/issues/v38n10/32448/32448.web.pdf)
6
Centers for Disease Control and Prevention. Hepatitis B Vaccination Coverage Among Adults
—United States, 2004. MMWR 2006;55:509-11
(http://www.cdc.gov/mmwr/PDF/wk/mm5518.pdf)
7
Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human
Services.October 14, 2011. Available at
http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part A
Performance Measure 2.9: Tobacco cessation counseling
Description: Percentage of patients1 with HIV infection who received tobacco cessation
counseling within the measurement year.
Number of HIV-infected patients who received tobacco cessation counseling
Numerator:
within the measurement year.
Number of HIV-infected patients who:
• Used tobacco products within the measurement year, and
Denominator:
• had a medical visit with a provider with prescribing privileges2 twice
within the measurement year
1. Patients who deny tobacco use throughout the measurement year.
2. Patients newly enrolled in care during last three months of the
Patient
measurement year.
Exclusions:
1. Is the patient HIV-positive? (Y/N)
a. If yes, did the patient use tobacco during the reporting period?
(Y/N)
Data Element:
i. If yes, did the patient receive tobacco cessation counseling
documented in the medical record during the reporting period?
(Y/N)
• Electronic Medical Record/Electronic Health Record
• CAREWare, Lab Tracker, or other electronic data base
Data Sources:
• HIVQUAL reports on this measure for grantee under review
• Medical record data abstraction by grantee of a sample of records
DHSP Benchmark: 90%
3
National HIVQUAL-US Data:
National Goals,
2003
2004
2005
2006
2007
2009
Targets, or
Top 10% 100%
100%
100%
100%
100%
100%
Benchmarks
Top 25% 93.3% 97.8% 98.4% 100%
for
Median* 75.8% 90.0% 88.2% 91.7% 93.0% 94.1%
Comparison:
Bottom 10%
45.5% 50.0%
*from HAB data base
Outcome
Measures for
Consideration

o Rate of head and neck, and lung cancer
o Rate of tobacco use in the clinical population
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Basis for Selection:
After Kaposi sarcoma and non-Hodgkin lymphoma, lung cancer is the most common cancer
among HIV-infected individuals, with an incidence rate that is two to three times higher among
HIV-infected individuals than in the general population. 4 . Risk factors associated with an
increased risk for bacterial pneumonia, include low CD4+ count, injection-drug use, and cigarette
smoking (454).
As tobacco use among HIV-infected patients poses significant health risks, tobacco-dependent
patients should be provided assistance to enroll in smoking cessation programs. Various studies
have shown that brief interventions by the clinician to encourage tobacco cessation and offer
5
6
substitution programs can decrease smoking rates and tobacco use. Cessation reduces the risk
7,8,9
of incidence or the progression of tobacco-related diseases and increases life expectancy.
HIV care providers should provide cessation assistance in the form of counseling, pharmacotherapy, or referral to cessation programs.
Tobacco use in all forms is the biggest risk factor for oral cancer. Alcohol abuse combined with
tobacco use increases risk. Clinicians should be alert to the possibility of oral cancer when
treating patients who use tobacco or alcohol. Patients should be encouraged to not use tobacco
and to limit alcohol use in order to decrease their risk for oral cancer as well as heart disease,
10
stroke, lung cancer, and cirrhosis.
11

The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians ask all adults
about tobacco use and provide tobacco cessation interventions for those who use tobacco
Products, (Grade: A Recommendation) and that clinicians ask all pregnant women about tobacco
use and provide augmented, pregnancy-tailored counseling for those who smoke. (Grade: A
Recommendation).
This USPSTF recommendation applies to adults 18 years or older and all pregnant women
regardless of age. The USPSTF plans to issue a separate recommendation statement about
counseling to prevent tobacco use in non-pregnant adolescents and children. Various primary
care clinicians may deliver effective interventions. There is a dose-response relationship between
quite rates and the intensity of counseling (that is, more or longer sessions improve quit rates).
Quit rates seem to plateau after 90 minutes of total counseling contact time. Helpful components
of counseling include problem-solving guidance for smokers (to help them develop a plan to quit
and overcome common barriers to quitting) and the provision of social support as part of
treatment. Complementary practices that improve cessation rates include motivational
interviewing, assessing readiness to change, offering more intensive counseling or referrals, and
using telephone “quit lines.” Combination therapy with counseling and medications is more
effective at increasing cessation rates than either component alone. Pharmacotherapy approved
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by the U.S. Food and Drug Administration and identified as effective for treating tobacco
dependence in nonpregnant adults includes several forms of nicotine replacement therapy (gum,
lozenge, transdermal patch, inhaler, and nasal spray), sustained-release bupropion, and
varenicline.
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part B
Performance Measure 2.10: Medical visits
Description: Percentage of HIV-infected patients who are enrolled in outpatient medical
services who had a medical visit with a provider1 with prescribing privileges, i.e. MD, PA, NP, in
an HIV care setting2 two or more times at least 3 months apart in the measurement year.
Number of HIV-infected patients who had a medical visit with an HIV
provider with prescribing privileges, i.e., MD, PA, NP, two or more times at
Numerator:
least 3 months apart in the measurement year.
Number of HIV infected patients who were enrolled in outpatient medical
Denominator:
services in the measurement year.
1. Patients newly enrolled in care during the last six months of the
measurement year.
2. Patients who were incarcerated during the measurement year.
3. Patients enrolled in another clinic during the last 6 months of the
measurement year.
2. Is the patient HIV-infected? (Y/N)
b. If yes, is the patient enrolled in outpatient medical care? (Y/N)
2. If yes, did the patient have a medical visit with an HIV provider
two or more times, at least 3 months apart within the
measurement year?

Patient
Exclusions

Data Element:

Data Sources:

Casewatch

National Goals,
DHSP Benchmark: 90%
Targets, or
Benchmarks
No national benchmarks identified at this time.
for
Comparison
o Rate of patient retention in care
o Rate of HIV related hospitalizations in the measurement year
Outcome
o Rate of HIV related emergency room visits in the measurement year
Measures for
o Rate of opportunistic infections in the measurement year
Consideration
o Mortality rates
Basis for Selection:
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Numerous studies describe the adverse impacts of poor retention in care on patient outcomes. In
particular, poor retention in care is associated with the following outcomes: decreased likelihood
of receiving antiretroviral therapy; higher rates of antiretroviral therapy failure; increased HIV
transmission risk behavior; increased hospitalization rates; and worse survival.
Patients with greater initial retention in care had the greatest survival over 5 years of follow-up,
and patients with the worst initial retention had the poorest survival3 Treatment guidelines
recommend to test CD4 at entry into care then follow-up every 3-6 months before ART, every 3-6
months when on ART, then, in clinically stable patients with suppressed viral load, CD4 count
can be monitored every 6–12 months.4 For adherent patients with suppressed viral load and
stable clinical and immunologic status for >2–3 years, some experts may extend the interval for
HIV RNA monitoring to every 6 months.
All patients who are clinically stable should be monitored at least every 4 months; this includes
both patients who are receiving ART and those who are not. Visits may require more frequent
scheduling at entry to care, for management of acute problems, or when starting or changing ART
regimens.5
Patients infected with HIV face a complex array of medical, psychological, and social challenges.
A strong provider-patient relationship, the assistance of a multidisciplinary care team, and
frequent office visits are key aspects of care. Through both the specific services they provide and
their overall approach to patients, clinics can have a substantial impact on the quality of care for
HIV-infected persons.6
Greater experience among primary care physicians in the care of persons with AIDS improves
survival.7
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Clinical Performance Measures for Adult /Adolescent Patients:
Supplemental Measures – Part B
Performance Measure 2.11: Viral load suppression < 200 copies/mL when on ART
Description: Percentage of HIV-infected patients on ARV therapy 12 weeks or more before last
viral load and with at least one viral load test, with the last viral load undetectable or <200
copies/mL in the measurement year.
Number of HIV-infected patients on ARV therapy 12 weeks or more before
last viral load and with at least one viral load test, with the last viral load
Numerator:
undetectable or < 200 copies/mL in the measurement year.
Number of HIV-infected patients on ARV therapy 12 weeks or more before
Denominator:
last viral load test during the measurement year.
1. Patients who are not on ARV therapy.
2. Patients who do not have a viral load test after 12 weeks or more of
ARV therapy.
Patient
3. Patients who were incarcerated during the measurement year.
Exclusions:
4. Patients who are newly enrolled in care within the last 3 months of the
measurement year.
1. Is the patient HIV-infected? (Y/N)
a. If yes, was the patient on ARV therapy at least 12 weeks or more?
(Y/N)
Data Element:
i. If yes, did the patient have at least one viral load test? (Y/N)
1. If yes, was the last viral load test undetectable (‘<’) or <200
copies/mL (list the date and result).
• Electronic Medical Record/Electronic Health Record
• Medical/laboratory record data abstraction of a sample of records
Data Sources:
• Health Way LA Data System
DHSP Benchmark: 80%
4
National Goals, National HIVQUAL-US Data:
Last viral load undetectable or <200, among patients on ARV therapy >12
Targets, or
weeks
Benchmarks
2009
for
Top
10%
94.1%
Comparison
Median
78.6%
Bottom 10%
50%
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Outcome
Measures for
Consideration

o
o
o
o

Rate of opportunistic infections in the measurement year
Rate of patients with progression to AIDS in the measurement year
Mortality rates
Virologic suppression rates (In+Care Campaign
http://www.incarecampaign.org/)

Basis for Selection:
The plasma HIV RNA (viral load) should be measured in all patients at baseline and on a regular
basis thereafter, especially in patients who are on treatment as viral load is the most important
indicator of response to ART5.
Measure reflects important aspects of care that significantly impacts survival and mortality. Data
collection is currently feasible and measure has a strong evidence base supporting the use.
Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents:
Plasma HIV RNA (viral load) should be measured in all patients at baseline and on a regular basis
thereafter, especially in patients who are on treatment, because viral load is the most important
indicator of response to antiretroviral therapy (ART) (AI). Analysis of 18 trials that included
more than 5,000 participants with viral load monitoring showed a significant association between
a decrease in plasma viremia and improved clinical outcome [1]. Thus, viral load testing serves as
a surrogate marker for treatment response [2] and can be useful in predicting clinical progression
[3-4]. The minimal change in viral load considered to be statistically significant (2 standard
deviations) is a threefold, or a 0.5 log10 copies/mL change.
Optimal viral suppression is generally defined as a viral load persistently below the level of
detection (<20–75 copies/mL, depending on the assay used). However, isolated “blips” (viral
loads transiently detectable at low levels, typically <400 copies/mL) are not uncommon in
successfully treated patients and are not thought to represent viral replication or to predict
virologic failure [5]. In addition, low-level positive viral load results (typically <200 copies/mL)
appear to be more common with some viral load assays than others, and there is no definitive
evidence that patients with viral loads quantified as <200 copies/mL using these assays are at
increased risk for virologic failure [6-8]. For the purposes of clinical trials the AIDS Clinical
Trials Group (ACTG) currently defines virologic failure as a confirmed viral load >200
copies/mL, which eliminates most cases of apparent viremia caused by blips or assay variability
[9]. This definition may also be useful in clinical practice. (See Virologic and Immunologic
Failure.)
At Initiation or Change in Therapy. Plasma viral load should be measured before initiation of
therapy and preferably within two to four weeks, and not more than eight weeks, after treatment
initiation or after treatment modification. Repeat viral load measurement should be performed at
four to eight week intervals until the level falls below the assay’s limit of detection.
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In Patients Who Have Viral Suppression but Therapy Was Modified Due to Drug Toxicity
or Regimen Simplification. Viral load measurement should be performed within two to eight
weeks after changing therapy. The purpose of viral load monitoring at this point is to confirm
potency of the new regimen.
In Patients on a Stable Antiretroviral Regimen. Viral load should be repeated every three to
four months or as clinically indicated. In adherent patients who have suppressed viral loads for
more than two to three years and who are at stable clinical and immunological status, some
clinicians may extend the interval to every six months.
Monitoring in Patients with Suboptimal Response. In addition to viral load monitoring, a
number of additional factors should be assessed, such as no adherence, altered pharmacology, or
drug interactions. Patients who fail to achieve viral suppression should undergo resistance testing
to aid in the selection of an alternative regimen.5
References/Notes:
Guidelines state that viral load should be measured at least every three to four months depending
on the stage of the disease. The timeframe of six months was determined by clinical expert
consensus for the purpose of this measure, but can and should be measured at more frequent
intervals if needed.
1

“Patients” include all patients aged 13 years or older.
A “provider with prescribing privileges” is a health care professional who is certified in their
jurisdiction to prescribe ART, i.e. MD, PA, NP.
3
IHI Measure reads, “Percent of Patients/Patients with a Viral Load Test in the Past 4 Months.”
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/Percentofpatientswithvir
alloadtestinthepast4months.htm.
4
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(January 1, 2009 to December 31, 2009) http://hivqualus.org/index.cfm/22/10039
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Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human
Services. October 14, 2011; 1–167. Available at
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1
Executive Summary
The Los Angeles County Department of Health Services’ Office of AIDS Programs and
Policy (OAPP) directs the overall response to the HIV/AIDS epidemic in the County of
Los Angeles under the supervision of the Los Angeles County Board of Supervisors. As
part of its mandate, OAPP manages hundreds of contracts with dozens of agencies to
provide high quality and cost-effective services to HIV-positive and AIDS-infected
residents of the County of Los Angeles. Currently, OAPP reimburses its contracted
outpatient medical clinics through a traditional line-item budget process. The Board of
Supervisors required OAPP to consider a cost reimbursement methodology that would
encourage provider accountability and productivity, track utilization more effectively, and
ensure that providers are utilizing other funding resources, such as Medi-Cal, when
available. Specifically, the primary medical care services for which the Board of
Supervisors and OAPP initially intended to develop a fee-for-service (FFS) cost
reimbursement methodology included:







Ambulatory/Outpatient Medical Care (AOM)
AIDS Drug Assistance Program (ADAP)
Drug Resistance Testing
Medical Case Management
Medical Specialty
Nutritional Counseling (Medical Nutritional Therapy)

The study specifications initially requested a service description and rate of
reimbursement for referrals to Medical Specialty services. Mercer Government Human
Services Consulting (Mercer) initially produced both a service description and rate of
reimbursement for this referral service. However, Public Health Services (PHS)
standards of care dictate that specialty services must be accessible to the HIV-positive
client by the primary care provider. The service description developed for HIV/AIDS
AOM, which considered the PHS requirements, requires referral standards for Medical
Specialty care. A separate Medical Specialty service description results in redundant
requirements. Mercer recommended Medical Specialty services not be funded as a
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separate service description. Continuing to fund it separately would result in duplicative
payment for the same service requirement under two service descriptions. Therefore, this
report contains no rate recommendations for a separately reimbursed referral to Medical
Specialty.
OAPP-funded providers have been successful in negotiating locally-derived rates of
reimbursement that financially create access to these expensive services. Mercer
recommends that special relationships between primary care and specialty care providers
not be interrupted. Where there are no special relationships between providers for a
needed specialty care service, Mercer recommends that rates of reimbursement should not
exceed the Medicare/Medi-Cal established rates. Conceding to the Medicaid/Medicare
rates (where there is no opportunity for rates derived through special relationships) is an
established practice in publicly-funded HIV/AIDS primary health care.
Likewise, the PHS HIV/AIDS standards of care for drug resistance testing were changed
to incorporate drug resistance testing and counseling as a routine component of
HIV-related primary health care. Therefore, and in interest of maintaining
recommendations that are current with the PHS standards, Mercer recommended the
service description for Drug Resistance Testing not be funded as a separate service
description, but rather be included as a routine requirement within the HIV/AIDS AOM
Care service description. No rate recommendation for a separately reimbursed Drug
Resistance Testing service is included in this report.
Further, during the time frame included in this study, Medical Case Management was
being closely scrutinized by OAPP and the Commission on HIV. Because the
configuration of services included in Medical Case Management was under review, this
report contains no rate recommendation for a separately reimbursed Medical Case
Management service.
The services for which Mercer set rates and developed service descriptions that are
included in this report include:
Outpatient Medical Care Services
Service Description and Rate Development

 Ambulatory/Outpatient Medical Care (AOM)
 AIDS Drug Assistance Program (ADAP)
 Nutritional Counseling (Medical Nutritional Therapy)
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Objectives of this study included:










Review of national and local standards of care
Review of the Los Angeles HIV/AIDS Continuum of Care Model included in the
County of Los Angeles HIV/AIDS Comprehensive Care Plan (August 2002)
Survey of other eligible metropolitan areas (EMAs) that have a FFS program
Survey of current practice regarding coding of procedures and diagnosis among
HIV/AIDS outpatient medical clinic providers
Analysis of the costs of providing outpatient medical services based on the accepted
standards of care
Preparation of recommendations of FFS rates for the identified outpatient medical
services
Identification of services that are commonly reimbursed by third-party payers
Identification of barriers to implementation
Recommended guidelines for collection of fees

Based on a competitive bid for Work Order Request No. 6-49 issued in December 2003
by the Department of the Auditor-Controller of the County of Los Angeles, Mercer was
engaged to complete this study and meet the aforementioned Board of Supervisors/OAPP
objectives.

Direct-Care, Staff-Driven Rate Architecture
Mercer’s direct-care, staff-driven rate architecture, tailored to the needs and objectives of
OAPP, was utilized to complete this study The four standard cost components included
in this architecture are direct service staff wage, employment-related expenditures,
program-related expenditures and general and administrative expenditures.
The rate architecture is a unique approach to reimbursement for health services in that it
emphasizes “hands on” staff resources provided to the people receiving services and
varies according to the professional level and quantity of staff time. Three key principles
serve as the foundation for this system:
1. The most prominent and important variable in the determination of quality and the
successful adherence to care standards is the direct service staff profile.
2. All other cost components, which are equally necessary, although less directly
variable in response to differences in standards of care, can be expressed in
relationship to direct service staff costs.
3. If all the compensation components are studied and their relationships to direct
service staff cost profiles are determined, a standardized rate system can be produced
by establishing the direct service staff profiles (in accordance with standards of care)
and then building the total compensation (rate) according to the relationships of the
other components to the service staff costs.
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Study Methodology
The methodology adopted for this study has been specifically designed and successfully
tested in numerous environments and jurisdictions to ensure reliability and soundness of
the rates and a strong linkage to appropriate standards of service. In general, the
methodology consists of the following steps:










Review of study methodology with providers
Collection and analysis of available information including clinical standards, best
practices, California and national regulations and codes, provider cost reports, and
provider general ledgers
Development of service descriptions for each service category
Completion of provider survey, interviews, and on-site reviews to collect additional
information
Establishment of costs associated with direct service staffing levels
Calculation of cost components to be incorporated into the rate architecture including
employment-related expense, program-related expenses and general and
administrative expense percentages
Synthesis of draft rates based on the combination of the various cost components
Completion of budget impact and provider impact analysis
Finalization of rates

The rate architecture for AOM is discussed in general below followed by a brief outline
of the rate development for ADAP and Nutritional Counseling. Specific rate
development processes are more fully outlined in Section 4.
For AOM services, the direct-care, staff-driven rate architecture is based on a blend of
costs associated with physicians, physician assistants and nurse practitioners (referred to
as physician-like professionals) who provide direct client services. Costs associated with
these positions were provided by providers through submission of general ledgers and
completion of an Encounter and Staff Information Sheet (ESIS) (Appendix F) in late
January and early February 2008. The direct service wage utilized in the study was
$147,519. This was based on provider information reported on the ESIS for physicians,
physician assistants, and nurse practitioners and then trended forward to the anticipated
start of the year of implementation.
The remaining cost components – employment-related, program-related and general and
administrative – were each calculated as a percentage of the direct care physician-like
average wage based on providers’ general ledger and ESIS information as described
below.
The employment-related percentage was based on the average of five providers whose
general ledger data was deemed complete enough for use in the study. Mercer used the
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most recent general ledger year provided. For three providers, the time frame was
March 1, 2006 to February 28, 2007. For one, the time frame was July 1, 2006 to
June 30, 2007. For the last provider, it was January 1, 2006 to December 31, 2006.
Mercer totaled the dollars from all providers in the employment-related category and
divided by the total dollars for all providers for direct care professionals (physicians,
physician assistants and nurse practitioners). The employment-related percentage used in
Mercer’s calculation was 42.07% of the direct service staff wage.
The program-related percentage was based on the average of the same five providers’
general ledgers’ information and was calculated in the same way as the
employment-related percentage, i.e., based on the total dollars and not the average of the
percentages. The program-related percentage used in Mercer’s calculation was 228.04%
of the direct service staff wage.
The general and administrative percentage was based on the average of four providers’
general ledgers’ information. One provider’s general and administrative expenses were
2.5 times higher (as a percentage) than the next closest provider and the providers’
general and administrative dollars were held out of the calculation. The general and
administrative percentage used in Mercer’s calculation was 31.7% of the total, or
171.79% of the direct service staff wage.
For the ADAP and Nutritional Counseling services, Mercer utilized wage information
available from the US Department of Labor’s Bureau of Labor Statistics (BLS) for the
Los Angeles metropolitan area. The remaining cost components – employment-related,
program-related and general and administrative – were each calculated as a percentage of
the direct care wage based on a combination of providers’ submission of cost reports,
BLS information and professional estimates.

Stakeholder Input
In April 2004, OAPP and Mercer provided an overview of the scope of the study to
HIV/AIDS outpatient medical care providers. Virtually all of the currently contracted
providers had representation at the meeting.
Input on Financial Information
After the orientation meeting, Mercer conducted a series of nine separate telephone
interviews with providers of services to gain a better understanding of the financial
operations of the providers. The interviews provided complementary and anecdotal
information in order to support the calculations that had been performed to derive cost
components (employment-related expenditures and program-related expenditures).
Interviewees included two different individuals from AIDS Healthcare Foundation, two
separate interviews with two different staff from Harbor UCLA Medical Center and two
staff with Northeast Valley Health Corporation. Also interviewed were The LA Gay and
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Lesbian Community Center, AltaMed Health Services Corporation and the Rand
Schrader clinic. There were a series of phone calls with smaller providers that were not
performed in the depth of those mentioned above.
Subsequent to this provider input, two Mercer staff visited eight provider sites in January
2007. The providers were asked to submit general ledgers with specific expenditure
line-item detail. Nine providers submitted the general ledger information. The interview
information and general ledger information were synthesized into an analysis resulting in
revisions to the rates originally prepared.
The rates were published in a draft report on the OAPP website in October 2007 and an
all-provider meeting was held on October 31, 2007. Providers voiced concerns at the
meeting and were given until mid-January 2008 to submit written comments.
As a result of provider verbal and written input after release of the draft report in late
October 2007, OAPP again requested recent general ledgers and completion of the ESIS
to complete the study (see Appendix F) in order to provide Mercer with the most
up-to-date provider general ledger information and to give providers an opportunity to
provide actual direct service wages and encounter information. Nine providers complied
by providing at least partial information.
Input on Clinical Information
Two specific tasks in the study related to the clinical delivery of services and necessitated
extensive provider feedback. The first task was to assess the current HIV/AIDS
Continuum of Care Model, County of Los Angeles (and Commission updates for 2003,
2004). See Appendix A for the graphic depiction of the approved model. Mercer staff
conducted 11 interviews with staff representing the Commission on HIV, the Prevention
Planning Committee, HIV/AIDS service providers and OAPP. These perspectives figured
directly in Mercer’s assessment of the HIV/AIDS Continuum of Care Model (Appendix
B) as adequate, which was ultimately assessed as appropriately challenging and not in
need of revisions.
The second task related to the delivery of clinical services was to develop service
descriptions for the services for which rates would be set. To continue evaluating the
appropriateness and effectiveness of the service descriptions for use in the County of Los
Angeles, Mercer staff facilitated a focus group on November 8, 2004, with medical
professionals providing HIV/AIDS services. The focus group meeting was attended both
by providers who are and are not currently in the OAPP provider network. Focus group
participants received the service descriptions in advance, and then were convened for a
group-wide discussion at OAPP. Because of time restraints, participants were asked to
submit comments on service descriptions that were not reviewed in this meeting. These
comments were synthesized and provided to participants prior to a group-wide conference
call in December 2004, where all final comments were addressed. A list of provider and
other stakeholders having input into the study is included in Appendix C.
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Additionally, at OAPP’s request, a physician not currently in the provider network was
interviewed in December 2004 regarding his review of the AOM service descriptions.
Lastly, relative to the AOM services description, a Commissioner from the Commission
on HIV provided written comments.
As a result of the comments from the focus group on the Nutritional Counseling (Medical
Nutritional Therapy) service description, an OAPP nutrition expert facilitated a review of
the service description by nine Los Angeles-area registered dietitians. The comments and
suggestions from these local professionals were also carefully considered and integrated
into the Nutritional Counseling service description (Medical Nutritional Therapy).
In order to make sure adequate service delivery time frames were set for the enrollment
services required for the ADAP service description, service providers were interviewed
by telephone, and the reports of time actually expended, together with the specific
activities provided, were synthesized and applied to both the service description and rate
determinations.
OAPP-funded providers of home-based case management services were interviewed to
make sure the Medical Case Management model would not duplicate these services. This
was in response to a concern raised by a focus group participant. The issue of duplicating
services was further researched with the OAPP staff and no duplications in service
requirements were found with the Medical Case Management service description
included in the rate study.
As noted in the previous section, two Mercer staff visited eight provider sites in January
2007. The purpose of the interviews was to gather additional and more in-depth
information related to service provision. The programmatic inquiry focused on the exact
nature of clinical services with attention given to the relationship between primary care
providers and registered nurses, as well as program-related expenditure issues.
Additional inquiry was made related to the nature of the people served and demographic
influences on service provision. The information from the interviews was summarized in
a report from Mercer titled “Summary of HIV/AIDS Medical Outpatient Services Rate
Study: Provider Site Visits” (Appendix D).
Throughout this process, provider input, both clinical and financial, has been sought and
considered in the development of the rates.

Study Outcomes
The outcomes and findings that emerged based on this study are documented in this
report.
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Rates were prepared for each service category based on the evaluation of national
standards and local practice and through the analysis of provider cost reports and general
ledgers. An impact analysis of these rates on OAPP’s budget, as well as individual
providers, was completed. The rates developed in accordance with the study (“rate
architecture”) methodology and recommended by Mercer are presented in the summary
below:
OUTPATIENT MEDICAL CARE SERVICES
AOM Care
Services

ADAP

Nutritional Counseling
(Medical Nutritional Therapy)
$89.36
Initial Assessment

Proposed Rate

$375.37*

$31.61
$29.79
Continuing Visit

*The recommended rate includes a “full load” of general and administrative costs. RWCA funds have
historically been limited to 10% for general and administrative costs. If the rate is limited to 10% general
and administrative costs, the rate would be $284.86. This is discussed is Section 4.

Policy Decisions and Recommendations
Policy decisions were made during the course of the study. These included decisions on:






Whether to fund the referral to a Medical Specialty service as a distinct service.
Requirements for referral to specialty care are considered standard in HIV/AIDS
AOM care and, as a result, are included in the AOM service description. Medical
Specialty services needed by clients that currently are reimbursed separately from
other services should be made as referrals and specialty providers should seek
reimbursement as appropriate.
Whether to fund the Drug Resistance Testing as a distinct service. Requirements for
drug resistance testing have been revised by PHS; these services are routinely offered
within the context of the routine medical management of HIV disease. The costs
associated with the actual testing for drug resistance will continue to be supported
through the State of California program; the medical tasks associated with screening
for drug resistance and for pre- and post-test counseling are routine with the
expectation that they be completed by the HIV/AIDS AOM care team.
Whether Medi-Cal certification should be mandatory. In discussions with OAPP
senior managerial staff, the importance of maximizing all available financial
resources was a consistent topic, together with noting the legislative restraints on the
use of Ryan White CARE Act (RWCA) funds as a funding source of last resort.
Mercer concurs with OAPP that Medi-Cal certification for all AOM services
providers should be required. All current providers are Medi-Cal certified. Any new
providers in the network should have Medi-Cal certification as a condition of
admission into the network.
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With regard to these specific policy decisions, Mercer makes the following
recommendations:
Medical Specialty
The service description for referral to Medical Specialty services initially addressed the
primary care provider’s assessment for the need for specialty care and the actual referral
process. The service description, and therefore the corresponding rate of reimbursement,
does not address the actual specialty care itself. OAPP will need to continue to fund the
costs for medical specialty services outside of the rate study’s rates.
Mercer recommends this service description no longer be funded as a distinct and
separate service category. Referral to medical specialty services is commonplace in the
medical management of HIV disease. The current standard of care and PHS guidelines
fully integrate the assessment for the need for specialty care, as well as direct focused
attention to referral tracking and monitoring for the benefit of the client being medically
managed in an HIV/AIDS primary health care model. This service description was
redundant with the guidelines for state-of-the-art HIV AOM care. The updated HIV/AIDS
AOM service description incorporates the PHS guidelines addressing referral to medical
specialty care.
Drug Resistance Testing
Because of recent changes in the PHS HIV/AIDS standards of care, Mercer recommends
this service description no longer be funded as a distinct and separate service category.
Drug resistance testing was earlier viewed as a highly specialized service but is now
considered routine within the medical management of HIV disease. Therefore, the new
expectations associated with drug resistance testing are incorporated as expectations
within the HIV/AIDS AOM Care service description.
Mercer recommends that the actual costs of the blood screening continue to be absorbed
by the State of California, Office of AIDS, Resistance Testing Program. The Mercer
recommendation, therefore, does not assume these lab costs will be absorbed by the
HIV/AIDS AOM providers contracted through OAPP. The medical tasks relevant to
client pre- and post-testing counseling and education for drug resistance are now routine
HIV/AIDS medical management services to be provided by HIV/AIDS practitioners
contracted through OAPP.
Medical Case Management
During the time frame included in this study, Medical Case Management was being
closely scrutinized by OAPP and the Commission on HIV. Because the configuration of
services included in Medical Case Management was under review, this report contains no
rate recommendation for a separately reimbursed Medical Case Management service.
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Maximizing Medi-Cal Funding
The use of RWCA funds is restricted for services for which there are no other sources of
funding. When a client meets the Center for Disease Control and Prevention’s definition
for a diagnosis of AIDS, the client becomes eligible for disability and thereby for
HIV/AIDS medical services reimbursed by Medi-Cal. Undocumented individuals are not
eligible for Medi-Cal services and therefore are eligible and remain dependent on RWCA
funding for advanced medical management of HIV disease. OAPP may wish to audit a
sample of medical records to ensure Medi-Cal is being used appropriately and RWCA
funds are used only for non-Medi-Cal services and/or for non-Medi-Cal eligible clients.
Currently, all providers of AOM care are Medi-Cal certified providers. Any new
providers in the network should have Medi-Cal certification as a condition of admission
into the network. The RWCA (2000, as amended) permits use of funds for agency and
system of care capacity building. This use of funds must be prioritized and allocated by
the local HIV Health Services Planning Council, however. OAPP may wish to work
collaboratively with the Los Angeles Commission on HIV to consider use of these funds
to build capacity for maximum results from Medi-Cal billing and collection.
Implementation of Rates: Budget Impact Concerns
The AOM rate developed considers the full cost related to general and administrative
expenditures. Historically RWCA funding has been limited to 10%. This limitation, of
course, would significantly impact the rate. In Mercer calculations, the 10% limitation
makes a $100 difference in the rate. This issue is discussed more fully in Section 4.
Mercer recognizes that changes to the funding structure may significantly impact
providers. For this reason, OAPP may wish to “shadow implement” the rate system. In
“shadow implementation”, providers are paid at historical funding levels and data is
collected regarding what they would have been paid under the FFS system. In this way,
OAPP would assess if the budget impact based on historical utilization presented in this
report was accurate and which providers fall over or under historical funding levels.
If OAPP elects to implement the FFS system using a single rate for all AOM providers,
Mercer recommends that OAPP should require an actual cash reconciliation no later than
six months after the contract is initiated, and the rates should be reviewed based on the
measurement of actual costs and utilization under the new system.
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2
Background
On December 23, 2003, the Department of the Auditor-Controller of the County of Los
Angeles issued Work Order Request No. 6-49 on behalf of the Department of Health
Services OAPP. The Work Order Request sought the services of a consulting firm to
develop appropriate FFS costs reimbursement rates for providing HIV/AIDS outpatient
medical care services. In late February, 2004, Mercer was engaged to complete the study.
With an approved budget by the Board of Supervisors, OAPP contracts with
County-operated and private outpatient medical clinics to provide comprehensive primary
health care to individuals diagnosed with HIV/AIDS. These clinics receive County, State
and RWCA funds that provide funding of last resort to individuals who meet eligibility
qualifications and do not qualify for other health insurance programs. RWCA resources
are prioritized by the Commission on HIV and provide reimbursement for those services
meeting OAPP contracted goals and standards of care.
Because RWCA funds are funds of last resort, all outpatient HIV/AIDS medical clinic
contractors must exhaust other sources of funds before billing the County for services.
These include, but are not limited to, Medicare and Medi-Cal. Providers are required to
screen and assess clients for other funding source eligibility, such as Medi-Cal, which
must be utilized to pay for care when the client is eligible.
Currently, OAPP reimburses its contracted outpatient medical clinics through a traditional
line-item budget process. The Board of Supervisors requested that OAPP consider a FFS
cost reimbursement methodology that encourages provider accountability and
productivity, tracks utilization more effectively and ensures that providers are utilizing
other funding resources, such as Medi-Cal, when available. A drawback of the current
reimbursement methodology is that there may be a financial disincentive to enrolling
clients in Medi-Cal, as providers may find line-item reimbursement easier and financially
advantageous.
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Through this Work Order approved by the Board of Supervisors, OAPP sought assistance
in implementing a FFS cost reimbursement methodology to replace the existing
reimbursement system for HIV/AIDS outpatient medical services.
Objectives of the study included:










Review of national and local standards of care
Review of the Los Angeles HIV/AIDS Continuum of Care Model included in the
County of Los Angeles HIV/AIDS Comprehensive Care Plan (August 2002)
Survey of other EMAs that have a FFS program
Survey of current practice regarding coding of procedures and diagnosis among
HIV/AIDS outpatient medical clinic providers
Analysis of the costs of providing outpatient medical services based on the accepted
standards of care
Preparation of recommendations of FFS rates for the identified outpatient medical
services
Identification of services that are commonly reimbursed by third-party payers;
Identification of barriers to implementation
Recommended guidelines for collection of fees

Specifically, the primary medical care services for which the Board of Supervisors and
OAPP initially intended to develop a FFS cost reimbursement methodology included:







AOM
ADAP
Drug Resistance Testing
Medical Case Management
Medical Specialty
Nutritional Counseling (Medical Nutritional Therapy)

The study specifications initially requested a service description and rate of
reimbursement for referrals to Medical Specialty services. Mercer initially produced both
a service description and rate of reimbursement for this referral service. However, PHS
standards of care dictate that specialty services must accessible to the HIV-positive client
by the primary care provider. The service description developed for HIV/AIDS AOM,
which considered the PHS requirements, requires referral standards for Medical Specialty
care. A separate Medical Specialty service description results in redundant requirements.
Mercer recommended Medical Specialty services not be funded as a separate service
description. Continuing to fund it separately would result in duplicative payment for the
same service requirement under two service descriptions. Therefore, this report contains
no rate recommendations for a separately reimbursed referral to Medical Specialty.
OAPP-funded providers have been successful in negotiating locally-derived rates of
reimbursement that financially create access to these expensive services. Mercer
recommends that special relationships between primary care and specialty care providers
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not be interrupted. Where there are no special relationships between providers for a
needed specialty care service, Mercer recommends that rates of reimbursement should not
exceed the Medicare/Medi-Cal established rates. Conceding to the Medicaid/Medicare
rates (where there is no opportunity for rates derived through special relationships) is an
established practice in publicly-funded HIV/AIDS primary health care.
Likewise, the PHS HIV/AIDS standards of care for drug resistance testing were changed
to incorporate drug resistance testing and counseling as a routine component of
HIV-related primary health care. Therefore, and in interest of maintaining
recommendations that are current with the PHS standards, Mercer recommended the
service description for Drug Resistance Testing not be funded as a separate service
description, but rather be included as a routine requirement within the HIV/AIDS AOM
Care service description. No rate recommendation for a separately reimbursed Drug
Resistance Testing service is included in this report.
Further, during the time frame included in this study, Medical Case Management was
being closely scrutinized by OAPP and the Commission on HIV. Because the
configuration of services included in Medical Case Management was under review, this
report contains no rate recommendation for a separately reimbursed Medical Case
Management service.
The services for which Mercer set rates and developed service descriptions that are
included in this report include:
Outpatient Medical Care Services
Service Description and Rate Development

 Ambulatory/Outpatient Medical Care (AOM)
 AIDS Drug Assistance Program (ADAP)
 Nutritional Counseling (Medical Nutritional Therapy)

Mercer’s direct-care, staff-driven rate architecture is a unique approach to rate
construction that emphasizes “hands on” staff resources provided to the people receiving
services and varies according to the professional level and quantity of staff time. Three
key principles serve as the foundation for this system:
1. The most prominent and important variable in the determination of quality and the
successful adherence to care standards is the direct service staff profile.
2. All other cost components, which are equally necessary, although less directly
variable in response to differences in standards of care, can be expressed in
relationship to direct service staff costs.
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3. If all the compensation components are studied and their relationships to direct
service staff cost profiles are determined, a standardized rate system can be produced
by establishing the direct service staff profiles (in accordance with standards of care)
and then building the total compensation (rate) according to the relationships of the
other components to the service staff costs.
While the direct service staff profile is critical to this rate system, it is not the only cost
component necessary to create rates. Rather, the direct service staff profile is the most
prominent in supporting the services descriptions that promote quality care. The clear
identification of service descriptions that promote quality care for the selected service
categories was an integral part of this study, since the goal of the County of Los Angeles,
as well as Mercer, was to develop rates that adequately support the provision of quality
services, as defined by current regulations and quality care practices.
This report not only provides rates for the outpatient service categories included within
this study, it also summarizes the methodology, findings, barriers to the implementation
of the proposed rate system and recommendations to address these barriers. The
remaining sections of the report are outlined below:


Section 3: Service Description Development
− Methodology for AOM, ADAP and Nutritional Counseling (Medical Nutritional
Therapy)
− Medical Specialty
− Drug Resistance Testing
− Medical Case Management
− Review of the HIV/AIDS Continuum of Care Model



Section 4: Rate Development
− Cost Components
− Methodology
− Other EMAs – Rates
− Future Rate Change Process



Section 5: Budget Impact Analysis
− Methodology
− Budget Impact Results



Section 6: Third-Party Payer Reimbursement
− Methodology
− Findings and Results
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Section 7: Barriers/Disincentives and Recommendations
− Exceeding Accepted Standards
− Maximizing Medi-Cal Funding
− Medical Specialty, Drug Resistance Testing, and Medical Case Management



Section 8: Next Steps
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3
Service Description Development
Methodology for AOM, ADAP and Nutritional Counseling (Medical
Nutritional Therapy)
Mercer’s methodology for the development of rates that support clinically-appropriate
outpatient services for people living with HIV/AIDS is based on the documentation of
clear and accurate standards of care for each service category under study. The
development of standard service descriptions was the first phase of the study. To
successfully complete this phase, Mercer adopted the following approach:
Step 1: Exploratory Meetings with OAPP
Mercer first met with OAPP through face-to-face meetings and telephonic discussions to
better understand the current standards of care in existing contracts with selected
providers, as well as to understand the Board of Supervisors’ expectations and OAPP’s
program requirements for the provision of quality services.
Step 2: Literature and Information Review
Following these initial discussions, Mercer performed an in-depth review of information
and literature from multiple sources on standards and protocols of care for outpatient
HIV/AIDS services. These sources include but are not limited to:







OAPP Contracts and Standards of Care
Commission on HIV Standards of Care
California Code of Regulations
Mayor’s AIDS Leadership Council, HIV and AIDS in Los Angeles: 21st Century
Challenges and Approaches, December 2003
County of Los Angeles HIV/AIDS Comprehensive Care Plan, August 2002 (and
Commission updates for 2003, 2004)
HIV/AIDS Continuum of Care Model, County of Los Angeles (and Commission
updates for 2003, 2004, see Appendices A and B)
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Other State Resources: Program Guidelines and Standards of Care, and Best Practices
from the California Department of Public Health, Office of AIDS (particularly, the
Early Intervention Program model, and guidelines for the ADAP program).
National Resources: the Public Health Service, Department of Health and Human
Services (DHHS) guidelines for the medical management of HIV infection and other
issues surrounding HIV infection, Standards of Care published by national health care
professional associations and Best Practice Recommendations from the AIDS
Education and Treatment Centers National Resource Center.

Step 3: Development of Service Descriptions
After reviewing and analyzing these materials, Mercer developed draft service
descriptions in each of the categories of services selected for this study. Mercer’s primary
goal in preparing these documents was to ensure that the rates developed for these service
categories were reflective of the most appropriate standards of care and were adequately
designed to compensate providers for high quality services.
Step 4: OAPP Review
Mercer sought feedback from OAPP on the service descriptions. Several iterations were
developed before the final drafts of the service descriptions were developed.
Step 5: Provider Interviews
Mercer conducted 11 interviews in September 2004 with staff representing the
Commission on HIV, the Prevention Planning Committee, HIV/AIDS service providers
and OAPP. These perspectives figured directly in Mercer’s assessment of the HIV/AIDS
Continuum of Care Model (Appendix B) as adequate, which was ultimately assessed as
appropriately challenging and not in need of revisions. Additionally, these interview
comments were considered during the revision to the initial draft of the service
descriptions.
Step 6: Provider Input into Service Descriptions
Mercer consulted with Los Angeles County HIV/AIDS service providers in order to make
the service descriptions as appropriate and effective as possible for use in the County of
Los Angeles. A summarized list of provider and other stakeholder input is included as
Appendix C.
As noted previously, Mercer conducted 11 interviews in September 2004 with staff
representing the Commission on HIV, the Prevention Planning Committee, HIV/AIDS
service providers and OAPP. These interview comments were considered during the
revision to the initial draft of the service descriptions.
To continue evaluating the appropriateness and effectiveness of the service descriptions
for use in the County of Los Angeles, Mercer facilitated a November 8, 2004 focus group
with outpatient care professionals providing HIV/AIDS services. The focus group was
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attended by both providers who are and are not currently in the OAPP provider network.
Focus group participants received the service descriptions in advance, and then were
convened for a group-wide discussion at OAPP. Because of time restraints, participants
were asked to submit written comments on service descriptions that were not reviewed in
this meeting. These comments were synthesized and provided to participants prior to a
group-wide conference call in December 2004 where all final comments were addressed.
All focus group comments and suggestions were carefully reviewed and considered for
inclusion as revisions to the service descriptions.
In order to have feedback from a physician practicing in the private sector who is not
currently funded by OAPP. This physician was selected to review the AOM service
description and feedback was obtained from this physician through telephone interview.
The physician was selected by OAPP. The comments provided by the physician,
encouraging Mercer and OAPP to continue with the development of state-of-the-art
service standards for use in publicly-funded HIV/AIDS medical care, were summarized
and presented to OAPP in memo format, as well as incorporated into the AOM service
description.
As a result of the comments from the focus group on the Nutritional Counseling (Medical
Nutritional Therapy) service description, an OAPP nutrition expert facilitated a review of
the service description by nine Los Angeles-area registered dietitians. The comments and
suggestions from these local professionals were also carefully considered and integrated
into the Nutritional Counseling (Medical Nutritional Therapy) service description.
In order to make sure adequate service delivery time frames were set for the enrollment
services required for the ADAP service description, service providers were interviewed
by telephone, and the reports of time actually expended, together with the specific
activities provided, were synthesized and applied to both the service description and rate
determinations.
OAPP-funded providers of home-based case management services were interviewed to
make sure the Medical Case Management model would not duplicate these services. This
was in response to a concern raised by a focus group participant. The issue of duplicating
services was further researched with the OAPP staff and no duplications in service
requirements were found with the Medical Case Management service description
included in the rate study.
Step 7: Commission’s Feedback
Copies of draft services descriptions were provided to the Commission on HIV. One
Commissioner provided written comments to OAPP staff and these comments were
forwarded to Mercer. The Commissioner had questions regarding the service definitions
and their comparison to definitions within Medi-Cal and Medicare, definition of fee
schedules, the definition of Quality Assurance and concern for additional paperwork that
may be required of potential clients to qualify for services. These questions are more
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appropriately addressed through the legislative definitions and requirements attached to
the RWCA or questions related to OAPP contracting guidelines and contracts. The
Mercer FFS project does not redefine the RWCA service definitions but rather uses them
explicitly. This study is not producing a fee schedule but rather specific reimbursement
rates for specific services.
Step 8: Commission’s Updated Standards of Care
During the same time period that the Mercer was developing service descriptions for this
study, the Commission on HIV updated its Standards of Care. The most recent Standard
of Care for Medical Outpatient was updated effective January 13, 2006. It notes that the
Standard of Care “represents a synthesis of a significant number of published standards
and research” including a key source document, the draft standard prepared for this study.
Step 9: Update Based on Comparison to Commission’s Updated Standards of
Care
OAPP provided a comparative analysis of differences in the Commission’s updated
Standards of Care in contrast to the service descriptions developed for this study. The
service descriptions were revised to ensure compatibility with the Commission’s
Standards of Care.
Step 10: Finalization of Service Descriptions
After reviewing feedback stakeholders and reconciling differences identified in the
Commission’s Standards of Care, Mercer developed final service descriptions. Copies of
service descriptions are provided in Appendix E.

Medical Specialty
The study specifications initially requested a service description and rate of
reimbursement for referrals to Medical Specialty services. Mercer initially produced both
a service description and rate of reimbursement for this referral service. However, PHS
standards of care dictate that specialty services must be accessible to the HIV-positive or
AIDS-inflected client by the primary care provider. The service description developed for
HIV/AIDS AOM, which considered the PHS requirements, requires referral standards for
Medical Specialty care. A separate Medical Specialty service description results in
redundant requirements. Mercer recommended Medical Specialty services not be funded
as a separate service description. Continuing to fund it separately would result in
duplicative payment for the same service requirement under two service descriptions.
Therefore, this report contains no rate recommendations for a separately reimbursed
referral to Medical Specialty.
OAPP-funded providers have been successful in negotiating locally-derived rates of
reimbursement that financially create access to these expensive services. Mercer
recommends that special relationships between primary care and specialty care providers
not be interrupted. Where there are no special relationships between providers for a
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needed specialty care service, Mercer recommends that rates of reimbursement should not
exceed the Medicare/Medi-Cal established rates. Conceding to the Medicaid/Medicare
rates (where there is no opportunity for rates derived through special relationships) is an
established practice in publicly-funded HIV/AIDS primary health care.

Drug Resistance Testing
Likewise, the PHS HIV/AIDS standards of care for drug resistance testing were changed
to incorporate drug resistance testing and counseling as a routine component of
HIV-related primary health care. Therefore, and in interest of maintaining
recommendations that are current with the PHS standards, Mercer recommended the
service description for Drug Resistance Testing not be funded as a separate service
description, but rather be included as a routine requirement within the HIV/AIDS AOM
Care service description. No rate recommendation for a separately reimbursed Drug
Resistance Testing service is included in this report.

Medical Case Management
Mercer worked collaboratively with select OAPP program management staff to identify
an appropriate model for HIV/AIDS Medical Case Management, taking into
consideration the Board of Supervisors’ expectations and OAPP’s existing service
delivery pattern of using clinical nurses to provide care coordination. The Roy Adaptation
Model for nursing case management was reviewed and mutually found appropriate for
this service description initially. The service description delineated the following
requirements for the delivery of Medical Case Management:


Medical Case Management services are provided by a Registered Nurse (RN) in good
standing and licensed in California by the State Board of Behavioral Sciences. The
RN must practice within the scope of practice defined in the California Business and
Professions Code, Section 2725, RN Scope of Practice (www.rn.ca.gov).



Medical Case Managers must be certified through the OAPP HIV Case Management
Certification Program (the OAPP Case Manager Certification Program is currently
being revised to include training specific to Medical Case Management).



Medical Case Managers are employed in provider agencies meeting the full
requirements for HIV/AIDS AOM Care Services.



Medical Case Management is a process of assessing, planning, coordinating,
monitoring, and evaluating the medical services required to respond to a client’s
HIV/AIDS prevention and health care needs. The overall goal of Medical Case
Management is to facilitate the coordination and sequencing of primary health care
services in order to achieve optimal health outcomes.
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Medical Case Management is a service in the HIV/AIDS Continuum of Care offered
in response to the growing complexity of HIV prevention and disease management. It
is also offered in response to the need clients have expressed for expert guidance
through an ever-increasing complement of services that comprise the comprehensive
HIV/AIDS Continuum of Care.



Medical Case Management focuses intentionally on the client’s access, utilization,
retention and adherence to Primary Health Care Core Services in the HIV/AIDS
Continuum of Care. These Primary Health Care Core Services are described in the
County of Los Angeles HIV/AIDS Comprehensive Care Plan (2002), available
through the OAPP.



Medical Case Management services are not required as a precondition for receiving
other services in the HIV/AIDS Continuum of Care, neither are they intended to
reduce or curtail the use of primary health care services. Rather, Medical Case
Management services are intended to facilitate the client in obtaining and sustaining
the best and most appropriate treatment. These services are client-centered and
provided within an overall philosophy of assisting the client in becoming an effective
self-manager of his or her own care.



While the Medical Case Manager focuses on Primary Health Care Core Services, the
Medical Case Manager also facilitates optimal health outcomes for the HIV-infected
client, partners and social affiliates and the diverse health care professionals providing
services in the HIV/AIDS Continuum of Care. The Medical Case Manager facilitates
optimal health outcomes through advocacy, liaison, and collaboration to achieve
continuity of care, effective communication and coordination of appropriate
HIV/AIDS prevention and treatment services.

An initial rate was developed for Medical Case Management based the services
description modeled on the Roy Adaptation Model. However, during the time frame
included in this study, Medical Case Management was being closely scrutinized by OAPP
and the Commission on HIV. The Commission revised its Standard of Care effective for
Case Management, Medical Services effective May 11, 2006. Because the configuration
of services included in Medical Case Management was under review, and continues to be
under review, this report contains no rate recommendation for a separately reimbursed
Medical Case Management service.

Review of Continuum of Care Model
A task identified in the Work Order requested a review of the Los Angeles HIV/AIDS
Continuum of Care Model Strategic Planning Process (1999–2001). In 2001, the new
HIV/AIDS Continuum of Care Model was jointly approved and adopted by the
Commission and OAPP.
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From the beginning, the HIV/AIDS Continuum of Care Model was a bold statement of
commitment to improving the HIV-related health outcomes for all individuals and
families at-risk for or infected with the HIV virus, and to reducing the disparities in
HIV-related health outcomes for racial, ethnic, and social minorities in the County of Los
Angeles. Moving towards fulfillment of this commitment, planners, providers and OAPP
staff use the model to focus concretely on how the HIV/AIDS Continuum of Care
Model’s HIV/AIDS Primary Health Care Core Services will be made available to County
of Los Angeles citizens who depend on publicly-funded HIV/AIDS services.
The HIV/AIDS Continuum of Care Model pushes beyond the single issue of “access to
services” to a more complex question of how to assure that clients have appropriate
access to services, utilize them consistently, are effectively retained in services over time,
and adhere to medical regimens while receiving HIV/AIDS services. This service
formula, “Access – Utilization – Retention – Adherence”, underscores a second
commitment, providing care coordination services for those who need them so that
improvements in HIV-related health outcomes may, in fact, be achieved. The HIV/AIDS
Continuum of Care Model is a client-centered and flexible one, with multiple points of
entry, and while it sets a clear standard by delineating the critical HIV/AIDS service
components in a state-of-the-art Continuum of Care Model, it does not impose a single set
of services for any one or all clients who may seek services within this Continuum of
Care Model.
There is a third commitment evidenced in the HIV/AIDS Continuum of Care Model’s
design, a commitment to effectively integrate HIV prevention services with care and
treatment services. HIV prevention services are an integral component of HIV/AIDS
primary health care core services. Planners, providers and OAPP staff are focusing not
only on how to seamlessly link the prevention and care service systems, but how to give
equal weight to HIV prevention in the context of routine and recurring medical care.
In the review conducted by Mercer, providers saw the Model’s attempt at “true
integration” and its view of “HIV disease as a continuum, clarifying the whole spectrum
of need” as clear strengths. Challenges to meeting the Continuum of Care Model’s
expectations included provider training and capacity-building needs, establishing provider
agreement on meeting the expectations when the service system is already so fully
developed and assistance in developing the provider partnerships needed to offer any one
client the full range of possible services.
The features of the HIV/AIDS Continuum of Care Model are concretely represented in
the service descriptions. Use of the service descriptions with updates over time will likely
assist providers in more closely approximating the expectations described in the
HIV/AIDS Continuum of Care Model. However, providers will need direct support to
enhance their abilities to fully implement this Model.
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Based on Mercer’s review of the national HIV/AIDS standards of care and on the
commitment of the providers to implement the HIV/AIDS Continuum of Care Model,
Mercer recommends that the Board of Supervisors support OAPP and its partners in
planning and system development based on the Continuum of Care Model as currently
defined.
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4
Rate Development
The second phase of the project involved the development of FFS rates for services
included in the study using the Mercer’s direct-Care, staff-driven rate architecture. To
understand this rate methodology, an understanding of the various cost components is
critical. The cost components, and a description of each, are presented below.

Cost Components
There are four standard cost components that are assumed to be common to all social and
medical services. These include:
1.
2.
3.
4.

Direct Service Staff Wage
Employment-Related Expenditures
Program-Related Expenditures
General and Administrative Expenditures

Direct Service Staff Wage
The definition of direct service staff wage consists of the following two elements:
1. The staff must be people who are performing tasks in the furtherance of the objectives
of the service. In other words, they must be doing what they are doing in order to
meet some objective defined in the service. They are not considered direct service
staff solely by their qualifications.
2. The person who is receiving the service and who is expected to benefit from it must
be present, most of the time. “Most” is defined as 90% or more.
There is a need to be specific in the definition of direct service staff because service
descriptions often describe minimal amounts of time that should be spent in any given
period. In some cases, this may be provided by a variety of qualifying staff. Equally, there
may be staff associated with the program that have the same qualifications as direct
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service staff but who do not perform tasks related to the service and so would not satisfy
the minimum requirements of the service standard.
Employment-Related Expenditures
Simply stated, employment-related expenditures are all the benefits received by
employees of the service agency. Benefits generally fall into two categories:
1. Discretionary Benefits: those benefits that employers may elect to provide but are not
mandated to do so by any governmental authority.
2. Non-Discretionary Benefits: those benefits that are mandated by a governmental
authority.
Program-Related Expenditures
Program-related expenditures are all the expenditures that support the objectives and the
provision of the service, but cannot be tied to any particular person receiving the service.
For this reason, program-related expenditures are considered “indirect” rather than
general and administrative expenditures. Supervision of direct service staff, staff who do
not spend 90% of time with clients but who work with clients, supplies related to the
service, consultative services to general staff, client transportation and staff
training/education are all examples of program-related expenditures. It is important to
note that many factors influence the inclusion or exclusion of cost types in this category,
but the two most prominent are the service descriptions and the funding source
regulations.
General and Administrative Expenditures
General and administrative expenditures are the costs of being in business. General and
administrative expenditures have nothing directly to do with the type of program, the type
of service, or the product offered. These expenditures are costs that are as common to
automotive manufacturing firms as they are to pizza parlors or as common to doctors’
practices as they are to amusement parks. General and administrative expenses include
administrative salaries, insurance, travel and entertainment, office expenses, lease or
rental costs for office space, depreciation, property insurance, equipment rental and other
interests. In most instances, the categories of costs included in this component are similar
in both non-profit and for-profit organizations.

Methodology
Mercer’s methodology for rate development is based on reported costs, appropriate
clinical practices, and established service descriptions. This methodology has been
successfully used and replicated in multiple states for a variety of health and human
services. The process chart on the following page provides an overview of rate
development, and each step is discussed in detail in subsequent sections of this report.
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Rate Development Methodology – A Process Chart

Determine the Cost Categories

Gather the Financial Data

Organize and Analyze Data

Review Service
Descriptions

Establish Direct Service Staff
Wage Profile
Determine Employment-Related
Expenditures Percentage

Determine Program-Related
Expenditure Percentage

Determine General and Administrative
Expenditure Percentage

Synthesize Components into
the Rate
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The following narrative explains each step of the rate development with a description of
the processes and actions taken by Mercer to successfully complete each of these steps.
Step 1: Determine the Cost Categories
The first step in developing standardized rates for services was to study each service
description in great detail to determine if the four cost categories described previously
will be sufficient, or if additional categories would be needed to address program and
provider-specific issues.
Some components will vary because of differences in the way services are described. For
example, in some institutional settings, nursing care is considered an integral part of the
services that each resident will need and levels of nursing are expressed as requirements
of the service description. In this case, a nurse would be considered a Direct Service Staff
because the two parts of the definition of Direct Service Staff (furtherance of objectives
and 90% client contact) have been met. In other settings, nursing care may or may not
occur, or it may be of a consultative nature to the facility itself and not specific to any
particular client. In this case, the cost of the nurse would be a part of program-related
expenditures.
For this study, for all services (AOM, ADAP and Nutritional Counseling) Mercer used
the component categories described earlier, including:





Direct Service Staff Wage
Employment-Related Expenditures
Program-Related Expenditures
General and Administrative Expenditures

Step 2: Gather the Financial Data
The next step undertaken by Mercer was to determine the nature, quantity and quality of
existing expenditure data for providers. The underlying questions that were addressed as
part of this exercise were as follows (in this order):
1. What are the line-item costs related to the services?
2. Are the costs reported in enough detail so as to be identifiable in the categorizations
determined necessary in Step 1?
3. If not, in what manner will the information be gathered?
4. Is the available data current?
5. Is the available data reliable?
6. Are the line-items somewhat consistent between providers of the same service?
Data must meet the following conditions to be useable in rate development:



The data must be available (reports must exist)
The data should be current
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The data should be accurate and objectively supportable
The data should be in enough detail so as to allow for categorization, according to the
determined categories necessary
Line-items within the data should be consistent between providers of the same service

With regard to AOM Services, Mercer found that the general ledgers and ESIS provided
by providers in late January/early February 2008, in general, met these conditions. For
ADAP and Nutritional Counseling, the cost reports provided in the first year of the study
were helpful but did not meet two of the criteria above. The cost report information was
not in enough detail to allow for categorization and line-items within the data were not
consistent between providers. For this reason, Mercer relied much more heavily on BLS
data for the Los Angeles metropolitan area to develop the rate for ADAP and Nutritional
Counseling as described in subsequent steps.
Step 3: Organize and Analyze Data
In this step, for AOM services, provider general ledger and ESIS information was
organized so that the cost components could be compared in a consistent manner across
providers. This organization of the information allowed for the successful completion of
the component analysis. The final result of the component analysis was an understanding
of each of the cost components’ relationship to Direct Service Staff costs for each of the
service categories analyzed. These components were expressed in terms of a relationship,
i.e., as a percentage. For ADAP and Nutritional Counseling services, cost report data and
BLS information was organized and analyzed for the completion of the component
analysis.
Step 4: Review Standards
In the fourth step of the rate development, Mercer reviewed the service descriptions
prepared in the first phase of the study to establish the proper type and quantity of Direct
Service Staffing levels and the general profiles of the Direct Service Staff specific to the
service description. This information formed the cornerstone of the completed rates.
Step 5: Establish Direct Service Staff Wage Profile
Mercer then proceeded to establish the wages associated with the staff described in the
service descriptions as Direct Service Staff. Depending on the unique nature of the
service being studied, this can be performed in a number of ways. Wage and benefit
studies can be performed, analysis of provider data can be completed, research into
objective sources of wage and benefit information such as BLS can be done, prevailing
market wages currently paid by providers in the area can be reviewed, and finally,
administrative discretion may be used to set wage levels as a matter of policy.
For this particular study, Mercer used the analysis of the provider general ledger data to
establish direct service staff wage levels for physician-like staff for AOM services. The
average physician-like costs from the usable provider general ledger data was
$147,519.85. Mercer first trended individual providers’ average physician-like wage at
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4% annually from the midpoint of the most recent year of the reported expenditures on
the ESIS to the midpoint of the year of the anticipated start date, March 1, 2009, and then
averaged all providers’ physician-like wages.
For ADAP and Nutritional Counseling services, Mercer utilized data from BLS wage
information. For ADAP, Mercer selected the occupation called Medical Records and
Health Information Technician (code 29-2071) for the Los Angeles metropolitan area.
The annual wage identified in the most recent BLS report was trended at a 4% increase
per year from the midpoint of the year of the available data to the midpoint of the year of
the anticipated start date, March 1, 2009. The annual direct service staff wage level for
an ADAP worker for purposes of the rate development was $46,110.91.
For Nutritional Counseling, Mercer selected the occupation called Dieticians and
Nutritionists (code 29-1031) for the Los Angeles metropolitan area. The annual wage
identified in the most recent BLS report was trended at a 4% increase per year from the
midpoint of the year of the available data to the midpoint of the year of the anticipated
start date, March 1, 2009. The annual direct service staff wage level for a
Dietician/Nutritionist for purposes of the rate development was $84,107.39.
Step 6: Determine Employment-Related Expenditures Percentage
Mercer calculated the employment-related expenditure percentage using provider general
ledger information for the AOM service. The average employment-related expenditures
percentage expressed as percentage of direct service staff wage level was 42.07%. The
employment-related percentage was based on the average of five providers whose general
ledger data was deemed complete enough for use in the study. Mercer used the most
recent general ledger year provided. For three providers, the time frame was
March 1, 2006 to February 28, 2007. For one, the time frame was July 1, 2006 to June 30,
2007. For the last provider, it was January 1, 2006 to December 31, 2006. Mercer totaled
the dollars from all providers in the employment-related category and divided by the total
dollars for all providers for direct care professionals (physicians, physician assistants and
nurse practitioners).
For ADAP and Nutritional Counseling, Mercer used historical BLS information,
considered the rise in trend of benefit costs, and ultimately used 30%.
Step 7: Determine Program-Related Expenditures Percentage
For the AOM service, Mercer isolated all accounts from information provided in provider
general ledgers that were identified as program-related. Then the amounts in those cost
line-items were totaled and compared to direct care staff costs in order to derive a
percentage (228.04%) that expressed the relationship. The program-related percentage
was based on the average of the same five providers’ general ledgers’ information and
was calculated in the same way as the employment-related percentage, i.e., based on the
total dollars and not the average of the percentages. The program-related percentage used
in Mercer’s calculation was 228.04% of the direct service staff wage.

Mercer Government Human Services Consulting

29

Medical Clinical Fee-for-Service
Reimbursement Rate Study

Office of AIDS Programs and Policy
Final Report

For the ADAP and Nutritional Counseling services, Mercer used initial analysis from cost
reports and estimated expenditures related to program-related needs, and ultimately
utilized 68% for ADAP services and 49% for Nutritional Counseling.
Step 8: Determine General and Administrative Expenditure Percentage
According to early discussions with OAPP and the Health Resources and Services
Administration (HRSA), the federal agency responsible for the award, administration, and
regulation of RWCA funding, OAPP is permitted to compensate provider agencies for
general and administrative expenditures, but only up to a maximum of 10% across all
provider agencies. In other words, the general and administrative percentage funding
cannot exceed 10% for the entire system. It is permitted to compensate individual
provider agencies at different general and administrative percentage levels provided that
the entire dollar expenditure in this category, taken in total, does not exceed 10%.
Based on this information, a general and administrative percentage of 10% was
calculated. The direct service staff wage plus the employment-related expenditures plus
the program-related expenditures constitutes a subtotal (subtotal 1), which is adjusted for
the general and administrative by “grossing up” the total by the general and
administrative percentage such that:
Subtotal 1 divided by (1 – General and Administrative Percentage) = Total Rate
Review of the providers’ general ledgers for AOM services show that the reported true
costs borne by providers exceed the 10% cap. On average, provider general and
administrative costs were approximately 32% of total program costs. It is important to
note that Mercer’s categorization of reported general and administrative costs included
facility costs such as rent and equipment. Providers may argue that they must have
specialized facilities and equipment to treat HIV-positive/AIDS-infected persons in a
primary care setting.
The goal of the rate development study was to develop a rate that considered all costs.
All costs should be considered and the final rate reflects the true reported cost of services.
The general and administrative percent of total program reported costs was 31.7% or
171.79% of the direct staff care wage. The general and administrative percentage was
based on the average of four providers' general ledgers’ information. One provider’s
general and administrative expenses were 2.5 times higher (as a percentage) than the next
closest provider and the providers’ general and administrative dollars were held out of the
calculation. The general and administrative percentage used in Mercer's calculation was
31.7%.
In Step 9, below, Mercer has included two calculations of the AOM Rate for OAPP’s
consideration: one rate with 10% general and administrative costs and one with 31.7% of
total costs (or 171.79% of the direct staff care wage).
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The general and administrative rate for ADAP and Nutritional Counseling was calculated
at 10%. The direct service staff wage plus the employment-related expenditures plus the
program-related expenditures constitutes a subtotal (subtotal 1), which is adjusted for the
general and administrative by “grossing up” the total by the general and administrative
percentage such that:
Subtotal 1 divided by (1 – General and Administrative Percentage) = Total Rate
Step 9: Synthesize Cost Components into the Rate
In this step, the individual calculations in the previous steps were combined to formulate
the rates for individual services. Once the percentages for the three components
(employment-related, program-related and general and administrative) have been
calculated, the final step is to identify the “denominator”, i.e., the number of encounters
expected to be delivered. For AOM services, Mercer calculated the average number of
encounters provided in the most recent year as reported on the provider ESIS resulting in
2,130 per year. For ADAP services, Mercer estimated 35 minutes per average encounter,
i.e., blended average encounters for new admissions and recertifications, for a total of
3,566 encounters per year adjusted by 10% less as a capacity adjustment for a total of
3,209 encounters per year. Similarly, for Nutritional Counseling services, Mercer
estimated 60 minutes per encounter for an initial assessment and 20 minutes per
encounter for a continuing visit for a total of 2,080 and 6,240 encounters per year,
respectively, adjusted by 10% less as a capacity adjustment for a total of 1,872 and 5,616
encounters per year, respectively.
AOM with 10% General and Administrative Cap
Direct Care Staff Wage = $147,518.85
Employment-Related = 42.0749% of direct care staff wage
Program-Related = 228.0417% of direct care staff wage
Subtotal
General and Administrative = 10% of total
Total
Encounters = 2,129.6462
Rate
AOM with Actual General and Administrative
Direct Care Staff Wage = $147,518.85
Employment-Related = 42.0749% of direct care staff wage
Program-Related = 228.0417% of direct care staff wage
Subtotal
General and Administrative = 31.7% of total or 171.7852% of
direct care staff wage
Total
Encounters = 2,129.6462
Rate
ADAP
Direct Care Staff Wage = $46,110.91
Employment-Related = 30% of direct care staff wage
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147,519
62,068
336,404
545,991
60,665
606,656
2,130
284.86

$
$
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147,519
62,068
336,404
545,991
253,416

$ 799,407
÷
2,130
$ 375.37

$
$

46,111
13,833
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$ 31,355
$ 91,299
$ 10,144
$ 101,443
÷
2,130
$
31.61

Nutritional Counseling – Initial Assessment
Direct Care Staff Wage = $84,107.39
Employment-Related = 30% of direct care staff wage
Program-Related = 49% of direct care staff wage
Subtotal
General and Administrative = 10% of total
Total
Encounters = 2,129.6462
Rate

$ 84,107
$ 25,232
$ 41,213
$ 150,552
$ 16,728
$ 167,280
÷
1,872
$ 89.36

Nutritional Counseling – Continuing Visit
Direct Care Staff Wage = $84,107.39
Employment-Related = 30% of direct care staff wage
Program-Related = 49% of direct care staff wage
Subtotal
General and Administrative = 10% of total
Total
Encounters = 2,129.6462
Rate

$ 84,107
$ 25,232
$ 41,213
$ 150,552
$ 16,728
$ 167,280
÷
5,616
$ 29.79

Other EMAs – Rates
Mercer interviewed three EMAs for comparisons on approaches to FFS contracting and
reimbursement methods. The EMAs were selected by OAPP.
1. Miami-Dade EMA: This EMA uses the Florida Medicare Part B rates as the basic
structure of a “unit cost” system. There are two sets of codes that are carved out for
special rates: one subset of codes is reimbursed at 150% of the Medicare Part B rate
and the fees for another subset of “supplemental” codes are individually negotiated
per provider. These codes are “supplemental” in the sense that they represent
procedures/services not covered under other fee schedules. Providers are issued a
contract with a line-item budget that describes acceptable expenditures and bill by
unit cost or by code. At the end of the contract period, should billings exceed actual
expenditures, providers must return the excess. Providers are not reimbursed for more
than the contract budget.
2. Harris County (Houston) EMA: This EMA uses a “unit cost model” that is not based
on actual costs as determined by the providers. The administrative agency and
planning council review customary payments for services from other payers (private
insurance, and especially Medicaid and Medicare), review the historical pattern of
numbers of visits/encounters the EMA has financially supported, and considers the
maximum funding available for each service category. A “unit cost” is subjectively
negotiated from these reviews. Each provider agency is reimbursed at this standard
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unit cost. The unit cost is actually a “maximum allowable” billing rate and providers
tend to bill at the maximum allowable rate. Unit definitions are very broadly defined.
Providers are contracted at a finite amount and these contracts are not augmented
within any one contract period.
3. St. Louis EMA: This EMA “borrowed” from the rates established by the State ten
years ago and these rates still exceed the Medicaid/Medicare rates for Missouri.
Providers sign a simple agreement to accept these reimbursement rates and bill by
CPT codes. The codes largely relate to a defined visit and are not procedure-driven.
All providers use a single lab, and the lab negotiates directly with the administrative
agency. There is a strong individual private provider network in this EMA.
If these three EMAs, taken with the Los Angeles County EMA as a fourth, are
representative of the approaches to FFS reimbursement, the following can be noted:








EMAs tend to use the Medicaid/Medicare rates as a basis to rate-setting, practically
and creatively building on these rates in varied ways. The end result is often specific
to the EMA, and reflects a negotiated “acceptability” between the RWCA
administrative agency and the contracted providers of RWCA services.
The decision to address actual costs, and to use these cost analyses in rate-setting,
varies with the EMAs capacity for cost-based analyses (i.e., whether there are
financial data management systems in place to collect and manipulate actual
cost-based information). The “amount of work” for providers in establishing true and
actual costs is frequently mentioned as a justification for conceding to
Medicaid/Medicare rates with some negotiated variations or augmentations that speak
to provider-identified concerns with public sector rates.
There is an operative assumption that the RWCA funds are not sufficient to fully
reimburse for true and actual costs for providing care. This is particularly acute when
discussing medical care services. There is always an assumption that the amount of
service delivery would have to be severely curtailed if true and actual costs were
reimbursed through RWCA funds alone.
Each EMA relies on a sense of “charity” within large institutional providers to show a
willingness to take care of HIV-positive clients knowing that only a reasonable
amount of the costs will be reimbursed through the RWCA funds.

Future Rate Change Process
The direct staff wage rate architecture is adaptable to change by making appropriate
adjustments to the calculations within the architecture. Mercer has provided OAPP with
the detailed rate modeling analytical files in Microsoft Excel that allow for adjustments to
various rate components which will result in automatic recalculation of rates. Some areas
where changes could occur are as follows:


If political will exists to increase the assumption of direct service staff wage levels
over time (Mercer assumed a 4% annual increase) and the decision to increase them is
made and funded, the wage levels can be immediately changed and the rates will
automatically recalculate.
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If unfunded mandates become funded, those changes can be made to the appropriate
component (usually employment-related expenditures or general and administrative
expenditures) and again, the rates will automatically recalculate.
Service descriptions will usually either affect the Direct Service Staff profile or the
program-related expenditure percentage. If so, these may involve a more complicated
recalculation of the rate system components but the architecture remains unchanged.

Data Manipulation Capacity: Claims Adjudication
At the request of the OAPP, Mercer performed an analysis of the Casewatch® data
management system. The purpose of the analysis was to express an opinion about the
system’s ability to process and report claims and authorization information in a format
and process compatible with that required by Medicaid (Medicaid Management
Information System). Mercer performed the analysis with the following findings:



The Casewatch® system contains fields which would allow for the prior-authorization
of services by modality code as identified by OAPP or through the use of Common
Procedural Terminology (CPT) procedure codes.
The system reporting capacities are quite flexible and can be designed to fit the needs
of the user in a variety of ways.
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5
Budget Impact Analysis
In any rate development exercise, the importance of evaluating the impact of the rates on
the program budget at the existing level of funding cannot be overemphasized.
Additionally, it is also critical to assess and seek to quantify the impact of the rates on the
individual providers. This is especially important for HIV AOM services in the County of
Los Angeles, where different compensation systems have been developed over long
periods of time, with different negotiation characteristics. In such an environment, the
replacement of these reimbursement amounts with a standardized published rate system
will result in increases in rates for some providers while others may see decreases in
reimbursement rates. For this reason, Mercer performed an in-depth budget analysis to
study the impact of the rate system on each provider to determine the amount of increase
or decrease they will experience. This information was provided in the draft report
released in October 2007. However, the provider community argued that the encounters
supplied by OAPP, against which the rate was multiplied, were problematic and should
not be used. In this final report, Mercer could only analyze the net gain/loss for those
AOM providers who had submitted an ESIS and a general ledger.

Methodology
The process used to perform the budget impact analysis for Los Angeles County
consisted of the following steps:





Establish existing allocation: This was provided by providers on the ESIS.
Establish proposed rates: The development of proposed rates is discussed in this
report in Section 4.
Calculate budget variance: Mercer calculated the difference between current
allocations and anticipated allocations if the new rate was implemented.
Measure impact on individual providers: The impact of the proposed rate system on
each individual provider agency was then calculated and expressed in total dollar
amounts.
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Budget Impact Results
A comparison to previous AOM allocation to anticipated allocation for those providers
who submitted an ESIS are provided below:
Provider
1
2
3
4
5
6
7
8
9

Net Gain or Loss
at $375.37 Rate
$ (737,047.59)
$
666,290.96
$
9,356.75
$ (961,383.38)
$
(85,422.36)
$
164,714.91
$ (444,172.57)
$
68,965.43
$
116,707.86

Net Gain or Loss
at $284.86 Rate
$ (3,515,187.20)
$
156,007.49
$
(146,769.36)
$ (1,663,181.54)
$
(275,850.96)
$
106,337.32
$
(568,982.95)
$
23,711.49
$
(327,414.35)
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6
Third-Party Payer Reimbursement
In delivering any health or health-related service, the presence of multiple funding and
payer sources inevitably results in high levels of complexity, both in terms of billing
practices and reimbursement mechanisms. This is all the more true for publicly-funded
systems such as the HIV/AIDS services that owe the majority of their budgets to funding
sources of last resort. Typically, processing claims as a payer of last resort is a function
described as Coordination of Benefits and relates to billing the appropriate entity
responsible for payment. Coordinating payment from multiple funding sources including
Medicare (Title XVIII), Medicaid (Title XIX), HRSA Ryan White CARE Act funds,
State and County, private-sector or private insurance can be daunting when a client is
eligible for more than one insurance or funding program. To better understand the
complexities of multiple reimbursement mechanisms and to create a rate system that
encourages the appropriate and optimal use of available funding sources, OAPP included
an evaluation of third-party reimbursement as a component of this rate study.

Methodology
To address the issue of third-party reimbursement and to identify whether services for
people living with HIV/AIDS are being reimbursed by other insurers or third-party
payers, Mercer performed a series of investigatory activities that are summarized in the
steps outlined below.
Mercer focused on a review of an array of services associated with people living with
HIV/AIDS for the purpose of analyzing the status of Coordination of Benefits. Mercer
also reviewed current processes for determining client co-payments.
Step 1: Collect Information on OAPP Data Systems
Mercer obtained existing information from the client information systems from OAPP
staff. The specific “screen prints” from the current OAPP prior-authorization and claims
processing information systems that were collected and reviewed include:
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Client Basic Data
OAPP Report Demographics
HRSA Client Level Information

Step 2: Analyze Information System Elements and Reports
Upon receiving the screen prints, Mercer evaluated each one for evidence of three
components of Coordination of Benefits among the funding sources:





Indication that the person receiving services was eligible for coverage under one of
the other funding programs, particularly at the time of eligibility for services, through
OAPP.
Identification of the agent that gathers the information for billing purposes and at
what stage of assessment or services the information is gathered from the person
receiving services. For example, was the information gathered at the time the referral
was being considered by the provider, during an eligibility or intake review, by the
provider at the time services were to be provided, or even later during services?
Any evidence that the data field in which the information would be entered is a
required field and whether it would be of the sort that might link to a claims
processing or prior-authorization module that would be able to pend a claim or a
prior-authorization as a result of the field being populated with the specific evidence
of third-party coverage.

Step 3: Discuss Initial Observations with OAPP
After the initial review and analysis, Mercer met with staff of OAPP and the Office of the
Auditor-Controller staff to discuss preliminary findings and to seek clarification on
certain issues related to third-party coverage. Through these discussions, many of
Mercer’s observations were confirmed.
Step 4: Review Public Sources of Funding
For the primary care services included within this study, Mercer evaluated other public
sources of funding available in the County of Los Angeles to determine if the services are
covered by these public programs and if so, whether providers are maximizing these
funds for the clients that they serve.
Step 5: Review Commercial Insurance Coverage
Another key area of focus for this rate study was the availability of commercial insurance
coverage for the service categories included in this study. To address this, Mercer
reviewed benefit packages of national and local commercial insurance providers and also
interviewed experts in insurance benefit design to determine existing levels of coverage
for these services.
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Findings and Results
The observations made as a result of this analysis are presented in this part of the report
under the following sub-sections:




Third-party Coverage and Reimbursement
Coordination of Benefits
Co-payments and Client Fees

Third-Party Coverage and Reimbursement
For the primary care services included within this rate study, RWCA funds obtained
through HRSA must be considered funds of last resort. This is clearly mandated in the
CARE Act of 2000 legislation. Outside this funding source, Mercer found that in the
County of Los Angeles, a number of third-party funding programs currently exist and
may be utilized to serve HIV/AIDS clients. Each of the key funding sources is discussed
below and wherever possible, the amount of funding available from each source is also
outlined.
Federally Qualified Health Center Program

Because the PHS Section 330 Community Health Center Program and the Federally
Qualified Health Center Programs are considered “sister” programs with other
federally-funded special population health programs, Mercer debated briefly the
advantages and disadvantages of OAPP-funded medical providers becoming federally
qualified health centers (FQHCs). This was considered because it would provide a way
to take advantage of the cost-based reimbursement the FQHC program provides to
community and public health centers. However, the organizational development
challenges that come with this designation proved to be too onerous for some of the
currently-funded community health providers. For example, the Board of Directors of an
FQHC must comply with the PHS Section 330 51% consumer member standard. The
administrative and financial reporting requirements are quite sophisticated and would
make for comprehensive technical assistance needs for some community providers,
together with demanding substantial financial development to support the corresponding
organizational development and management needs. Most important, however, is the
wholesale change of organizational focus this designation would require as FQHCs must
demonstrate a capacity to provide comprehensive general primary care to all clients.
Currently, OAPP funds are used to support specialized HIV/AIDS primary care only and
some of the currently funded providers do not directly provide general comprehensive
primary care to their clients, let alone to the client’s family members or social affiliates.
Therefore, to recommend this designation be pursued by all OAPP-funded providers at
this time is too sweeping an organizational, financial and mission change.
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Medi-Cal Program

Medi-Cal is the State of California’s Title XIX Medicaid entitlement program and the
largest source of publicly-funded care services in the State. Medi-Cal is governed by
stringent and complex federal regulations, as well as California-specific rules, to ensure
optimal and appropriate use of public funds for health care delivery. Physical health
providers appear to be more aware of Medi-Cal funding regulations and utilize this fund
source where appropriate. However, providers should be clear that the expectation is that
all Medi-Cal allowable service reimbursement be collected and the contracts should
reflect this requirement.
On the surface, obtaining Medi-Cal reimbursement may seem a fairly simple process
linked to three main criteria:




Service must be a covered Medi-Cal benefit
Client must be eligible and enrolled in Medi-Cal or the designated waiver
Provider must be certified to participate in Medi-Cal

However, the more one delves into the program and its regulations, the more complicated
and elaborate the system becomes. For providers, the complexity of Medi-Cal begins with
the large number of unique programs that exist under the Medi-Cal umbrella. Some of
these programs are structured as traditional FFS reimbursement models while others are
covered through managed care arrangements. States, such as California, have exercised
the option made available through the Social Security Act to “waive” certain federal
requirements and implement innovative health delivery programs through both program
waivers (Section 1915(b) and (c)) and research and demonstration waivers (Section
1115). Each of these waiver programs targets a specific population, has its own unique
eligibility criteria and often has distinct services covered within the program’s benefit
package. Adding to this complexity, each individual Medi-Cal program has its own
provider application process. This process may also vary by provider category.
Medi-Cal Covered Services

As a way of assessing whether the Mercer rates of reimbursement are within the public
sector range, Mercer conducted a review of services covered by Medi-Cal. For this
particular set of medical services, the attempt to make one-to-one comparisons with
Medi-Cal was not possible. This is because of the particular approach used by OAPP in
the delivery of a service (e.g., the Roy Adaptation model for medical case management),
because there were no one-to-one correspondences in services (e.g., the State model for
ADAP enrollment services), or because of the recent revisions to PHS guidelines that are
changing HIV/AIDS medical service delivery. The service descriptions developed by
Mercer were based on the service delivery approaches discussed with OAPP and
stakeholders. Additionally, the Mercer rate setting architecture is a method that weds
reimbursement rates with the most current standards of care. Therefore, as the following
summary will demonstrate, the Mercer rates are not comparable to Medi-Cal rates (with
the exception of Nutritional Counseling (Medical Nutritional Therapy):
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1. HIV/AIDS AOM Care Services: This service description has two new aspects that are
not paralleled in the service model underlying current Medi-Cal rates. First, the
service description includes new service components, implemented in the routine
medical encounter, that are based on the PHS guidelines’ recent emphasis on the
integration of HIV prevention within primary medical care, the significance of
treatment adherence services and the essential attention to nutrition. These
requirements expand the scope and duration of the routine medical encounter, and
define enhanced areas of expertise needed by the primary care provider in each
routine medical encounter.
Second, the service description (and corresponding rate of reimbursement) is based on
a specific personnel model (physician-like professionals).
As a result the Mercer rate of reimbursement incorporating these features is not
comparable with current Medi-Cal FFS rates of reimbursement nor with the service
model on which the Medi-Cal rates are based.
2. Eligibility, Education and Enrollment Services for ADAP: California service
components in this service description are defined and specified by the California
Department of Public Health, Office of AIDS and they are distinctive to how the
RWCA, AIDS Drug Assistance Program is implemented in California. There is no
comparable Medi-Cal program with which to compare rates of reimbursement for this
service.
3. Nutritional Counseling (Medical Nutrition Therapy): There is a Medi-Cal
reimbursement rate for Medical Nutrition Therapy; however, this rate was established
January 1, 1993, for the AIDS Medi-Cal Waiver Program (MCWP). The development
of AIDS Waiver Programs preceded advances in health outcomes as a result of
HIV-related pharmaceuticals, and State health financing departments established
them as a way to keep AIDS patients out of expensive hospital and/or nursing home
care.
The Medi-Cal rate is: Nutritional Counseling $33.48/hour
The OAPP service description and corresponding reimbursement rate currently does
not include the costs for nutritional supplements as a discrete billable item, and
neither does the above Medi-Cal rate. In the MCWP, “Nutritional Supplements/Home
Delivered Meals” are capped at $150.00 per client per month. This cap also was
established January 1, 1993. The Mercer rate study uses current, geographically
relevant Bureau of Labor Statistics data as an indicator of actual personnel hiring
costs, and then factors these costs with other real-time program and administrative
costs derived from actual agency cost reports. Therefore, the Mercer rate of
reimbursement is a more realistic reimbursement rate for this service in 2007.
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A note from Medicare/Medicaid: The American Dietetic Association (ADA)
proactively works to assist Registered Dietitians in understanding billing procedures
and actively describes appropriate billing codes. There are Medicare/Medicaid CPT
codes for Medical Nutrition Therapy released by the Centers for Medicare and
Medicaid Services (CMS) and included in the American Medical Association’s
(AMA) Current Procedural Terminology CPT book. Medi-Cal has not adopted these
codes for reimbursement.
Coordination of Benefits (Third-Party Payment)
Coordination of Benefits is described as the function of identifying third-party coverage
for services needed by a client and to bill these multiple third-party payers before
accessing funds of last resort. This is often the responsibility of the provider of service
and oversight and monitoring is provided by the funding agency. In many cases, a
designated third-party administrator may also be used to assist in this process. As
demonstrated through the preceding discussion, there are multiple funding sources for
AOM Care services in the County of Los Angeles and the task of Coordination of
Benefits across all these funding sources becomes all the more critical especially in the
wake of increasing costs of care and flat or declining budgets for service delivery.
On examination of OAPP information system screen prints, Mercer found that there is a
single question in the group of screen prints that, if filled in, would indicate whether or
not the individual was covered for services by a third-party insurance plan. Mercer also
found that third-party coverage information is supposed to be gathered by provider
agencies at referral and periodically thereafter.
Mercer was able to confirm that while the data field in the current system is a required
field for providers and that the information is sometimes gathered about third-party
coverage, the submission of the data confirming third-party payment is not linked to any
outside claims adjudicating system. Therefore, there is no process within OAPP to
actually track whether the client has third-party coverage and if the provider submitted a
third-party claim.
Utilization of third-party payer information in a client information file by
cross-referencing the information in claims adjudication assures a “cost avoidance”
approach as opposed to a “pay and chase” approach. The cost avoidance approach is
recommended by federal funding sources, such as Medicaid. However, linking the data
field related to third-party payer to prior-authorization and claims adjudication systems
that are apart from the systems containing third-party information, and particularly when
used by agents other than the prior-authorization and claims processing agencies (as is the
case with OAPP), can involve major systems restructuring and be prohibitively
expensive.
Due to the costs associated with the integration of systems to link third-party payer
information to prior-authorization and claims adjudication data, Mercer recommends that
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the most efficient and cost-effective solution is to build on the processes already in place.
Specifically, by ensuring that the data field for third-party payment is a required field and
the information system links the field to the invoice from the provider, OAPP will have
this information available for its back-end review and follow up. Through discussions
with OAPP staff it was noted that currently OAPP does review fee determination and
third-party payer coverage as part of their on-going monitoring processes. This
retrospective monitoring process is often time-consuming and complicated.
In practical terms, OAPP could employ one of two different options to accurately track
third- party coverage information:
Option 1

OAPP could require that the providers submit an invoice that contains third-party payer
information. When a client has third-party payer coverage, the invoice must be
accompanied by an Explanation of Benefits from the insurer as evidence the insurer has
been billed for covered services. OAPP then can reimburse providers only for the
uncovered service up to the amount of the published rate.
The Health Insurance Portability and Privacy Act (HIPAA) contains certain clauses
related to claims processing and Coordination of Benefits which though once were
recommendations of the General Accounting Office, are now requirements under HIPAA.
Clause §162.1801 Coordination of Benefits Transactions and Clause §162.1802
Standards for Coordination of Benefits require that all electronic claims be submitted in
ASC X 12N 837- Health Care Claim format which includes any prior paid components of
the claim. Towards this end, HIPAA Subpart P – Health Care Payment and Remittance
Advice §162.1601(b) Health Care Payment Remittance Advice Transaction requires the
submittal of Explanation of (Medicare) Benefit (EOB, EOMB) documentation as part of
claim submission, again in ASC X 12N 835 format.
This means that it is now required for publicly-funded health and social services which
are subject to HIPAA to submit all claims after having been determined to be coverable
by any third party, that such documentation be submitted with the claim in the proper
format, and that only the unpaid (net) amount be claimed by the HIPAA-compliant
agency.
Option 2

A second option for OAPP could be the use of a Third-Party Administrator (TPA) or a
similar external entity to work with the providers to provide confirmation of client
eligibility prior to reimbursement and to verify that the primary insurer has been billed for
covered services. This option may be a simpler alternative to implement given the
complexity of current funding streams and should be explored further by OAPP.
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Co-payment and Client Fees
Co-payment is a cost-sharing arrangement in which a person pays a specified charge for a
specified service, such as $10 for an office visit. The covered person is usually
responsible for payment at the time the health care is rendered. The service provider has
responsibility for collection of the co-payment because insurance payments to the
provider are made net the co-payment. However, in the case of Medi-Cal enrollees and
Medi-Cal-funded services, it is not permissible for an agency to assess a co-payment from
the person receiving services.
Providers interviewed in the first phase of this project universally reported that most of
their clients were not assessed a co-payment. According to the providers, two issues made
collecting co-payments problematic. Providers worried about the administrative burden
of collecting the co-payment and about their liability if they refused services because the
client did not have the co-payment.
Co-payment is probably not an avenue for significant additional revenue collection by
OAPP. Hence, AOM rates that have been proposed as part of this study are designed to be
net of any client fees or co-payments.
OAPP should develop a standard policy specifying the management of client fees. The
Medicare program has established some guidelines relating to the management of client
fees and may be referenced in establishing this policy. The guidelines are incorporated
within various chapters of the Medicare Claims Processing Manual.
It is important to note that based upon early conversations with HRSA staff, Mercer
found that HRSA does not have any specific recommendations on client fees and allows
individual HIV/AIDS Agency discretion as to the structure and management of such an
arrangement with appropriate disclosure.
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7
Barriers/Disincentives and Recommendations
The best designed and most successful rate systems are those that are based on
requirements for quality care. Mercer has sought to adapt the rate architecture based on
service descriptions developed based on a combination of current program requirements
and recognized best practices. Throughout this process, Mercer identified barriers to the
implementation of the proposed rate architecture that could potentially discourage or even
prevent cost-effective, high quality service delivery. Specific attention was given to the
following areas:







Restrictions on financial compensation methodologies
Restrictions from outsourced labor and the collection of donations
Any guiding regulations that may impede the ability of the County of Los Angeles to
develop the provider network related to procurement
Prohibitive regulation for management and establishment of sites
Excessive restrictions and requirements that are not feasible in the County of Los
Angeles
Community-based restrictions, such as availability of qualified staff that meet staff
requirements

Some of the key barriers identified through the course of this study are listed and
discussed below. Wherever appropriate, Mercer has recommended strategies that the
Board of Supervisors through OAPP could explore to address or alleviate these barriers or
disincentives.

Exceeding Accepted Standards
In Work Order No. 6-49, Mercer was asked to suggest ways to incentivize providers to
exceed the accepted standards; however, Mercer found that the adoption of the new
HIV/AIDS Continuum of Care Model set a high standard for all providers of HIV-related
medical services in Los Angeles County. The model was based on earlier
federally-funded pilot or “demonstration project” innovations (e.g., the integration of
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prevention and treatment services in medical settings) that are now accepted standards in
the PHS Primary Care Guidelines. To date, the Office of AIDS Programs and Policy and
the Commission on HIV are cooperating in system planning and agency infrastructure
development initiatives that will facilitate fulfilling these accepted standards. When
interviewing providers, Mercer found them in full support of the new HIV/AIDS
Continuum of Care Model but also interested in technical support and capacity-building
opportunities that will assist them in meeting the Model’s expectations. The
recommendation at this time is to solidly implement the accepted, higher standards of
care that support the HIV/AIDS Continuum of Care Model.
Because the science and practice of HIV/AIDS medical management continues to rapidly
evolve, exceeding the current PHS standards in any one year is rarely achieved. Mercer
recommends OAPP and the Commission on HIV continue to implement its public health
role in announcing and distributing standards of care revisions and updates, and continue
their roles in agency and provider education, training, development and capacity-building
as a way to remove barriers to meeting these standards of care.

Maximizing Medi-Cal Funding
As discussed in the previous section of this report, Medi-Cal is a significant, albeit a
complex, source of funding for HIV/AIDS services and it is critical that providers
maximize the funding available through this entitlement program.
Mercer Recommendations: CARE Act of 2000 legislation mandates that CARE Act
funds be the payer of last resort, and HRSA has mandated that wherever other programs
such as Medicaid exist for HIV/AIDS services, these funds must be maximized before
using RWCA funding. Based on these mandates, many states and jurisdictions require
their HIV/AIDS providers actively participate in the Medicaid program. For the selected
services in the County of Los Angeles, Mercer recommends the following:






OAPP and the Commission should work closely with the California Department of
Public Health to identify and clearly define HIV/AIDS services that could be
reimbursed by Medi-Cal and to identify the appropriate Medi-Cal programs/waivers
that HIV/AIDS providers may participate in.
The collaboration with California Department of Public Health could extend to the
task of increasing awareness and knowledge among HIV/AIDS providers of the
importance and need for maximizing Medi-Cal funding for individual service
components that are delivered. The California Department of Public Health provides
training sessions to providers on various topics related to the Medi-Cal program.
Providers should be encouraged to avail of these training opportunities.
OAPP could use its established training curriculum to offer additional training and
technical assistance to providers on the utilization of Medi-Cal as a fund source. This
is an area that has been deemed a HRSA priority and RWCA grant funds have been
utilized in other states to offer this type of technical assistance. In the past, HRSA has
provided third party payment training in the County of Los Angeles. Attendance at
these types of training should be mandatory for providers that contract with OAPP.
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OAPP may wish to audit a sample of medical files to determine if Medi-Cal funding
is underutilized.

Medical Specialty, Drug Resistance Testing and Medical Case
Management
Mercer Recommendation: Mercer recommends the service description written for
Referral to Medical Specialty Service not be funded as a separate and distinct
reimbursable service. The requirement to assess for, refer to, and track specialty care
services is an integrative component of the PHS guidelines for HIV-related primary
medical care. Therefore, the separate service description for Referral to Medical Specialty
Service is redundant and duplicative of the service description for Ambulatory/Outpatient
Medical care services.
In making this recommendation, Mercer is also recognizing and recommending the long
term RWCA “best practice” of local provider-to-local specialty provider negotiated rates
for specialty care be continued. This practice and the subsequent negotiated rates
customarily have a charity basis that has prevented significant use of RWCA funds for a
single expensive specialty care service and thereby permitted distribution of these limited
funds across many needed medical services.
This recommendation in no way is intended to lessen the focus and attention given by
OAPP to continue to fund medical specialty services; however, as prior discussion in the
report has emphasized, a single rate of reimbursement for medical specialty service is
neither feasible nor desirable.
Mercer Recommendation: Because of changes in the PHS HIV/AIDS standards of care,
Mercer recommends this service description no longer be funded as a distinct and
separate service category. Drug resistance testing was earlier viewed as a highly
specialized service but is now considered routine within the medical management of HIV
disease. Therefore, the new expectations associated with drug resistance testing are
incorporated as expectations within the HIV/AIDS Ambulatory Outpatient Medical Care
service description.
Mercer recommends that the actual costs of the blood screening continue to be absorbed
by the State of California, Office of AIDS, Resistance Testing Program. The Mercer
recommendation, therefore, does not assume these lab costs will be absorbed by the
HIV/AIDS AOM providers contracted through OAPP. The medical tasks relevant to
client pre- and post-testing counseling and education for drug resistance are now routine
HIV/AIDS medical management services to be provided by HIV/AIDS practitioners
contracted through OAPP.
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Mercer Recommendation: Because the configuration of services included in Medical
Case Management was under review, this report contains no rate recommendation for a
separately reimbursed Medical Case Management service. Mercer worked collaboratively
with select OAPP program management staff to identify an appropriate model for
HIV/AIDS Medical Case Management, taking into consideration the Board of
Supervisors’ expectations and OAPP’s existing service delivery pattern of using clinical
nurses to provide care coordination. The Roy Adaptation Model for nursing case
management was reviewed and mutually found appropriate for this service description
initially. An initial rate was developed for Medical Case Management based on the Roy
Adaptation Model. During the time frame included in this study, Medical Case
Management was being closely scrutinized by OAPP and the Commission on HIV. The
Commission revised its Standard of Care effective May 11, 2006. However, Medical
Case Management continues to be reviewed and revised as a service and no service
description or rate recommendation is included in this report.

Acuity Modifier
OAPP asked Mercer to explore an acuity modifier in the rate development process. The
construction of such a modifier should follow these steps:
1. Identify the co-morbidity(s) that would most probably result in a more intense level of
need (e.g. hepatitis).
2. Select the case files of individuals for whom the co-morbidity diagnosis applies.
3. Pull the expenditure records for the individuals with co-morbidities and make a
comparison between those cost profiles and those of the general patient population.
4. Express the modifier as a percentage applied to the proposed rates.
The use of a diagnostic profiling approach (International Classification of Disease) or
service procedure approach (CPT codes) is not recommended unless the consistency and
accuracy of the use of diagnostic and procedure codes can be established and linked to
expenditure records in a meaningful way.
It is also possible to adjust the rates by providers based on the percentage of
AIDS-infected persons treated versus the percentage of HIV-infected people treated. The
table below shows a list of current providers and the range of the clients’ status.
Providers’ Self-Reported Percentage of AIDS Patients (January 2007)
Provider
% AIDS-infected
Harbor UCLA
90%
Catalyst
60%
St. Mary’s
60%
City of Pasadena
54%
El Proyecto
50%
AltaMed
47%
T.H.E. Clinic
47%
Watts
35% – 40%
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Provider
North East Valley
AIDS Health Care Foundation
MLK/OASIS
Children’s Hospital
Gay and Lesbian Center

% AIDS-infected
30% – 40%
35%
32%
20% – 30%
13%

Lastly, OAPP could consider an adjustment based on the status of the client in treatment:
New Patient/Newly Diagnosed, Regular Visit, Follow-Up/Brief Visit. However, current
cost data is not available to differentiate the rates but could be studied over time.
Mercer Recommendation: Because accurate cost data on acuity differentials is not
readily available, Mercer recommends OAPP initially pay providers a single rate,
reconcile payment against actual costs on a routine basis, and develop an acuity adjuster,
if necessary, as the issue is studied further.

Implementation of Rates: Budget Impact Concerns
Mercer Recommendation: Finally, Mercer offers recommendations related to the
implementation of the standardized rate system. The first recommendation addresses the
issue of the general and administrative percentage to be used for the final rate calculation
and the second recommendation relates to reconciliation of the allocation paid to
providers at the single rate versus the true costs.
Mercer recommends that OAPP engage in internal policy decisions regarding the general
and administrative percentage to be used for a single provider rate. At the 10% cap rate,
providers may be under-funded for their true total costs.
OAPP should consider a reconciliation process that compares paid rates against true costs
for providers after six months. OAPP could choose to “shadow implement” the rates,
paying the providers with the historical funding methodology and comparing it to what
payment would have been if providers had been paid the single rate.
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8
Next Steps
Through this study, an actuarially sound and locally relevant rate system has been
proposed that supports clinically appropriate services for people living with HIV/AIDS in
the County of Los Angeles. A critical next step in the implementation of the rates is the
finalization of policy and process decisions related to the level of budget funding
available for these services. This will also involve policy decisions regarding the level of
impact that OAPP will allow individual providers to sustain as a result of the new rates.
Adjustments to the rates can be made based on these policy decisions.
It is commendable that throughout the study, OAPP has demonstrated a strong
commitment to ensuring a collaborative process in rate development. To that end, OAPP
and Mercer have met with and interviewed providers on an on-going basis. To facilitate
the successful implementation of this proposed rate architecture, this level of County and
provider collaboration should be continued and strengthened.
In any rate development exercise, the initial hurdles and barriers that may be encountered
are numerous. This is clearly demonstrated in the list of barriers that were identified
through the course of this rate study and that were presented in this report. While Mercer
has sought to present recommendations and potential solutions that address or mitigate
these barriers, it is clearly understood that implementation will not be without issues. The
issue of the general and administrative percentage to use in the rate calculation is an
example of an immediate policy issue that must be considered and resolved. Some
recommendations deserve immediate attention while others should be addressed in and
throughout the RFP process. Other issues may require a more sustained and long-term
approach and can be addressed after the release of the RFP. A summary of the
recommendations are presented in the table below.
Mercer is privileged to have had the opportunity to work with OAPP and the County of
Los Angeles on this exciting and innovative rate study. Based upon Mercer’s experiences
in the areas of HIV/AIDS and rate development across the United States, it is clear that
the County of Los Angeles is a leader in the effort to link HIV/AIDS reimbursement to
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appropriate clinical standards and practices thereby ensuring both high quality and
cost-effective service delivery. Mercer is confident that through the collaboration of the
County and its HIV/AIDS providers, a planned and coordinated implementation strategy,
and appropriate training for all those involved, OAPP will be able to successfully
implement this rate architecture and serve as a model for structured and equitable
reimbursement methodologies for other HIV/AIDS programs nationwide.
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A
HIV/AIDS Continuum of Care Model, County of Los
Angeles
The Commission on HIV approved the HIV/AIDS continuum October 14, 2004
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HIV/AIDS CONTINUUM OF CARE MODEL, COUNTY OF LOS ANGELES
Only funded service
categories are listed
Prevention Services
(not CARE Act-Funded)

Case Management, Psychosocial
Case Management, Medical
Translation/interpretation

Food Bank, Home DM,
Nutritional supplements
Housing assistance
& services
Transportation
Child care

6. PROGRAM SUPPORT
Service Coordination
Capacity Building
Service Enhancement
Evaluation
Training and Education
Program Research/Review
Rate and Fee Review
Mercer Government Human Services Consulting

HIV Counseling/Testing
Partner Counseling/Referral
Heath Education/Risk Reduction
Medical outpatient
General and Specialty
Treatment Adherence
Nutritional Counseling
HIV/AIDS Medications
Mental health: Psychiatric
Mental health: Psychological
Oral Health
Substance Abuse Services
5. ENHANCEMENT SERVICE
Psychosocial Support
Service HIV Support

Legal Services
Permanency planning

7. PLANNING COUNCIL SUPPORT
Priority- and Allocation-Setting
Evaluation Activities
Public Awareness Efforts
Training Activities
Staffing Pattern
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Introduction
The HIV/AIDS Continuum of Care Model is an outcome of the County of Los Angeles
Strategic Planning Process (1999-2001). In 2001, the new Continuum of Care was jointly
approved and adopted by the County of Los Angeles Commission on HIV (Commission),
the Prevention Planning Committee (PPC), and the Office of AIDS Programs and Policy
(OAPP).
The model was first adopted for use in health systems planning and development, and
planners and staff continue to use this model as a foundation in the annual “Priority and
Allocations Process” required by the Ryan White CARE Act (RWCA). The model
figured prominently in the development of the County of Los Angeles HIV/AIDS
Comprehensive Care Plan (August 2002) and has proven helpful in broadening the focus
of planners and providers beyond government resources when financial planning and
development needs are raised.
Improving HIV-Related Health Outcomes. From the beginning, the HIV/AIDS
Continuum of Care Model was a bold statement of commitment to improving the HIVrelated health outcomes for all individuals and families at risk for or infected with the
HIV virus, and to reducing the disparities in HIV-related health outcomes for racial,
ethnic, and social minorities in the County of Los Angeles. Moving towards fulfillment of
this commitment, planners, providers, and OAPP staff use the model to focus concretely
on how the Continuum of Care Model’s HIV/AIDS Primary Health Care Core Services
will be made available to County of Los Angeles citizens who depend on publicly-funded
HIV/AIDS services.
Patient Care Coordination. The HIV/AIDS Continuum of Care Model pushes beyond
the single issue of “access to services” to a more complex question of how to assure that
clients have appropriate access to services, utilize them consistently, are effectively
retained in services over time, and adhere to medical regimens while receiving HIV/AIDS
services. This service formula, Access-Utilization-Retention-Adherence, underscores a
second commitment (i.e., providing Patient Care Coordination services for those who
need them so that improvements in HIV-related health outcomes may, in fact, be
achieved). The HIV/AIDS Continuum of Care Model is a client-centered and flexible
one, with multiple points of entry, and while it sets a clear standard by delineating the
critical HIV/AIDS service components in a state-of-the-art continuum of care model, it
does not impose a single set of services for any one or all clients who may seek services
within this Continuum of Care Model.
Integration of Prevention and Care Services. There is a third commitment evidenced in
the HIV/AIDS Continuum of Care Model’s design; a commitment to effectively
integrating HIV prevention services with care and treatment services. HIV prevention
services are an integral component of the HIV/AIDS Primary Health Care Core
Services. Planners, providers, and OAPP staff are focusing not only on how to seamlessly
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link the prevention and care service systems, but how to give equal weight to HIV
prevention in the context of routine and recurring medical care.
The HIV/AIDS Continuum of Care Model is a conceptual tool that helps planners,
providers, and staff review service needs from a comprehensive perspective, not just in
terms of the services categorical funding sources are willing to support. It is being used to
better inform quality assurance and standard of care activities, and is used as a general
guideline when monitoring the practice of clinicians and other health/social service
practitioners. Finally, the HIV/AIDS Continuum of Care Model is currently being used by
OAPP staff to revise funding program “Requests for Proposals,” and one provider
interviewed for this report described using the model to “better integrate and manage the
core team” now needed in the HIV/AIDS primary health care program she supervises.
Approach to Model Review. As a part of The HIV/AIDS Medical Clinics Fee-forService Reimbursement Rate Study (Work Order Request No. 6-49, January 2004),
Mercer Government Human Services Consulting (Mercer) agreed to review the
HIV/AIDS Continuum of Care Model noting specifically:
the key strengths and weaknesses of the current model;
existing barriers to the attainment of the goals of the model;
opportunities to address these barriers and enhance the model; and
opportunities to link this model with appropriate incentives.
Mercer reviewed the model and related goals described in the County of Los Angeles
HIV/AIDS Comprehensive Care Plan (August 2002). Because the Commission continues
to improve the model through its planning processes, Mercer also reviewed the most
current version of the model approved by the Commission on October 14, 2004.
The Work Order Request called for interviews with Commission members, HIV/AIDS
service providers, and OAPP staff. OAPP and Commission staff jointly identified the
individuals to be interviewed by Mercer. They included individuals capable of speaking
from both the prevention services and care services perspectives. A set of open-ended
interview questions was developed to permit interviewees to respond to each of the four
areas listed above. Mercer conducted the interviews by telephone and sorted the
responses into the same four areas listed above. The interview responses are presented in
summary form in this report.
Relying significantly on the interview material, Mercer completed the review by drawing
observations from the collected perspectives and formulated suggestions provided in the
last section of this report.
Mercer Peer Review. All work performed by Mercer is subjected to a strict quality
assurance process. Mercer has clear professional standards regarding the process of “peer
review” (quality control) at various steps in product development. Mercer utilized this

Mercer Government Human Services Consulting

Office of AIDS Programs and Policy
Final Report

Medical Clinical Fee-for-Service
Reimbursement Rate Study

peer review process in the development of this report. We applied peer review from a
number of perspectives, reviewing this work product as follows:
Technical Peer Review to ensure accuracy and overall reasonableness;
Consulting Peer Review to ensure the soundness of the approach and to ensure that
the appropriate issue/question has been completely addressed in a clear manner;
Editorial Peer Review for grammatical and spelling correctness as well as
professional appearance; and
Final Look Peer Review to ensure a professional work product appearance that meets
the delivery and other specifications.
OAPP Internal Review. Before release of this report, Mercer reviewed its contents with
the managerial staff of OAPP and incorporated the revisions suggested by them. Drafts of
the report were reviewed by managerial staff representing both HIV prevention and
care/treatment services.

The HIV/AIDS Continuum of Care Model
HIV/AIDS Continuum of Care

Primary Health
Health Care Core Services
HIV Counseling and Testing
Partner Counseling and Referral
Health Education and Risk
Reduction
Outpatient Medical
Outpatient Medical Specialty
Psychiatric Services
Psychological Services
Nutritional Counseling
Oral Health Care
Substance Abuse Services
Treatment Adherence

The HIV/AIDS Continuum of Care Model is conceptually
defined by a core of HIV/AIDS Primary Health Care
Core Services considered to be essential to improving the
health outcomes for all citizens of the County of Los
Angeles at risk for or infected with HIV/AIDS. Primary
care in this model includes services for physical and
emotional health, and the core gives mutual weight to
both HIV prevention and care and treatment services. 1
Medication services are a component of Outpatient
Medical Services, provided to interrupt or delay the
progression of HIV disease, prevent and treat
opportunistic infections, and promote optimal health.

The Primary Health Care Core Services is supported
by Wrap-around Services categorized as services for the
Hospice Services
Removal of Barriers, for Patient Care Coordination and
Language Services, services related to Economic Wellbeing, and Enhancement Services.
While the Wrap-around Services are related generally to improving health outcomes,
these services, when combined with the Primary Health Care Core Services, are
especially related to reducing the disparities in health outcomes experienced by racial,
ethnic, and social minorities in the County of Los Angeles. They are also intended to
assure clients access and receive appropriate primary care services.

1

For a thorough description of the HIV/AIDS Continuum of Care Model, see the County of Los Angeles HIV/AIDS
Comprehensive Care Plan (August 2002), pp. 1-3 through 1-8, available through OAPP.
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The services listed within Removal of Barriers are designed to help optimize the critical
paths through which clients access, utilize, are retained in and are adherent to primary
care services. Patient Care Coordination and Language Services provide clients with the
expert guidance needed to fully utilize continuum of care services. Services related to
Economic Wellbeing assist in the amelioration of poverty and the removal of financial
roadblocks to continuing in prevention and care services. Enhancement Services are selfhelp oriented services designed to improve the quality of life for specific populations or
communities.
The HIV/AIDS Continuum of Care Model is intended to guide planners and service
providers in the development of quality, state-of-the-art services in HIV/AIDS. It is
intended to promote a more equitable development and access to HIV/AIDS Primary
Health Care Core Services in the County of Los Angeles, and intended to permit a more
culturally-appropriate development of Wrap-around Services within and across
communities in the County of Los Angeles.

The Model Review’s Relationship to the Rate Study
The medical services rate reimbursement study focuses on six services that are critical
components to the HIV/AIDS Continuum of Care Model’s Primary Health Care Core
Services. The study includes a thorough review and revision of service descriptions
according to national standards of care, and takes into consideration costs and service
delivery issues related to meeting the national standards.
Medical Services Rate Study

Ambulatory/Outpatient
Medical Care
Referral to Medical Specialty
Services
Drug Resistance Testing
Medical Nutrition Therapy
Medical Case Management
ADAP Enrollment

The study is designed to facilitate OAPP in procuring and
providing quality, state-of-the-art HIV prevention, and care
services. Therefore, the rate study includes a general review of
the HIV/AIDS Continuum of Care Model in order to flag
variables that strengthen and/or challenge the provision of
these services within the prescribed HIV/AIDS Continuum of
Care.
The Continuum of Care Model review is not a full-scale
evaluation of the HIV/AIDS Continuum of Care Model, but
rather a supporting activity that offers broad perspective and
helpful suggestions to improve the model that cradles the
medical services in the rate reimbursement study.

Summary of Model Review Interviews
The summary that follows is paraphrased from 11 telephone interviews conducted by
Mercer. Phrases presented in quotation marks are direct, anonymous quotes from
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interviewees. A few quotes are selected for emphasis in text boxes and are linked, with
permission, to the interviewee that made the statement.2
Key Strengths and Weaknesses. Planners, providers, and staff all expressed full support
for the HIV/AIDS Continuum of Care Model, saw it as providing appropriate direction
for HIV/AIDS services in the County of Los Angeles, and described weaknesses more in
terms of challenges in implementing the model. Interviewees tended to pair strengths and
weaknesses rather than to list discrete or unrelated strengths or weaknesses.
The model is a “true attempt at integration” and looks at “HIV disease as a Continuum
of Care.” However, it is “difficult to get providers to look at HIV in this same way,” to
not look at the service they provide as a distinct unit. Providers need to work within the
linkages and “view the client’s overall care as a continuum.”
The HIV/AIDS Continuum of Care
Model recognizes that each client is an
individual with “a specific need for a
specific set of services.” However, the
geography of the County of Los Angeles is
very large and is “hard to navigate
services.” This allows for “splitting and
duplication of services” within the
Continuum of Care Model.

Fariba S. Younai, DDS
“HIV disease is a continuum. You cannot say one service
is more important than the other. A client’s overall care
is a continuum.”

The model “clarifies the whole spectrum of need” but it is sometimes “unclear that just
because the service is needed does not mean RWCA funds will provide it.”
The model actually synthesizes “all that has gone on before in HIV” and presents this
as a “phenomenal Continuum of Care Model.” However, the presentation is “not simple
enough” for those who do not have “a historical background in HIV.” It is hard to “get the
whole meaning of the recipe” and there is “not enough room to learn” about the model.
The model identifies needs overall and “allows the County of Los Angeles to take a
look at how the County should respond” to these needs. The model “shows that services
are interlinked and there must be collaboration among the agencies.” However, the model
does not have “specific pathways” that describe how the
model will be implemented across the County of Los
Angeles.
Debbi Collins, MPAS, PA-C

The model “envisions a continuum that is not linear.”
It is “holistic and it reflects accurately the multiple
points of entry” needed in a Continuum of Care Model.
2

Any misstatement in the paraphrased or directly quoted
phrases is the unintended error of Mercer.

“Management of HIV disease is complicated. It cannot be
managed without all the disciplines cohesively involved.
The Continuum of Care model supports the ‘good
management’ of care that crosses many areas of life,
community, and families.”
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The model promotes the understanding that “not everyone will experience the Continuum
of Care Model the same.” Not actually a weakness of the model, but when applying the
model “it is difficult to comply with the requirements of funders who are more rigid and
more linear in their thought patterns.”
The “concept is ideal. People are not linear and need many things.” However, “we need
to communicate it better” and the model “assumes that people have skill sets they don’t
have, like prevention skills.”
The model “wants you to institute other aspects of care, not just medical care, and it
supports patient involvement. It supports the Primary Health Care Core Services
having linkages between the patient and the community. It breaks down a lot of barriers
for people with chronic illness.” However, the model is challenged by “changing dollars”
and by “changing types of patients” whose health management is more difficult.
Barriers to Attaining the Model’s Goals.
The goals related to the HIV/AIDS Continuum of Care Model discussed in this review are
those described in the County of Los Angeles HIV/AIDS Comprehensive Care Plan
(August 2002). Interviewees were encouraged to refresh themselves generally on these
goals prior to the interview.
The procurement process cannot be “based solely on the Continuum of Care Model”
and both the “preservation of historically-funded agencies” and “stakeholder protection”
is sometimes barriers to making the changes needed in the service delivery system.
The “system had already developed and grown large” before the new Continuum of
Care Model was approved. Changes after-the-fact are difficult to make. Also, providers in
the Continuum of Care “get funding through different streams” and these funders have
“existing mind-sets” that differ from the goals of the HIV/AIDS Continuum of Care
Model.
The goal of the Continuum of Care Model “is really seamless services and the barriers
are logistic. Seven to ten ‘Centers of Excellence’ are needed that are medically-centered
with support services built around them.”
The goals require “changes to the way services
have been organized traditionally” and “working
with new partners” is sometimes a barrier for
providers who have been “working within the same
structures for 15 to 20 years.” It is “hard for some
providers to affect ‘cultural diversity’ because of
who they are and where they are.”

Mercer Government Human Services Consulting

Wilbert C. Jordan, MD, MPH
“’Barriers’ is the wrong word. I am not sure we
are aware, it has not been put to us right. My
plate is full. We need someone to come and point
out to us what we need to do on-site.”
“We have to find people who are interested in
broadening their horizons. We need people with
greater interests. Then, we have to teach them
when they do become interested. We need a way
to feed each other within regions or districts, not
just at the Commission where things have gotten
very technical.”
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The Continuum of Care Model’s goals and objectives are “not yet incorporated into
agency contracts” and many providers “do not know there are goals related to an
HIV/AIDS Continuum of Care Model.” Most providers are “responding to the contract
deliverables only and are not involved in setting the goals” and “do not see how the
money plays out according to the new continuum.”
Agencies do not have the funds and “lack the infrastructure to make this [meeting the
goals] happen. Medical staffs are being pulled off to get other things done. There is a
nursing shortage.”
It is hard to know if goals are being met when data is not being collected that is needed
to measure the goals. Agency staff is not “computer savvy” and “overall technological
capacity is low.” There needs to be an “integrated, standardized Continuous Quality
Improvement Program across the board.”
HIV/AIDS is a “difficult disease to manage and you have to help clients manage their
lives” to manage HIV disease well. “You have to have help; you must be a part of a
network and providers lack knowledge about how this type of network works.”
Opportunities to Address Barriers and Enhance the Model. The interviewees were
uniformly engaged in offering suggestions for how to address barriers they identified.
Rather than offering suggestions on ways to change the conceptual model, suggestions
were made for how to enhance abilities to fully implement the model as currently defined.
The suggestions may be summarized as follows:
1) Continuing education and technical support is needed to assist planners and providers
in transitioning from thinking about discrete services to thinking about services in a
Continuum of Care Model and how one set or category of HIV services relates to
other sets or categories of services.
Staff providing services need education and on-site support to apply “this
thinking” to direct patient prevention and care services.
2) More attention should be directed toward a “system-wide approach” to evaluation and
Continuous Quality Improvement Program, together with concrete support to agency
staff to collect and synthesize computerized service utilization and service outcome
data.
3) Hands-on assistance to develop effective partnerships and practical training on how to
work within service partnerships, across professional, cultural, social, and
geographical boundaries is needed.
Medical care and social service providers need to “better align themselves as
equally necessary partners, creating cohesion and unity in the continuum.”
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4) Opportunities for providers and planners within regions or districts to “talk about how
the whole continuum is evolving” should be available, and an improved
approach/method for needs assessment must be developed.
Linking Incentives to the Model. This section of the Work Order Request was
conceptualized when the County of Los Angeles HIV/AIDS service environment
included a few providers who, on their own initiative or through special demonstration
funding, were attempting to innovatively restructure services in a way that now
corresponds to the HIV/AIDS Continuum of Care Model. The question was how to
motivate or “incentivize” all agencies to exceed program standards and adopt the
innovations, particularly the integration of prevention with care and treatment services,
when federal program guidance did not yet require these changes.
The development of the HIV/AIDS Continuum of Care Model occurred during this same
period. Many of the innovative features of the model were included as a way to prepare
the County of Los Angeles service providers for the anticipated adoption of these same
features as program standards by federal sources like the RWCA and the Community HIV
Prevention Planning Programs. Over the last two years, national standards of care and
federal program guidance indeed have been revised. Service innovations once seen as
exceeding the requirements are now national standards within federally-required models
of service delivery.
While some technical aspects and innovative features of the HIV/AIDS Continuum of
Care Model may not be fully understood by all County of Los Angeles providers,
interviewees agreed the model has become the normative standard to guide an evolving
HIV/AIDS service delivery system in the County of Los Angeles. Interviewees were
uniformly in support of incentives (i.e., technical assistance, educational opportunities,
skills, and capacity-building initiatives) to encourage continual organizational
improvement among all agencies. “Money” was described as a tool, an appropriate and
needed tool, for providing quality services or for constructing a changed system of care.
Interviewees uniformly agreed provider agencies should be fully reimbursed for actual
costs associated with fulfilling the expectations of the model. However, interviewees also
uniformly agreed agencies “should not simply be given more money” because they meet
the expectations of the HIV/AIDS Continuum of Care Model.
While interviewees acknowledged the growing problem of increasing administrative and
service mandates in a shrinking funding environment, most were more concerned about
how to capture financial information in order to be able to “maximize the use of RWCA
funds” to fully support needed services. Planners, providers, and staff wanted to know
how to stretch funds efficiently to meet unmet needs rather than augmenting agency
budgets as a way to motivate compliance with Continuum of Care Model standards.
Others expressed a priority for addressing disparities in agency funding and capacity that
are evident across districts and the County of Los Angeles service planning areas before
“rewarding agencies with more money.”
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Mercer Observations and Recommendations: the
County of Los Angeles HIV/AIDS Continuum of Care
Model
1) Based on Mercer’s review of the current national HIV/AIDS standards of care and the
commitment of those interviewed to implementing the HIV/AIDS Continuum of Care
Model, Mercer recommends OAPP and its partners in planning and systems
development; continue on the established course with the model as currently defined.3
One interviewee commended the HIV/AIDS Continuum of Care Model’s ability
to “define the relationship between services.” This is a critical point: the model
clusters services in relationship to desired health outcomes, suggesting that certain
clusters of services must be available to any one single patient if a specific health
outcome is desired. Other interviewees noted the necessity of providing services
within a network of providers; necessary because, again, certain clusters of services
are needed to produce certain desired health outcomes, and no one agency offers all
services within the HIV/AIDS Continuum of Care Model.
Providers are socialized into thinking more categorically and singularly about the
services they provide. Mercer recommends continuing education of provider agencies
on the “relationship between services” as this will facilitate agency partnership
development and will lead naturally into a shared quality assurance approach for the
resulting service delivery system.
2) Having turned a sophisticated corner in defining a state-of-the-art HIV/AIDS
Continuum of Care Model and setting expectations for its full implementation, Mercer
concurs with OAPP’s first step of establishing the costs associated with the provision
of state-of-the-art services and determining a rate of reimbursement to financially
support agencies in providing these services.
While financial reimbursements are typically prominent in discussions of service
delivery expectations, adequate financial reimbursements alone will not assure the full
implementation of the HIV/AIDS Continuum of Care Model. Mercer suggests OAPP
engage in technical assistance and capacity-building efforts targeted specifically to

3

Due to the legislative requirements for Priority and Allocations in the RWCA, the Commission and OAPP
engage in discussions annually about the rank order of services in the HIV/AIDS Continuum of Care
Model. This activity is relevant to meeting grant requirements but is no longer particularly helpful in
solving more complex implementation problems posed by providing HIV/AIDS services in the County of
Los Angeles. Therefore, “as currently defined” indicates, Mercer finds the components of the HIV/AIDS
Continuum of Care Model to be well defined; it does not indicate support for or against the rank ordering of
services in any one specific grant year.
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agencies needing support to fulfill the service expectations set by the HIV/AIDS
Continuum of Care Model.
3) HIV/AIDS is still a service environment where key individuals personally impact the
availability and quality of services within and among agencies. Mercer encourages
efforts by OAPP to develop and sustain visionary leadership among agency directors
(and other managers) and among health care providers employed in managerial roles.
A shared vision and continued inspiration for the HIV/AIDS Continuum of Care
Model among agency medical and managerial leaders will directly impact the success
if its implementation across the County of Los Angeles.
Leadership development among direct care providers is another area to target for
HIV/AIDS Continuum of Care Model support. Because of the conflict of interest
concerns in RWCA and Community HIV Prevention Planning, finding a way to
involve direct care providers in system of care development can be a challenge.
Providers will be interested most in how the HIV/AIDS Continuum of Care Model
concretely, practically is applied in direct care or practice settings. Mercer
recommends OAPP create special opportunities to support peer relationships among
health care practitioners, and use these relationships as a way of mutually encouraging
and supporting state-of-the-art service provision.

Mercer wishes to express gratitude to the following individuals for their insight and
perspectives on the HIV/AIDS Continuum of Care Model provided through interviews.
Commission and PPC Members/Staff
Fariba S. Younai, DDS
Clinical Professor, Oral Biology and Medicine
UCLA School of Dentistry
Anna Long, Chief of Staff of Public Health
County of Los Angeles, Department of Health Services
Kathy Watt, Executive Director
Van Ness Recovery House
Wilbert C. Jordan, MD, MPH
Medical Director, Oasis Clinics HIV/AIDS Programs
Craig Vincent-Jones, Executive Director
Commission on HIV
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HIV/AIDS Service Providers
Deborah O. Collins, MPAS, PA-C
Director, Preventive Health Clinical Services
City of Long Beach, Department of Health and Human Services
Andrew Signey, Assistant Director
St. Mary’s Medical Center, CARE Programs and Clinics
Nick Rocca, LCSW
Clinic Administrator, HIV Division
Katrin Dayanim, Grants and Contracts Manager
North East Valley Health Corporation

OAPP Staff
Sophia Rumanes, Program Supervisor
Prevention Services Division
Rochelle Floyd, RN, MSN, FNP
Program Manager, Medical Outpatient, CARE Services Division
Phillip Barragan, Program Manager
Medical Outpatient, CARE Services Division
Shirlissa Johnson-Edwards, RN, BSN
Public Health Nurse, Medical Outpatient, CARE Services Division
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Stakeholder and Provider Input into the Mercer Rate Study
As described in the report narrative in Section 3, “Service Description Development”,
Mercer received input from stakeholders and HIV/AIDS service providers during the
course of the study. The individuals providing input are listed below, categorized
according to the specific aspect of the study in which they participated.
1. Review of the HIV/AIDS Continuum of Care Model
Commission and Prevention Planning Committee (PPC) Members/Staff included:
 Fariba S. Younai, DDS, Clinical Professor, Oral Biology and Medicine, UCLA
School of Dentistry; Anna Long, Chief of Staff of Public Health, County of Los
Angeles, Department of Health Services; Kathy Watt, Executive Director, Van
Ness Recovery House;
 Wilbert C. Jordan, MD, MPH, Medical Director, Oasis Clinics HIV/AIDS
Programs; and,
 Craig Vincent-Jones, Executive Director, Commission on HIV.
HIV/AIDS Service Providers included:
 Deborah O. Collins, MPAS, PA-C, Director, Preventive Health Clinical Services,
City of Long Beach, Department of Health and Human Services;
 Andrew Signey, Assistant Director, St. Mary’s Medical Center, CARE Programs
and Clinics;
 Nick Rocca, LCSW, Clinic Administrator, HIV Division;
 Katrin Dayanim, Grants and Contracts Manager, North East Valley Health
Corporation.
OAPP Staff included:
 Sophia Rumanes, Program Supervisor, Prevention Services Division;
 Rochelle Floyd, RN, MSN, FNP, Program Manager, Medical Outpatient, CARE
Services Division;
 Phillip Barragan, Program Manager, Medical Outpatient, CARE Services
Division; and
 Shirlissa Johnson-Edwards, RN, BSN, Public Health Nurse, Medical Outpatient,
CARE Services Division.
2. Service Description Focus Group
Participants were asked to sign an OAPP sign-in sheet. Representatives from the
following agencies (listed in order of signing) attended the Focus Group:



Mallory Witt, MD and Julie Rees from Harbor-UCLA;
Adam Ouderkirk, Peter Reis and Scott McKenzie from AIDS Health Care
Foundation;
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David Burdem and Wilbert C. Jordan, MD, from OASIS;
Maxine Liggins from Public Health/SPA 5 and 6; and,
Felix Carpio, MD from AltaMed.

OAPP Staff attended the Focus Group also, including Jan King, MD, Medical
Director, who provided comments.
3. Private Physician Unfunded by RWCA
Feedback from a physician practicing in the private sector, not currently funded by
OAPP, was provided by Mark Katz, MD (Regional HIV/AIDS Physician Coordinator,
Department of Internal Medicine, West Los Angeles Kaiser Permanente) reviewed the
HIV/AIDS Ambulatory/Outpatient Medical Care Services service description. Mark Katz,
MD was selected by OAPP as a reviewer representing the private sector.
4. ADAP Enrollment Clarifications
Providers giving input on timeframes for enrollment for ADAP services were Irma
Ramirez and Deama Sherman, both ADAP enrollment coordinators in locally funded
agencies.
5. Home Based vs. Medical Case Management Clarifications
The question as to whether the new Medical Case Management model would duplicate
services provided in the Home Based Case Management Program was raised by Felix
Carpio, a Focus Group participant. The question was further researched with the OAPP
Attendant Care and Homemaker Services staff members, Roberta Young and Bonnie
Moore.
6. Written Comments from a Commission Member
Brad Land, HIV+ Fifth District Commissioner, sent written questions to OAPP that were,
in turn, forwarded to Mercer.
7. On-site Provider Reviews
Two Mercer staff visited providers in January 2007. Please see Appendix D for more
information.
8. Provider Meeting on Draft Report
Mercer presented information and listened to provider feedback in a meeting on October
31, 2007 after release of draft report.
9. Review of Provider Written Comments
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Provider comments provided from November 2007 to January 2008 were reviewed.
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D
Executive Summary of HIV/AIDS Medical Outpatient
Services Rate Study: Provider Site Visits (January
2007)
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Executive Summary
The Los Angeles County (County) Department of Public Health, Office of AIDS
Programs and Policy (OAPP) directs the overall response to the HIV/AIDS epidemic in
the County under the supervision of the County’s Board of Supervisors. As part of its
mandate, OAPP contracts with numerous service providers (Providers) in various
categories to provide high quality and cost-effective care services to HIV-positive
residents of the County. OAPP contracts with both County operated and private
outpatient medical clinics to provide comprehensive primary care to individuals
diagnosed with HIV/AIDS. Currently, OAPP reimburses its 24 contracted outpatient
medical clinics through a traditional line-item budget process. The Board of Supervisors
requires OAPP to consider a cost reimbursement methodology that will encourage
Provider accountability and productivity, track utilization more effectively, and ensure
that Providers are utilizing other funding resources, such as MediCal, when available.
Based on a competitive bid for Work Order Request No. 6-49 issued by the Department
of the Auditor-Controller of the County, Mercer Government Human Services Consulting
(Mercer) was engaged to complete this study and meet the aforementioned Board of
Supervisors/OAPP objectives. Because of the number and complexity of services
included in primary care ambulatory outpatient medical care, and in an effort to ensure
Providers are not overburdened with billing and reporting requirements, the rate
architecture for this particular service is being developed separately and will be discussed
in the final report.
As part of the rate study development process, Mercer drafted service descriptions for
four service areas including medical outpatient care. A careful review of the draft service
descriptions was completed by both the Commission on HIV (COH) and the OAPP
contracted HIV/AIDS outpatient service Providers. This analysis prompted a series of rate
study related questions from community stakeholders, including the HIV Medical
Outpatient Providers Caucus (Caucus). In response to the concerns raised related to the
rate study development process, OAPP revised the Mercer rate study deliverables to
include six to eight on-site visits to medical outpatient Providers, and one community
stakeholders meeting to allow for additional rate study input and clarification. In
consideration of recommendations offered by the Caucus, OAPP scheduled site visits for
Mercer that reflected the diversity of the Provider types (small, large, HIV only, HIV in a
primary care setting, rural, single site, multi-site, hospital-based, County Provider site,
etc.) and represented each Service Planning Area (SPA). Providers not hosting a site visit
were invited to attend the Stakeholders meeting with Mercer and OAPP to be held after
the completion of the scheduled site visits. The Stakeholders meeting was open to all
OAPP-funded medical outpatient Providers and offered an opportunity to share any
additional rate study related input not captured through the site visits.
To assist in this information gathering effort, a Discussion Guide was created by OAPP,
with input from the Caucus, and was distributed prior to the site visits. Providers hosting
a site visit were advised to be prepared to answer questions listed in the Discussion Guide
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at the time of the site visit. Providers not hosting a site visit were encouraged to complete
the Discussion Guide and submit their responses to OAPP.
To ensure that the clinical complexities in the treatment of HIV/AIDS and the breadth and
depth of the services being delivered by the Providers would be captured during this
process, OAPP requested that a clinician with expertise in HIV/AIDS conduct the site
visits. Mercer’s Linda Shields, RN, BSN, of the Clinical and Behavioral Health Services
division conducted a total of seven site visits, two Provider interviews at the OAPP
offices, and participated in the Stakeholders meeting. Additionally, Mercer’s John
Villegas-Grubbs, Rate Architect Consultant, participated in the series of visits, interviews,
and meetings in order to gain a better understanding of the financial operations of the
Providers. Mr. Villegas-Grubbs provided clarification on the methodology of the rate
architecture, as well as gathered anecdotal information to support calculations to be
performed on the cost components being used in the study. Providers were asked to
submit general ledgers as well as cost reports to assist in the calculations.
On-site visits were conducted with AIDS Healthcare Foundation, The Catalyst
Foundation, City of Pasadena Andrew Escajeda Clinic, St. Mary Medical Center
C.A.R.E. Clinic, Northeast Valley Health Corporation, L.A. Gay & Lesbian Center, and
Harbor-UCLA Medical Center. A joint interview session was conducted at the OAPP
offices with Watts Healthcare Corporation and T.H.E. Clinic, Inc. A total of 11 Providers
attended the Stakeholders meeting including AIDS Healthcare Foundation, The Catalyst
Foundation, City of Pasadena Andrew Escajeda Clinic, St. Mary Medical Center
C.A.R.E. Clinic, L.A. Gay & Lesbian Center, Northeast Valley Health Corporation, Watts
Healthcare Corporation, T.H.E. Clinic, Inc., AltaMed Health Services, El Proyecto del
Barrio, and Martin Luther King Jr. / Charles Drew OASIS Clinic. An additional 5
Providers completed the Discussion Guide questionnaire, including: AltaMed Health
Services, El Proyecto del Barrio, Martin Luther King Jr. / Charles Drew OASIS Clinic,
Childrens Hospital Los Angeles Division of Adolescent Medicine, and East Valley
Community Health Center HIV Comprehensive Care Clinic. General ledgers were
submitted by Watts Healthcare Corporation, AltaMed Health Services, The Catalyst
Foundation, City of Pasadena Andrew Escajeda Clinic, Northeast Valley Health
Corporation, AIDS Healthcare Foundation, L.A. Gay & Lesbian Center, St. Mary
Medical Center C.A.R.E. Clinic, and El Proyecto del Barrio. A summary of Provider
participation is included as Appendix A.

Findings
The outcomes and findings that emerged during this information gathering phase of the
study are documented in the report in detail and sorted by individual Provider.
Additionally, an overview of the collective findings is presented below.


The patient demographics within each SPA varied tremendously. There were
differences noted between individual Providers within the same SPA. This diversity is
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not significantly unusual, as it appears to be a reflection of the diversity of the general
population of the County itself. Demographics varied by age, race, and lifestyle. The
average patient’s age fell within the 25 – 49 year old range. Although Caucasians
made up a large portion of the HIV/AIDS population, there was a significant number
of ethnic minorities represented. Males made up the majority of the cases; however,
the number of females was reportedly growing. Substance Abuse and homelessness,
as well as an increasing number of undocumented clients, was noted throughout the
County.


Comorbidities consistent across each SPA were Depression/Mental Health, Substance
Abuse, Hepatitis C, and Cardiovascular Conditions, particularly Hypertension. The
lack of antihypertensives on AIDS Drug Assistance Program (ADAP) formulary
presented treatment issues for many. Also notable was the rise in the incidence of
sexually transmitted diseases (STDs) including a high reinfection rate. The most
prevalent of which being Syphilis.



Service delivery patterns of each Provider appeared to be adapted to meet the specific
needs of their community and the patient demographics they served. Community
dynamics varied around each Provider location from an existing HIV/AIDS stigma
and phobia to a strong history of activism, acceptance, and general support.



Providers indicated they were overburdened with billing and reporting requirements
from various Funders, both private and government. There were multiple forms to
complete and numerous data entry screens necessary to input required client
documentation. Most found the information system “Casewatch” to be cumbersome
to navigate, and resource intensive with issues such as: connection drops; mandated
fields for every entry; difficult to update; confidentiality concerns using a shared
system; conflicts with Providers internal organizational Privacy Policies; lack of
interface with existing systems, and a backlog of cases to be entered. Also, extensive
time was noted to be spent by Direct Care Staff completing supplemental services
forms such as Housing, ADAP, Dental, Disability, Food Provisions, as well as
reviewing and processing medication refills, lab and testing results, and clinical trial
progress. There were eligibility, payment and denial issues, as well as difficulties in
getting clients enrolled in other programs such as MediCal.



The majority of Providers struggled with treatment issues resulting from lack of
timely access to specialists and subspecialists. The most difficult referrals to obtain
throughout the County were consistently those to Orthopedics, Neurology,
Dermatology, and Gastroenterology. Additionally, lack of access to Preventive Health
services was noted within every SPA particularly in the areas of colon cancer
screenings (flex sig/colonoscopy) and breast cancer screenings (timely
mammograms).
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Transportation costs and coordination was a barrier to service and care for many.
Whether it was due to the geographic distances between necessary services, or the
homelessness and transience, or the poverty level of the clients who had neither a car
nor funds for a bus, it remained a concern throughout the County.



The staff at each site visited appeared to be dedicated and personally committed to
serve the population. Many of whom would work additional uncompensated hours,
and/or donate needed resources. However, the Nursing shortage and lack of qualified
medical staff (HIV experience and interest) as well as insufficient, noncompetitive
salaries and benefit packages is causing staffing challenges for all Providers.

Recommendations
The report provides recommendations intended to assist OAPP and key stakeholders in
addressing the barriers to service and care delivery and to ensure successful
implementation of the new rate architecture.




Because the science and practice of HIV/AIDS medical management continues to
rapidly evolve, Mercer recommends OAPP continue to collaboratively work with
Providers to remove barriers to delivering and providing access to quality care and
service within the County by such means as:
–

Encourage the use of the Caucus as a forum for Quality Improvement initiatives,
such as the sharing of best practices in both care and service.

–

Continue to implement its public health role, in collaboration with Providers, in
distributing standard of care revisions and updates.

–

Assess and respond to the unique needs within specific patient demographics and
evaluate service variances.

–

Continue in its role in Provider education, training, development, and capacitybuilding.

–

Reevaluate OAPP’s data needs and collection methods, assessing the impact of
the reporting requirements to the Providers overall resources, as well as potential
integration with their existing Informatics and Financial Systems.

–

Work collaboratively with the Caucus, the local Physician community, and
existing stakeholders to evaluate methods of attracting and retaining Specialty and
Subspecialty services for the HIV/AIDS population.

MediCal is a significant, albeit, a complex source of funding for HIV/AIDS services
and it is critical that Providers maximize the funding available through this
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entitlement program. The Ryan White Comprehensive AIDS Resources Emergency
(CARE) Act legislation mandates that CARE Act funds be the payer of last resort,
and the Health Resources and Services Administration (HRSA) has mandated that
wherever other programs such as Medicaid exist for HIV/AIDS services, these funds
must be maximized before using Ryan White CARE Act funding. Based on these
mandates, many states and jurisdictions require their HIV/AIDS Providers actively
participate in the Medicaid program. For the selected services in the County, Mercer
recommends the following to OAPP:
–

Work closely with the Providers to identify and clearly define HIV/AIDS services
that could be reimbursed by MediCal and to identify the appropriate MediCal
programs/Waivers that Providers may participate.

–

Collaborate with the California Department of Public Health/Office of AIDS to
increase awareness and knowledge among Providers of the importance and need
for maximizing MediCal funding for individual service components that are
delivered. DHS provides training sessions to Providers on various topics related to
the MediCal program. Providers should be encouraged to participate in these
training opportunities.

–

Consider use of OAPP’s established training curriculum to offer additional
training and technical assistance to Providers on the utilization of MediCal as a
funding source. This is an area that has been deemed a HRSA priority and Ryan
White grant funds have been utilized in other states to offer this type of technical
assistance. In the past, HRSA has provided third party payment training in the
County. Attendance at these types of training should be mandatory for Providers
that contract with OAPP.

–

Audit a random sample of medical files and claims information from various
Providers to determine if MediCal funding is underutilized. Additionally, conduct
an analysis of trends in MediCal denials (reasons and frequency), as well as issues
in eligibility.

Mercer is privileged to have had the opportunity to work with OAPP and the Providers in
the County on this exciting and innovative segment of the rate study. Based upon
Mercer’s experiences in the areas of HIV/AIDS and rate development across the US, it is
clear that the County is a leader in the effort to implement a structured model of equitable
reimbursement methodology for HIV/AIDS services, while upholding appropriate clinical
standards and practices, thereby ensuring both high quality and cost-effective service
delivery. Mercer is confident that through the collaboration of the County and its
HIV/AIDS Providers, a planned and coordinated implementation strategy, and
appropriate training for all those involved, OAPP will be able to successfully implement
this rate architecture and thereby serve as a model for other HIV/AIDS programs
nationwide.
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Department of Public Health
Office of AIDS Programs and Policy
Medical Clinic Services
Special Rate Study
HIV/AIDS AMBULATORY/OUTPATIENT MEDICAL CARE
SERVICES DESCRIPTION
This service description is adopted by the County of Los Angeles, Department of Public
Health, Office of AIDS Programs and Policy (OAPP), to guide providers in the
development and implementation of HIV/AIDS Ambulatory/Outpatient Medical
(AOM) Care Services to individuals at risk for and living with HIV/AIDS. Federal
legislation, policy and program guidance, and State of California statutes, regulations, and
rules governing licensing and service provision, supersede the HIV/AIDS AOM Care
Services description.
SERVICE
HIV/AIDS AOM Care Services
TABLE OF CONTENTS

Page

Description ..................................................................................... 1
Program Requirements .................................................................. 2
Definition of Encounter ................................................................ 10
Required Staffing ......................................................................... 11
DESCRIPTION
HIV/AIDS AOM Care Services are provided by a Medical Doctor (MD) or Doctor of
Osteopathic Medicine (DO), Physician’s Assistant (PA), or Nurse Practitioner (NP) in an
outpatient, community-based, or office-based setting. HIV/AIDS AOM Care Services
are provided in accordance with the Los Angeles Commission on HIV Standards of Care,
Medical Outpatient Services (final January 13, 2006) and form the critical foundation of
the HIV/AIDS Continuum of Care adopted on October 14, 2004.
HIV/AIDS AOM Care Services are guided by practice guidelines and protocols (i.e.,
www.hopkins-aids.edu, www.hivguidelines.org, or www.hab.hrsa.gov) consistent with
the Public Health Service (PHS) guidelines (www.aidsinfo.nih.gov/) and the Los Angeles
Commission on HIV Standards of Care.

Mercer Government Human Services Consulting

Medical Clinical Fee-for-Service
Reimbursement Rate Study

Office of AIDS Programs and Policy
Final Report

HIV/AIDS AOM Care Services funded by the OAPP are implemented in a service
delivery environment where other models of HIV/AIDS primary care are developed and
supported by other funders (e.g., the “Early Intervention Program” funded through the
State of California, Office of AIDS). While there may be differences in the service
delivery requirements among these programs, it is the intent and practice of OAPP to
collaborate and cooperate with other funded programs so as to not create unnecessary
barriers or impediments for clients who utilize these programs.
PROGRAM REQUIREMENTS
The following requirements are minimum for HIV/AIDS AOM Care Services; provider
agencies providing these services may exceed these requirements.
General Requirements: The provider agency must ensure its ability to meet the needs of
the client by meeting the following general requirements:


Administrative and Clinical Policies and Procedures. The provider agency must
develop, implement, and revise, as necessary, standardized administrative policies and
procedures and clinical protocols to comprehensively guide the HIV/AIDS AOM
Care Services, including assessment, treatment, and referral of clients. The
procedures and protocols must be submitted to OAPP for review and approval upon
request. Upon request, revisions to the procedures and protocols may require OAPP
approval.
Provider agencies must have a Client Grievance
Policy and Procedure that is reviewed with each
client in a language and format the client can
understand. A written copy must be provided to
each client and a signed and dated receipt form
must be included in each client record. All
AOM professionals must comply with the
established process for client grievances.



Clinic Management
Policies, Protocols, and Procedures

For assistance in developing
administrative policies and
procedures related to clinical
and health program
management, consult the
technical assistance and training
Tuberculosis Screening. All HIV/AIDS AOM services available through the
Care Services staff, other provider agency National Association of
employees, volunteers, and consultants must be Community Health Centers,
screened for tuberculosis when providing services to persons with HIV disease or
AIDS and who have routine, direct contact with clients. Provider agencies must
comply fully with the “Guidelines for Tuberculosis Screening” required for all
agencies with County of Los Angeles contracts.
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Guidelines for Tuberculosis Screening
The TB Control Program
2615 S. Grand Avenue, Los Angeles, CA 90007
(213) 744-6151


Postexposure Prophylaxis (PEP). Provider agencies must have a policy and procedure
to reduce the risks for occupational HIV and Hepatitis exposure. Provider agencies
must aggressively promote and monitor risk reduction behaviors and must actively
support HIV/AIDS AOM primary care professionals in PEP (National Clinician’s
PEP Hotline: (800) 448-4911 or www.ucsf.edu/hivcntr; Hepatitis Hotline: (888) 4437232 or www.cdc.gov/hepatitis; Reporting of Occupationally Acquired HIV: (800)
893-0485).



State Mandated HIV Reporting. Consistent with the State Health and Safety Code
(Section 2643.5), all AOM practitioners and OAPP-funded County of Los Angeles
and community-based HIV medical outpatient clinics must comply with the mandated
reporting of clients whose laboratory test results indicate HIV, a component of HIV,
or antibodies to or antigens of HIV. Each HIV/AIDS AOM practitioner must, within
seven calendar days of receipt of a client’s confirmed HIV test, report the client's full
name, date of birth, and gender.



Clinical Trials. The provider agency’s
HIV/AIDS AOM Care Services must
be directly linked with AIDS clinical
treatment units and research consortia
of community physicians.



Clinical Trials
AIDS Clinical Trials Group (ACTG):
AIDS Clinical Trials Info: (800) 874-2572
HIV/AIDS Treatment Info Service:

www.aidsinfo.nih.gov

Clinical Care Protocols. The HIV/AIDS AOM Care Services must be consistent
with the PHS guidelines (www.aidsinfo.nih.gov) and the Los Angeles Commission on
HIV Standards of Care. AOM Care primary care professionals must utilize
established practice guidelines in order to facilitate consistency in providing state-ofthe-art prevention and care services for all clients.
HIV/AIDS prevention and care practice guidelines may be downloaded or ordered in
bulk from the following websites: Los Angeles Commission on HIV Standards of
Care (www.hivcommission-la.info/soc.asp) Johns Hopkins AIDS Service
(www.hopkins-aids.edu), New York Department of Health
New Guidelines: nPEP
AIDS Institute (www.hivguidelines.org), federal HIV/AIDS
Bureau (www.hab.hrsa.gov), and CDC’s Division of AIDS
Antiretroviral Postexposure
Prevention-Treatment (www.cdc.gov). [A Guide to Primary Prophylaxis After Sexual,
Care for People with HIV/AIDS, 2004 provides clinical Injection-Drug Users, or Other
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treatment guidelines in a question-and-answer format to health professionals treating
adults
living
with
HIV/AIDS.
CD-ROM,
www.ask.hrsa.gov/detail.cfm?id=HAB00355,
with
a
Pocket
Guide,
www.hab.hrsa.gov/tools/HIVpocketguide/index.htm.]
HIV/AIDS AOM health care professionals are encouraged to remain current with the
research literature related to adherence by referencing the American Public Health
Association’s special HIV/AIDS treatment adherence initiative: “Best Practices:
Adherence to HIV Treatment Regimens” (www.apha.org: “Science & Programs”).


AOM HIV Prevention and Disease Management Competency. The provider agency
must have personnel policies and procedures requiring and supporting the continued
education of all HIV/AIDS health care professionals. Provider agencies are expected
to budget costs for HIV/AIDS continuing education, specifically in HIV prevention
and disease management, to purchase practice guidelines in formats easily accessible
and usable for practitioners, and to provide routine access to computerized
educational
and
prevention/care
treatment
problem-solving
(i.e.,
www.thebodypro.com,
www.hivinsite.ucsf.edu,
www.hopkins-aids.edu,
or
www.nlm.nih.gov/medlineplus/aids.html).
Clinical Management of the HIV-Infected Adult: A Manual for Mid-Level Clinicians

http://bphc.hrsa.gov/quality/HIVAIDSManual.htm

National HIV
Telephone
Consultation Service
Warmline
(800) 933-3413

Provider agencies must have consultation protocols to assist
HIV/AIDS AOM health care professionals in easily seeking
expert advice and consultation whenever there is any
question about the best way to manage a specific client. This
is especially important when a client is experiencing ARV
treatment failure or when a client with advanced HIV
disease is vulnerable to multiple opportunistic processes.
Seeking expert advice and utilizing the many local or
regional university-based consultation services is evidence
of competent prevention and disease management.



Client-Staff-Colleague Communication. Provider agencies must have current written
policies and procedures addressing communications between the AOM staff, clients,
or other professionals.



Client Appropriateness for Provider Agency Services. Prior to or during an initial
assessment, if it is determined the medical needs of the client cannot be met by the
agency providing HIV/AIDS AOM Care Services, a referral must be made to an
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alternate provider. The HIV/AIDS AOM Care Services staff must directly assist the
client with access to another HIV/AIDS AOM provider.


Client Satisfaction. The agency providing HIV/AIDS AOM Care Services must
perform semi-annual assessments of clients’ needs and satisfaction by conducting
random, anonymous client surveys.



Client Records. The agency providing HIV/AIDS AOM Care Services must
maintain a client record for each client, documenting each face-to-face
patient/practitioner encounter. Documentation must be consistent with the agency’s
clinical policies and procedures for client record keeping.
HIV/AIDS Clinical Charting Forms?
The Florida/Caribbean AIDS Education and Training Center offers a comprehensive set
http://www.faetc.org/charting_forms/index.asp



Records Maintenance. Provider agencies must have a formal process for storing,
maintaining, and managing client files. Client file systems must be organized for ease
in information retrieval and synthesis. Client records must be secure to ensure
confidentiality and should not be disclosed without the client authorization, guardian
authorization, or other legal requirement.
Medical Record
has Current?
Problem Lists
Medication Lists
Flow Sheets
Lab Reports
Special Study Reports
Consult Reports
Inpatient Discharge
Summaries
Immunizations
Risk Assessments
Verification of HIV Status

Records of Health Maintenance Activities Appropriate
for HIV Infected Individuals
Influenza Vaccine
Tetanus/Diphtheria Update
Pneumovax
Pap Screening
Hepatitis Screening, Vaccination
TB Screening
Family Planning
Counseling on Safer Sex
Counseling on Food and Water Safety
Counseling on Nutrition
Harm Reduction for Alcohol and Drug Use

Patient



Service Evaluation. The client record must include a record of services provided by
multiple professionals and paraprofessionals in sufficient detail to permit an
evaluation of these multidisciplinary services.

Eligibility: Eligibility requirements ensure that OAPP funds are used only for the
purchase of HIV/AIDS AOM Care Services that cannot be paid for through other
sources. Clients are eligible for HIV/AIDS AOM Care Services after a financial
screening that validates OAPP funds are the payer of last resort for the client’s care. In
addition, clients must meet all of the following criteria:
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HIV Status. Client must provide verification of HIV status. Acceptable verification
includes one of the following: (a) a copy of the client’s seropositive test results (Elisa
and Western Blot) from the test provider, (b) a signed document from a physician
verifying the client is HIV-positive, (c) lab results (i.e., viral load) at any time during
the client’s lifetime that show the presence of the human immunodeficiency virus, or
(d) written verification from a psychosocial or medical case manager or other health
and social services provider who has one of the above documents in the client’s file.



County of Los Angeles Residence. Client must provide information to establish
residency in the County of Los Angeles.



Income. Clients must provide proof/documentation of income to verify OAPP funds
will be used as the payer of last resort for the service. Clients who do not have
coverage under or are ineligible for Medi-Cal or other third-party payment, are
eligible for OAPP-funded services. Income eligibility must be verified annually.
All clients must be assessed for ADAP, Medi-Cal, Medicare, VA Benefits, HMO, or
private insurance. Providers are required to screen clients for eligibility to these
programs before providing services supported by CARE Act Part A funding.

Client Rights: All clients requesting and/or receiving HIV/AIDS AOM Care Services
have rights and responsibilities outlined in “People with HIV/AIDS Bill of Rights and
Responsibilities” adopted by the County of Los Angeles Commission on HIV Health
Services (April 2004).
Provider agencies must have a Client Rights and Responsibilities Statement that is
reviewed with each client in a language and format the client can understand. A written
copy must be provided to each client and a signed and dated receipt form must be
included in each client record.
Client-Centered Treatment: HIV/AIDS AOM Care Services must ensure that clients
are given the opportunity to ask questions and receive accurate answers regarding health
and social services provided by HIV/AIDS AOM practitioners. In addition, clients must
be given the opportunity to ask questions and receive accurate answers on services to
which they are referred, especially (but not limited to) the full compliment of services
making up the Primary Health Care Core Services in the HIV/AIDS Continuum of Care.
Patient and health care provider discussions during prevention and care services
encounters form the foundation of a relationship built on trust and confidence where
clients are seen as active partners in the decisions about their personal health care
regimen. HIV/AIDS AOM practitioners are encouraged to review client-oriented
HIV/AIDS prevention and care websites to become more familiar and versatile in
discussing HIV/AIDS from a client-centered approach (i.e., www.projectinform.org,
www.aidsnutrition.org,or www.thebody.com).
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Clients must be fully educated about their medical needs and treatment options within the
standards of medical care. Client education must be documented in the client record with
details of each intervention.
Referral and Coordination of Care: HIV/AIDS AOM Care Services must have written
procedures and protocols in place for referring clients to health and social services. The
referral system must include a process for tracking and monitoring referrals and for
documenting the results of referrals from the providers of health and social services to
which clients are referred. HIV/AIDS AOM practitioners are required to follow the
provider agency’s established referral policies and procedures for services beyond their
internal HIV/AIDS AOM Care Services.


Medical Specialists and Required Memoranda of Understanding (MOUs).The
provider agency must have written MOUs with all medical specialists, treatment
adherence educators, Registered Dietitians (RDs), and psychosocial case managers
used by the provider agency’s AOM practitioners for referral. The MOUs must
describe the procedure for both written and verbal communications between the
referring HIV/AIDS AOM practitioner and the consulting health or social service
professionals. All MOUs must be submitted to OAPP’s Medical Director for review
before the MOUs are formally executed. All revisions to the MOUs, and revisions to
provider agency referral policies and procedures, must be approved by OAPP.



California Regulations on Referrals to RDs. In California, referrals to RDs must be
made by health care providers authorized to prescribe dietary treatments. The referral
must be accompanied by a written prescription signed by the health care provider
detailing the client’s diagnosis and including a statement of the desired objective of
dietary treatment. An RD may accept or transmit verbal orders or electronicallytransmitted orders from the referring physician consistent with an established protocol
to implement Medical Nutrition Therapy (California Business and Professions Code,
Sections 2585-2585.8). Provider agency policies and procedures for making and
receiving referrals for Medical Nutrition Therapy must comply with California
regulations.

Quality Management (QM): Provider agencies funded to provide HIV/AIDS AOM
Care Services are required to have a QM Program that will facilitate the delivery of
state-of-the-art HIV/AIDS services. Provider agencies needing technical assistance (TA)
guidance on the development of QM Programs are encouraged to consult the Quality
Management Technical Assistance Manual (this TA document is available at
www.hab.hrsa.gov/).
The provider agency’s QM Program must include:


QM Plan. The QM Program must be based on a provider agency-wide, written QM
Plan that addresses both HIV prevention and care services.
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QM Committee. The QM Program must be guided by a provider agency QM
Committee formally convened minimally quarterly to assure the QM Program’s goals
and objectives are met.



Client Feedback Process. The QM Program must describe how ongoing client
feedback will be obtained and utilized to improve access, utilization, retention, and
adherence to HIV preventative services and care.



Client Grievance Process. The QM Program must describe the implementation of the
provider agency’s Client Grievance Process (see requirement for Client Grievance
Policy and Procedure above). Client grievance data must be tracked, trended, and
reported to the provider agency’s QM Committee for use in making improvements in
HIV services and care.

The provider agency’s QM Program must be able to meet the following expectations:


Medical Record System. Routine and recurring audits of the provider agency’s
medical record system must demonstrate service records are organized, complete, and
current. HIV/AIDS service delivery information must be organized clearly and
consistently, supporting ease of review and consideration by any and all social and
health care practitioners. Reports from these audits must describe the identification of
concrete problems in HIV/AIDS services record keeping, together with practical
solutions and documentation for problem-resolve.
Basic HIV/AIDS Medical Records Policy and Procedure Checklist




















Uniform format with a logical flow of information
Information, including prescriptions, legible
Timely entry of data
All information appropriately dated
Problem-oriented in SOAP format: including documentation of reason for every visit, past and present medical
histories, findings of physical examinations, documentation of special studies ordered, documentation of clinical
assessments or diagnoses, health education and risk reduction activities, documentation of referrals and consults,
treatment plans (return appointments, drug therapy, referrals, etc.), and HAART discussion
Necessary patient and family identifiers
Signed consents for prevention and treatment services
Consents signed by client for release of information for each referral made
Provider signatures legible
Conspicuous listing of quantitative viral measures, drug allergies, and drug resistance
Documentation of patient education (risk reduction, treatment regimens, adherence, nutrition, and health
maintenance, etc.)
Evidence of screening or referral of patients at risk for TB, hepatitis, or sexually-transmitted disease (STD)
infection
Evidence of screening and referral of patients for medical nutrition therapy
Evidence of referral for health care maintenance, including immunizations
Evidence of coordination of services among providers
Evidence of assessment for the need and/or provision of psychosocial and/or medical case management
Evidence of assessment for mental health and/or substance abuse services
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Consistency of HIV Practice Patterns. The provider agency QM Program must make
routine and recurring audits of service delivery records in order to assess the degree to
which individual practitioners are providing services consistent with the federal
guidelines for the medical management of HIV infection and other issues surrounding
HIV infection. OAPP strongly encourages internal peer review as an approach to
continually improving quality and consistency in HIV practice patterns. The federal
guidelines are available at www.aidsinfo.nih.gov.
In order to specifically focus the provider agency’s audits for compliance within the
guidelines, provider agencies are encouraged to adopt currently published HIV/AIDS
practice guidelines that assist practitioners in following concrete and specific service
protocols. These practice guidelines are typically available from the websites
supported by the respective professional associations and from selective HIV/AIDS
academic
research
institutions
(i.e.,
www.hopkins-aids.edu
or
http://hivinsite.ucsf.edu). Practitioners providing HIV prevention in medical settings
must consult and comply with “Incorporating HIV Prevention into the Medical Care
of Persons Living with HIV,” (MMWR: July 18, 2003/Vol. 52/No. RR-12).



Required Provider Agency Indicators. The provider agency QM Program must
identify quality assurance indicators documenting successful clinical and service
delivery outcomes in the following areas:
(a) Documenting the completion and incorporation of needed referrals from across
the HIV/AIDS Continuum of Care Primary Health Care Core Services and the
integration of referral results and recommendations into the client’s primary care
treatment process.
(b) Documenting the successful integration of care and treatment services in medical
care settings.
(c) Documenting the provider agency’s success in achieving adherence with care and
prevention treatment plans.
(d) Documenting the clinical outcome indicators as required by OAPP.



Required System-Wide Indicators. Finally, provider agencies are required to
participate in all system-wide QM reviews conducted by OAPP. The specific
indicators for the system-wide review will be identified annually by OAPP and will
focus on four critical areas:
(a) Reducing disparities in health outcomes for the County of Los Angeles’ social,
racial, and/or ethnic minorities.
(b) Increasing health outcomes for all recipients of services in the HIV/AIDS
Continuum of Care.

Mercer Government Human Services Consulting

Medical Clinical Fee-for-Service
Reimbursement Rate Study

Office of AIDS Programs and Policy
Final Report

(c) Prevention of HIV infection and prevention of progression to HIV-related illness
and disease, disability, and death.
(d) Indicators related to the HIV/AIDS Continuum of Care’s emphasis on the
continuity of access, utilization, retention, and adherence for clients.
Cultural Sensitivity and Linguistic Competence: Clients have the right to HIV/AIDS
AOM Care Services provided by a qualified, HIV-knowledgeable and capable primary
health care practitioner who is culturally- and linguistically-competent, who
communicates and educates in culturally-congruent ways, and who works in collaboration
with the client’s team. The AOM staff must demonstrate cultural sensitivity and linguistic
competency specifically in the service they provide. The AOM staff must also
demonstrate cultural sensitivity and linguistic competency for the target population they
are serving (see, “The Provider’s Guide to Quality and Culture,”
http://bphc.hrsa.gov/quality/Cultural.htm).
Translation/Language Interpreter’s federal and state language access laws (Title VI of the
Civil Rights Act of 1964 and California’s 1973 Dymally-Alatorre Bilingual Services Act)
require health care facilities that receive federal or state funding to provide competent
interpretation services to Limited English Proficiency (LEP) patients at no cost, in order
to ensure equal and meaningful access to health care services.
Resources on Culturally-Competent Health Care?
UCSF School of Medicine, Department of Medicine

“Primary Care: Clinical Practice Guidelines”
http://medicine.ucsf.edu/resources/guidelines/culture/html
“National Standards for Culturally and Linguistically Appropriate Services in Health Care”
http://www.omhrc.giv/clas/finalcultural1a.htm
“Rationale for Cultural Competence in Primary Care”
Policy Brief 1, National Center for Cultural Competence
http://gucchd.georgetown.edu//nccc/nccc6.html

Documentation: Provider agencies providing HIV/AIDS AOM Care Services are
required to meet all expectations for client and service delivery contract reporting and
documentation. Provider agencies must utilize the County of Los Angeles’s “Casewatch”
system to register the client’s eligibility data, demographic/resource data, enter service
utilization data, medical and support service outcomes, and to record linkages/referrals to
other service providers and/or systems of care.
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For clients not receiving Medi-Cal benefits, providers are required to document if a client
was referred to apply for Medi-cal, if recently applied for Medi-Cal, date/ applied,
application status, and if not referred, must document why the client was not referred.
The “Casewatch” system must be used to invoice for all delivered services, to
standardized reporting, to improve efficiency of billing, to support program evaluation
processes, and to provide OAPP and participating contractors with information relative to
the HIV/AIDS epidemic in the County of Los Angeles. Provider agencies must ensure
data quality and compliance with all data submission requirements.
DEFINITION OF ENCOUNTER
The US Department of Health and Human Services/Health Resources and Services
Administration (HRSA) publishes the Uniform Data System (UDS) Reporting
Instructions for Section 330 Grantees (last updated in 2006). The definition of an
encounter is:
“Encounters are Documented, face-to-face contact between a patient and
a provider who exercises independent professional judgment in the
provision of services to the individual. To be included as an encounter,
services must be documented.” (Page 5)
Additional guidance relative to encounters includes:
1.

To meet the criterion for "independent judgment," the provider must be acting on
his/her own when serving the patient and not assisting another provider. For
example, a nurse assisting a physician during a physical examination by taking vital
signs, taking a history or drawing a blood sample is not credited with a separate
encounter. Independent judgment implies the use of the professional skills
associated with profession of the individual being credited with the encounter and
unique to that provider or other similarly or more intensively trained providers.

2.

To meet the criterion for "documentation," the service (and associated patient
information) must be recorded in written or electronic form. The patient record does
not have to be a full and complete health record in order to meet this criterion. For
example, if an individual receives services on an emergency basis and these
services are documented, the documentation criterion is met even though a
complete health record is not created. Screenings at health fairs, immunization
drives for children or the elderly and similar public health efforts do not result in
encounters.

4.

Such services as drawing blood, collecting urine specimens, performing laboratory
tests, taking X-rays, giving immunizations, and filling/dispensing prescriptions do
not constitute encounters.
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5.

A provider may be credited with no more than one encounter with a given patient in
a single day, regardless of the types or number of services provided.

6.

The encounter criteria are not met in the following circumstances:
 When a provider participates in a community meeting or group session that is
not designed to provide clinical services. Examples of such activities include
information sessions for prospective patients, health presentations to community
groups (high school classes, PTA, etc.), and information presentations about
available health services at the center.
 When the only health service provided is part of a large-scale effort, such as a
mass immunization program, screening program, or community-wide service
program (e.g., a health fair).
 When a provider is primarily conducting outreach and/or group education
sessions, not providing direct services.
 When the only services provided are lab tests, x-rays, immunizations, TB tests
and/or prescription refills.
 Services performed under the auspices of a WIC program or a WIC contract.

REQUIRED
STAFFING
Staffing and the HIV/AIDS Continuum of Care Model: The HIV/AIDS Continuum of
Care Model and the Los Angeles Commission on HIV Standards of Care have clear and
distinct implications for staffing models needed to fully implement comprehensive
services. Provider agencies providing HIV/AIDS AOM Care Services should develop
staffing models with four key points in mind:
1. The HIV/AIDS Continuum of Care’s “Primary Health Care Core Services”
represents a set of multidisciplinary services that by definition requires a coordinated
team of medically-diverse professional and auxiliary health care practitioners. While
this collection of practitioners generally may all be categorized as medically-related,
each health care professional must practice with a multidisciplinary understanding of
his or her professional knowledge and skills. In other words, the practice of
HIV/AIDS medicine…prevention or care…is not narrowly biomedical in its focus.
Professionals must work in multidisciplinary teams with an expanded
understanding of HIV/AIDS primary health care services.
2. Experience and research has shown that services must be provided to a client through
a coordinated and seamless approach, even though no one single provider agency
necessarily directly employs all categories of professional and auxiliary staff needed
to provide the full compliment of Continuum of Care services. This coordinated and
seamless approach is actually reflected in the PHS standards and made even more
concrete in the established HIV/AIDS practice guidelines. Provider agencies are
required to comply with the PHS Standards of Care and Los Angeles
Commission on HIV Standards of Care, yet provider agencies are not expected
to directly employ all of the needed health care professionals as a way to fully
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meet these standards. Provider agencies will need to collaborate in order to make the
HIV/AIDS Continuum of Care accessible across the County of Los Angeles, and
AOM Care professionals will need to collaborate across provider agency boundaries
in order to surround a client with the full compliment of needed services.
3. The multidisciplinary approach to providing services in a professionally-diverse
Continuum of Care is not an artifact of luxury, but rather a result of the complex
nature of HIV disease itself coupled with the challenges the populations most affected
by HIV bring to the service setting. Making sure communities in the County of Los
Angeles have access to any and all of the services in the HIV/AIDS Continuum of
Care is a daily and determined act of financial problem-solving. Provider agencies
must use financial resources from many sources in a resource-limited funding
environment. AOM staffing patterns will combine direct hire, targeted consulting
and contracting, and referral as a way of fulfilling the expectations in the PHS
Standards, Los Angeles Commission on HIV Standards and the HIV/AIDS
Continuum of Care.
4. The clinical care of persons with HIV/AIDS requires clinicians with specialized
experience in the practice of HIV medicine. Knowledge about the clinical
management of HIV infection has rapidly evolved requiring frequent changes in stateof-the-art practice and the integration of evidence-based advances into routine care for
persons at risk for or living with HIV. Extensive clinical care experience with direct
management of ARV therapy, along with significant diagnostic, therapeutic, and
prevention education experience in the ambulatory care of the HIV-infected client is
requisite. Provider agencies must employ, contract, or refer to AOM health care
professionals who are prepared to provide services in a scientifically-rigorous
(including culturally-competent) environment.
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Department of Public Health
Office of AIDS Programs and Policy
Medical Clinic Services
Special Rate Study
ELIGIBILITY, EDUCATION, AND ENROLLMENT
SERVICES
for the AIDS DRUG ASSISTANCE PROGRAM
SERVICE DESCRIPTION
This service description is adopted by the County of Los Angeles, Department of Public
Health, Office of AIDS Programs and Policy (OAPP), to guide providers in the
development and implementation of Eligibility, Education, and Enrollment Services
for the AIDS Drug Assistance Program (ADAP). These services are provided to
individuals living with HIV/AIDS. Federal legislation, policy and program guidance, and
State of California statutes, regulations, and rules governing licensing and service
provision, supersede the Ambulatory/Outpatient Medical (AOM) Care Services
description.
SERVICE
Eligibility, Education, and Enrollment Services for ADAP
TABLE OF CONTENTS

Page
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DESCRIPTION
ADAP provides drugs that prolong quality of life and delay the deterioration of health to
individuals infected with HIV who otherwise could not afford them. ADAP is funded by
the Ryan White CARE Act (RWCA) and state funds (see www.dhs.ca.gov/aids/
Programs/CARE/adap.htm).
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To access ADAP drug reimbursement services, clients must be enrolled through local
enrollment sites. The local enrollment sites provide drug reimbursement services to HIVinfected individuals in the County of Los Angeles who have no other means to pay for
these services. Enrollment sites in the County of Los Angeles are reimbursed for services
through an OAPP contractual agreement.

PROGRAM REQUIREMENTS
The following requirements are minimum for Eligibility, Education, and Enrollment
Services for the AIDS Drug Assistance Program. Provider agencies providing these
services may exceed these requirements.
General Requirements: The program must ensure its ability to meet the needs of clients
by meeting the following general requirements:


Administrative and Program Policies and Procedures. The provider agency must
develop, implement, and revise, as necessary, standardized administrative policies and
procedures and program protocols to comprehensively guide the drug reimbursement
Eligibility, Education, and Enrollment Services for the AIDS Drug Assistance
Program. The procedures and protocols specific to the ADAP program are provided
by the California Department of Public Health /Office of AIDS, including periodic
updates. The provider agency providing enrollment services must fully comply with
these state guidelines (see ADAP Coordinator’s Reference Guide, May 2001, and the
Ramsell Corporation’s California State ADAP Enrollment and Eligibility Manual,
April 2004).
 Provider agencies must have a Client Grievance Policy and
All clients requesting and/or
Procedure that is reviewed with each client in a language
receiving drug reimbursement
services
and format the client can understand. A written copy must
have rights and
be provided to each client and a signed and dated receipt
responsibilities outlined in
“People with HIV/AIDS Bill of
form must be included in each client record. All staff must
Rights and Responsibilities”
comply with the established process for client grievances.
adopted by the
County of Los Angeles
Commission on HIV Health
Services (April, 2004).



Client Records. Provider agencies must have a formal
process for storing, maintaining, and managing client files.
Client file systems must be organized for ease in
information retrieval and synthesis. Client documentation
must be continuous and consistently current. Client records
must be secure to ensure confidentiality and should not be disclosed without the client
authorization, guardian authorization, or other legal requirement. Access to charts and
records for periodic monitoring by the California Department of Public Health/Office
of AIDS and OAPP staff is required.
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Confidentiality. All staff with access to client information must receive training on
confidentiality, appropriate exchange of information, and consent processes. This
training must be consistent with the established policies and procedures that
professionally govern release of medical information. Provider agency consent forms
must comply with state and federal law, must be signed by an individual legally able
to give consent, and must include a consent for release/exchange of information for
every individual/provider agency to whom client identifying information is disclosed,
regardless of whether or not HIV status is revealed.



Physical Office Space. The provider agency must provide the Enrollment Coordinator
and Eligibility Staff with space to conduct uninterrupted interviews for eligibility
screening.



Client-Staff-Colleague Communication. Provider agencies must have current written
policies and procedures addressing communications between the enrollment staff,
clients, or other professionals.



Documentation. Provider agencies providing Eligibility, Education, and Enrollment
Services for AIDS Drug Assistance Programs are required to meet all expectations
for client and service delivery contract reporting and documentation. Provider
agencies must utilize the County of Los Angeles’s “Casewatch” system to register the
client’s eligibility data, demographic/resource data, enter service utilization data,
medical and support service outcomes, and to record linkages/referrals to other
service providers and/or systems of care.
For clients not receiving Medi-Cal benefits, providers are required to document if a
client was referred to apply for Medi-cal, and if the client recently applied for MediCal, the date applied, application status. If the client is not referred, the provider
must document why the client was not referred.
The “Casewatch” system must be used to invoice for all delivered services, to
standardized reporting, to import efficiency of billing, to support program evaluation
processes, and to provide OAPP and participating contractors with information
relative to the HIV/AIDS epidemic in the County of Los Angeles. Provider agencies
must ensure data quality and compliance with all data submission requirements.

Eligibility: Eligibility requirements ensure that OAPP funds are used only for the
purchase of services that cannot be paid for through other sources. Clients are eligible for
services after a financial screening validates OAPP funds are the payer of last resort for
the client’s care. In addition, agencies providing services must ensure clients meet all of
the following criteria:


HIV Status. Client must provide verification of HIV status. Acceptable verification
includes one of the following: (a) a copy of the client’s seropositive test results (Elisa
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and Western Blot) from the test provider, (b) a signed document from a physician
verifying the client is HIV-positive, (c) lab results (i.e., viral load) at any time during
the client’s lifetime that shows the presence of the human immunodeficiency virus, or
(d) written verification from a psychosocial or medical case manager or other health
and social services providers who have one of the above documents in the client’s
file.


County of Los Angeles Residence. Clients must provide information to establish
residency in the County of Los Angeles.



Income. Clients must provide proof/documentation of income to verify OAPP funds
will be used as the payer of last resort for the service. Clients who do not have
coverage under or are ineligible for Medi-Cal or other third-party payment are eligible
for services. Income eligibility must be verified annually.



Age. Clients must be 18 years of age or older.

ADAP Enrollment Sites: Provider agencies providing Eligibility, Education, and
Enrollment Services for AIDS Drug Assistance Programs must first be approved by
California Department of Public Health/Office of AIDS and OAPP as an ADAP
Enrollment Site. ADAP Enrollment Sites, further, are registered by jurisdiction and must
be registered prior to housing any Enrollment Coordinator/Eligibility Staff within the
facility.


Staff Training. Provider agencies must cooperate in assuring the required staff
training for the Eligibility Coordinator and Eligibility Staff is completed. The
Enrollment Coordinator and Eligibility Staff must be certified through and receive
training from Ramsell Corporation prior to enrolling clients in ADAP or within 90
days of beginning enrollment services.

Client Rights: All ADAP clients and people who wish to become ADAP clients have the
following rights according to the statement of Client Rights. These rights include, but are
not limited to (www.ramsellcorp.com/client/ca):


Information on Eligibility Requirements. Clients or potential clients must be advised
of ADAP eligibility requirements and the right to apply for ADAP assistance by
completing the ADAP eligibility screening process and submitting an enrollment
application.



Confidentiality. All ADAP enrollment application and all ADAP transactions
conducted with a participating pharmacy will be handled in a confidential manner in
compliance with applicable state and federal laws.



Right to Appeal. The right to appeal a program denial due to income requirements or
to appeal the inaccuracy of an ADAP co-payment computation.
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Nondiscrimination. The right to receive services without discrimination as to race,
color, age, disability, homelessness, religion, gender, sexual orientation, or national
origin.



Courteous and Respectful Service. The right to receive courteous and respectful
service from ADAP Enrollment Coordinators and Eligibility Staff and participating
pharmacies.



Grievance. The right to grieve any event related to access or to delivery of ADAP
services that violates any of the above-stated rights.
”If you believe you have been denied your rights or treated unfairly or discourteously at any point in the
ADAP enrollment process, or in receiving pharmacy services, you may contact your local ADAP
coordinator for your area or the State Office of AIDS at (916) 327-6806.”
www.ramsellcorp.com/client/ca/client_rights.php

Referral and Coordination of Care: The provider agency providing drug reimbursement
enrollment services must have written procedures and protocols in place for referring
clients to other health and social services. The referral system must include a process for
tracking and monitoring referrals, and for documenting the results of referrals from the
providers of health and social services to which clients are referred. The Enrollment
Coordinator and Eligibility Staff are required to follow the agency’s established referral
policies and procedures when referring clients to other health and social in the HIV/AIDS
Continuum of Care.
The Enrollment Coordinator will maintain current information on
County-wide HIV/AIDS care and prevention services, for
example, a current HIV L.A. Directory of Services. The
Enrollment Coordinator will maintain knowledge of local, state,
and federal service and funding resources or service-funding
resource limitations influencing the client’s availability or
utilization of HIV/AIDS services.
HIV L.A.

Quality Management (QM): Provider agencies funded to
provide drug reimbursement enrollment services are required to
have a QM Program that will facilitate the delivery of state-ofthe-art HIV/AIDS services. Provider agencies needing technical assistance (TA) guidance
on the development of QM Programs are encouraged to consult the Quality Management
Technical Assistance Manual (this TA document is available at www.hab.hrsa.gov/).
Updated every six months.
www.hivla.org
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The agency must report on QM indicators specific to Eligibility, Education, and
Enrollment Services for the AIDS Drug Assistance Program.
Cultural Sensitivity and Linguistic Competence: Clients have the right to Eligibility,
Education, and Enrollment Services for the AIDS Drug Assistance Program
provided by qualified, HIV-knowledgeable and capable staff who is culturally-sensitive
and linguistically-competent, who communicate and educate in culturally-congruent
ways, and who work with the client’s health care team. The Enrollment
Coordinator/Eligibility Staff must demonstrate cultural sensitivity and linguistic
competency specifically in the services provided. The staff must also demonstrate cultural
sensitivity and linguistic competency for the population receiving the services (see “The
Provider’s Guide to Quality and Culture,” http://bphc.hrsa.gov/quality/Cultural.htm).
Translation/Language Interpreter’s federal and state language access laws (Title VI of the
Civil Rights Act of 1964 and California’s 1973 Dymally-Alatorre Bilingual Services Act)
require health care facilities that receive federal or state funding to provide competent
interpretation services to Limited English Proficiency (LEP) clients at no cost, in order to
ensure equal and meaningful access to health care services.
DEFINITION OF ENCOUNTER
The US Department of Health and Human Services/Health Resources and Services
Administration (HRSA) publishes the Uniform Data System (UDS) Reporting
Instructions for Section 330 Grantees (last updated in 2006). The definition of an
encounter is:
“Encounters are Documented, face-to-face contact between a patient and
a provider who exercises independent professional judgment in the
provision of services to the individual. To be included as an encounter,
services must be documented.” (Page 5)
Additional guidance relative to encounters includes:
1.

To meet the criterion for "independent judgment," the provider must be acting on
his/her own when serving the patient and not assisting another provider. For
example, a nurse assisting a physician during a physical examination by taking vital
signs, taking a history or drawing a blood sample is not credited with a separate
encounter. Independent judgment implies the use of the professional skills
associated with profession of the individual being credited with the encounter and
unique to that provider or other similarly or more intensively trained providers.

2.

To meet the criterion for "documentation," the service (and associated patient
information) must be recorded in written or electronic form. The patient record does
not have to be a full and complete health record in order to meet this criterion. For
example, if an individual receives services on an emergency basis and these
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services are documented, the documentation criterion is met even though a
complete health record is not created. Screenings at health fairs, immunization
drives for children or the elderly and similar public health efforts do not result in
encounters.
4.

Such services as drawing blood, collecting urine specimens, performing laboratory
tests, taking X-rays, giving immunizations, and filling/dispensing prescriptions do
not constitute encounters.

5.

A provider may be credited with no more than one encounter with a given patient in
a single day, regardless of the types or number of services provided.

6.

The encounter criteria are not met in the following circumstances:
 When a provider participates in a community meeting or group session that is
not designed to provide clinical services. Examples of such activities include
information sessions for prospective patients, health presentations to
community groups (high school classes, PTA, etc.), and information
presentations about available health services at the center.
 When the only health service provided is part of a large-scale effort, such as a
mass immunization program, screening program, or community-wide service
program (e.g., a health fair).
 When a provider is primarily conducting outreach and/or group education
sessions, not providing direct services.
 When the only services provided are lab tests, x-rays, immunizations, TB tests
and/or prescription refills.
 Services performed under the auspices of a WIC program or a WIC contract.

Specific guidance on encounters related to Eligibility, Education, and Enrollment
Services for the AIDS Drug Assistance Program includes the following:



Providers should request reimbursement when an Enrollment Coordinator or
Enrollment Staff completes an eligibility determination after meeting face-to-face
with a client for approximately 45 minutes or more.
Providers should request reimbursement for the provision of education and
information when the Enrollment Coordinator or Enrollment Staff meets face-to-face
with the client for approximately 20 minutes or more to provide education or
information.

REQUIRED STAFFING
Eligibility, Education, and Enrollment Services for the AIDS Drug Assistance
Program is provided by Enrollment Coordinators who supervise ADAP services at local
sites and by Eligibility Staff who screen clients for eligibility to receive services, provide
basic education about drug reimbursement services, provide clients with information on
approved drug formulary and pharmacy sites, address client grievances and complaints,
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maintain documentation on services provided for each client, and re-certify client
eligibility annually, or more frequently, if needed.
The ADAP Enrollment Site Program must have the following staff:



Enrollment Coordinator.
Eligibility Staff.

There are no minimum educational or credentialing standards for an individual to be an
Enrollment Coordinator or Eligibility Staff. However, the Enrollment Coordinator and
Eligibility Staff must be certified through and receive training from Ramsell Corporation
prior to enrolling clients in ADAP or within 90 days of beginning enrollment services.
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Department of Public Health
Office of AIDS Programs and Policy
Medical Clinic Services
Special Rate Study
NUTRITIONAL COUNSELING
(MEDICAL NUTRITION THERAPY)
SERVICE DESCRIPTION
This service description is adopted by the County of Los Angeles, Department of Public
Health, Office of AIDS Programs and Policy (OAPP), to guide providers in the
development and implementation of Nutritional Counseling (Medical Nutrition
Therapy) services to individuals living with HIV/AIDS. Federal legislation, policy and
program guidance, and State of California statutes, regulations, and rules governing
licensing and service provision, supersede the Medical Nutrition Therapy service
description.
SERVICE
Medical Nutrition Therapy
TABLE OF CONTENTS
Page
Description ..................................................................................... 1
Program Requirements .................................................................. 2
Definition of Encounter .................................................................. 9
Required Staffing ......................................................................... 11
DESCRIPTION
In HIV/AIDS, clients may be at nutritional risk at any point of their illness. Medical
Nutrition Therapy is a critical companion service to HIV/AIDS disease prevention and
management. Medical Nutrition Therapy services are provided in accordance with the
Los Angeles Commission on HIV Standards of Care, Medical Nutrition Therapy (final
October 8, 2006), are provided in conjunction with routine and recurring HIV/AIDS
primary health care services, and are preferably delivered on-site with the HIV/AIDS
Ambulatory/Outpatient Medical (AOM) Care Services to better support a client’s access
to, utilization of, retention in, and adherence to Medical Nutrition Therapy.
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In the County of Los Angeles’ HIV/AIDS Continuum of Care adopted on October 14,
2004, Medical Nutrition Therapy is a Primary Health Care Core Service. Medical
Nutrition Therapy is directly related to improving health outcomes for HIV-infected
clients, and it combines an emphasis on disease prevention and disease management.
Good nutrition is important in building and sustaining the immune system. Achieving
good health and preventing malnutrition is essential in maintaining positive health
outcomes for people living with HIV.

HIV/AIDS Resource on Food-Drug
Interactions?
www.foodmedinteractions.com

Medical Nutritional Therapy is appropriate
both for clients who have or have not
initiated medication therapies for HIV
disease management.

PROGRAM REQUIREMENTS
The following are minimum requirements for the provider agency providing Medical
Nutrition Therapy. Service providers may exceed these requirements.
General Requirements: The provider agency providing Medical Nutrition Therapy
must ensure its ability to meet the needs of the client by meeting the following general
requirements:


Administrative and Clinical Policies and Procedures. The provider agency offering
Medical Nutrition Therapy must develop, and revise, as necessary, related
standardized administrative policies and procedures and clinical protocols as part of
the overall AOM Care Services. The policies, procedures, and protocols must be
submitted to OAPP for review and approval upon request. Revisions to the procedures
and protocols may, upon request, require OAPP approval.



Provider agencies must have a Client Grievance Policy and Procedure that is reviewed
with each client in a language and format the client can understand. A written copy
must be provided to each client and a signed and dated receipt form must be included
in each client record. All AOM professionals must comply with the established
process for client grievances.



Clinical Care Protocols. The provider agency offering Medical Nutrition Therapy
services must comply with the Public Health Service (PHS) guidelines
(www.aidsinfo.nih.gov) and the Los Angeles Commission on HIV Standards of Care.
Agency primary care professionals must utilize established practice guidelines in
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order to facilitate consistency in providing state-of-the-art prevention and care
services for all clients.
HIV/AIDS prevention and care practice guidelines may be downloaded or ordered in
bulk from the following websites: Los Angeles Commission on HIV Standards of
Care for Medical Nutrition Therapy (www.hivcommission-la.info/soc.asp), Johns
Hopkins AIDS Service (www.hopkins-aids.edu), New York Department of Health
AIDS
Institute
(www.hivguidelines.org),
federal
HIV/AIDS
Bureau
(www.hab.hrsa.gov), and CDC’s Division of AIDS Prevention-Treatment
(www.cdc.gov).
The agency must have a written policy, procedure, and protocol to facilitate
compliance with the California Business and Professions Code, Section 2585-2586.8
(www.leginfo.ca.gov/calaw.html) which, among other aspects, specifies that a referral
shall be accompanied by a written prescription signed by the health care provider
detailing the patient's diagnosis and including a statement of the desired objective of
dietary treatment, unless a referring physician and surgeon has established or
approved a written protocol governing the patient's treatment.
The provider agency offering Medical Nutrition Therapy services must comply with
the Los Angeles Commission on HIV Standards of Care for Medical Nutrition
Therapy and with Guidelines for Implementing HIV/AIDS Medical Nutrition Therapy
Protocols (revised December 2002). The provider agency will utilize established HIV
nutrition practice guidelines and protocols in order to facilitate consistency in
providing state-of-the-art Medical Nutrition Therapy services for all clients.
Other Medical Nutrition Therapy guidelines and protocols may be obtained from
the American Dietetic Association (www.eatright.org/Public/Other/index_
adap0600.cfm, Health Resources and Services Administration (www.aidsetc.org/aidsetc?page=et-30-20-01) and as noted in the Commission on HIV Standard
of Care for Medical Nutrition Therapy.
The provider agency must utilize the “Nutrition Screen and Referral Criteria for
Adults (18+Years) with HIV/AIDS, March 2005” 4,5 (http://www.hivaidsdpg.org/
Data/QM/HIV_Adult_Nutrition_Screen_Referral Criteria_200207.pdf.


HIV Prevention and Disease Management Competency. The provider agency must
have personnel policies and procedures requiring and supporting the continued

4
Adapted from: Fenton M, Heller L, Vazzo L, et al. Dietitians in AIDS Care, AIDS Project Los Angeles, 1998. Nutrition screening referral criteria included in: Guidelines form
Implementing HIV/AIDS Medical Nutrition Therapy Protocols. Approved by the Los Angeles County Commission on HIV Health Services, September 1999.
5

Adapted from the C.A.R.E. Program and Clinics – Catholic Healthcare Org, a Ryan White CARE Act Title III Grantee providing early intervention services and primary health
care to people living with HIV and AIDS in Long Beach, CA; developed by Tammy Darke, RD, CNSD. Adapted by Fenton M, 5/2000, then by the ADA HIV/AIDS DPG special
working groups members in 5/2002 and 3/2005.

Mercer Government Human Services Consulting

Medical Clinical Fee-for-Service
Reimbursement Rate Study

Office of AIDS Programs and Policy
Final Report

education of all HIV/AIDS health care professionals, including Registered Dietitians
(RD) and Dietetic Technician Registered (DTR). All DTRs must work under the
supervision of an experienced RD. Provider agencies are expected to budget costs for
HIV/AIDS continuing education, specifically in HIV prevention and disease
management, to purchase practice guidelines in formats easily accessible and usable
for primary care providers, and to provide routine access to computerized educational
and prevention/care treatment problem-solving (i.e., www.thebodypro.com,
www.hivinsite.ucsf.edu,
www.hopkins-aids.edu,
or
www.nlm.nih.gov/medlineplus/aids.html) for all agency health care professionals,
including RDs.

The American Dietetic Association (ADA) has developed a Scope of
Dietetics Practice Framework and supporting documents, “Evaluation tools
practitioners and their managers can use to gauge and channel performance” (Journal
of the American Dietetics Association, April 2005, www.adajournal.org). These
evaluation tools include:
a. RDs Standards of Practice in Nutrition Care.
b. Standards of Professional Performance for Dietetics Professionals (expands
the previously titled “Standards of Professional Practice”).
c. ADA’s Code of Ethics.


Client-Staff-Colleague Communication. Provider agencies must have current written
policies and procedures addressing communications between the primary care staff
(including RDs), clients, or other professionals.



Client Satisfaction. RDs providing Medical Nutrition Therapy services must
perform semi-annual assessments of clients’ needs and satisfaction by conducting
random, anonymous client surveys. RDs may cooperate with the agency’s general
needs assessments and client satisfaction surveys so long as these assessments and
surveys adequately address need for and satisfaction with Medical Nutrition
Therapy services.



Client Records. The provider agency must maintain a client record for each client,
documenting each face-to-face patient/practitioner encounter. Documentation of
Medical Nutrition Therapy services must be consistent with the agency’s clinical
policies and procedures for client record keeping.



Records Maintenance. Provider agencies must have a formal process for storing,
maintaining, and managing client files. Client file systems must be organized for ease
in information retrieval and synthesis. Client records must be secure to ensure
confidentiality and should not be disclosed without the client authorization, guardian
authorization, or other legal requirement.

Mercer Government Human Services Consulting

Medical Clinical Fee-for-Service
Reimbursement Rate Study



Office of AIDS Programs and Policy
Final Report

Case Conferencing. To fully address the HIV/AIDS Continuum of Care needs, and in
order to coordinate patient care services, the agency must provide primary health care
services in a multidisciplinary team approach. Case conferencing is required. Case
conferencing should focus on client treatment concerns and challenges and must
include perspectives from medical, social, and prevention team providers. The RD
offering Medical Nutrition Therapy must participate regularly, in person or by
phone, in the multidisciplinary team case conferences at the HIV/AIDS AOM Care
Services sites.

Eligibility: Eligibility requirements ensure that OAPP funds are used only for the
purchase of Medical Nutrition Therapy that cannot be paid for through other sources.
Clients are eligible for Medical Nutrition Therapy services after a financial screening
that validates OAPP funds are the payer of last resort for the client’s care. In addition,
clients must meet all of the following criteria:


HIV Status. Client must provide verification of HIV status. Acceptable verification
includes one of the following: (a) a copy of the client’s seropositive test results (Elisa
and Western Blot) from the test provider, (b) a signed document from a physician
verifying the client is HIV-positive, (c) lab results (i.e., viral load) at any time during
the client’s lifetime that show the presence of the human immunodeficiency virus, or
(d) written verification from a psychosocial or medical case manager or other health
and social services provider who has one of the above documents in the client’s file.



County of Los Angeles Residence. Client must provide information to establish
residency in the County of Los Angeles.



Income. Clients must provide proof/documentation of income to verify OAPP funds
will be used as the payer of last resort for the service. Clients who do not have
coverage under or are ineligible for Medi-Cal or other third-party payment are eligible
for OAPP-funded services. Income must be verified annually.

Client Rights: All clients requesting and/or receiving Medical Nutrition Therapy have
rights and responsibilities outlined in “People with HIV/AIDS Bill of Rights and
Responsibilities” adopted by the County of Los Angeles Commission on HIV Health
Services (April 2004).
Provider agencies must have a Client Rights and Responsibilities Statement that is
reviewed with each client in a language and format the client can understand. A written
copy must be provided to each client and a signed and dated receipt form must be
included in each client record. RDs must comply with the established policies and
procedures for Client Rights and Responsibilities.
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Client-Centered Treatment: The provider agency providing Medical Nutrition Therapy
must ensure that clients are given the opportunity to ask questions and receive accurate
answers regarding all health and social services provided by the provider agency’s health
care practitioners. In addition, clients must be given the opportunity to ask questions and
receive accurate answers on services to which they are referred, especially (but not
limited to) the full compliment of services making up the Primary Health Care Core
Services in the HIV/AIDS Continuum of Care.
Patient and health care provider discussions during prevention and care services
encounters form the foundation of a relationship built on trust and confidence where
clients are seen as active partners in the decisions about their personal health care
regimen. RDs are encouraged to review client-oriented HIV/AIDS prevention and care
websites to become more familiar and versatile in
discussing HIV/AIDS from a client-centered
www.apla.org,
approach
(i.e.,
www.projectinform.org,
www.aidsnutrition.org,
or
Did You Know?
www.thebody.com).
California has State Requirements
For Referrals to RDs!

Clients must be fully educated about their health
care needs and treatment options within the standards of medical care. Client education
must be documented in the client record with details of each intervention.
Referral and Coordination of Care: The provider agency providing Medical Nutrition
Therapy services must have written procedures and protocols in place for referring
clients to other health and social services. The referral system must include a process for
tracking and monitoring referrals and for documenting the results of referrals from the
providers of health and social services to which clients are referred. RDs are required to
follow the provider agency’s established referral policies and procedures for services
beyond their internal Medical Nutrition Therapy Program.


California Regulations on Referrals to RDs. Referrals to RDs in California must be
made by health care providers authorized to prescribe dietary treatments. The referral
must be accompanied by a written prescription signed by the health care provider
detailing the client’s diagnosis and including a statement of the desired objective of
dietary treatment. A RD may accept or transmit verbal orders or electronically
transmitted orders from the referring physician consistent with an established protocol
to implement Medical Nutrition Therapy (California Business and Professions
Code, Sections 2585-2585.8). Provider agency policies and procedures for making
and receiving referrals for Medical Nutrition Therapy must comply with California
regulations.



Written Reports. The RD offering Medical Nutrition Therapy must provide a
written report of the nutrition assessment, plan, and intervention(s) to the referring
provider agency within an agreed upon and reasonable period of time but not to
exceed more than two weeks. Copies of the comprehensive nutrition assessment,
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nutrition progress notes, and care plan must be sent to the referral provider agency
and placed in the client’s file.
Quality Management (QM): Provider agencies funded to provide Medical Nutrition
Therapy are required to have a QM Program that will facilitate the delivery of
state-of-the-art HIV/AIDS services. Provider agencies needing technical assistance (TA)
guidance on the development of QM Programs are encouraged to consult the Quality
Management Technical Assistance Manual (this TA document is available at
www.hab.hrsa.gov/).
The provider agency’s QM Program must include:


QM Plan. The QM Program must be based on a provider agency-wide, written QM
Plan that addresses both HIV prevention and care services.



QM Committee. The QM Program must be guided by a provider agency QM
Committee formally convened minimally quarterly to assure the QM Programs goals
and objectives are met. The RD offering Medical Nutrition Therapy must
participate regularly with the QM Committee to discuss operational and quality
improvement issues and utilization review.



Client Feedback Process. The QM Program must describe how ongoing client
feedback will be obtained and utilized to improve access, utilization, retention, and
adherence to HIV preventative services and care.



Client Grievance Process. The QM Program must describe the implementation of the
provider agency’s Client Grievance Process (see requirement for Client Grievance
Policy and Procedure above). Client grievance data must be tracked, trended, and
reported to the provider agency’s QM Committee for use in making improvements in
HIV services and care.

The provider agency’s QM Program must be able to meet the following expectations:


Medical Record System. Routine and recurring audits of the provider agency’s
medical record system must demonstrate service records are organized, complete, and
current. HIV/AIDS service delivery information must be organized clearly and
consistently, supporting ease of review and consideration by any and all social and
health care practitioners. Reports from these audits must describe the identification of
concrete problems in HIV/AIDS services record keeping, together with practical
solutions and documentation for problem-resolve.



Consistency of HIV Practice Patterns. The provider agency QM Program must make
routine and recurring audits of service delivery records in order to assess the degree to
which individual practitioners are providing services consistent with federal
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guidelines for the medical management of HIV infection and other issues surrounding
HIV infection. The federal guidelines are available at www.aidsinfo.nih.gov.
− In order to specifically focus the provider agency’s audits for compliance with the
guidelines, provider agencies are encouraged to adopt currently published
HIV/AIDS practice guidelines that assist practitioners in following concrete and
specific service protocols (i.e., Clinical Infectious Disease 2003:36, Supplement
2:S52-62). These practice guidelines are typically available from the websites
supported by the respective professional associations (i.e., www.hivaidsdpg.org or
www.eatright.org) and from selective HIV/AIDS academic institutions or
research-based organizations (i.e., www.aids-etc.org, www.hopkins-aids.edu, or
http://hivinsite.ucsf.edu). Practitioners providing HIV prevention in medical
settings must consult and comply with “Incorporating HIV Prevention into the
Medical Care of Persons Living with HIV” (MMWR: July 18, 2003/Vol. 52/No.
RR-12).


Required Provider Agency Indicators. The provider agency’s QM Program must
identify quality assurance indicators documenting successful clinical and service
delivery outcomes in the following areas:
(a) Documenting the completion and incorporation of needed referrals from
across the HIV/AIDS Continuum of Care Primary Health Care Core Services
and the integration of referral results and recommendations into the client’s
primary care treatment process.
(b) Documenting the successful integration of care and treatment services in
medical care settings.
(c) Documenting the provider agency’s success in achieving adherence with care
and prevention treatment plans.
(d) Documenting the clinical outcome indicators as required by OAPP.



Required System-Wide Indicators. Finally, provider agencies are required to
participate in all system-wide QM reviews conducted by OAPP. The specific
indicators for the system-wide review will be identified annually by OAPP and will
focus on four critical areas:
(e) Reducing disparities in health outcomes for the County of Los Angeles’s social,
racial, and/or ethnic minorities.
(f) Increasing health outcomes for all recipients of services in the HIV/AIDS
Continuum of Care.
(g) Prevention of HIV infection and prevention of progression to HIV-related illness
and disease, disability, and death.
(h) Indicators related to the HIV/AIDS Continuum of Care’s emphasis on the
continuity of access, utilization, retention, and adherence for clients.

Cultural Sensitivity and Linguistic Competence: Clients have the right to Medical
Nutrition Therapy services provided by a qualified, HIV-knowledgeable, and capable
RD who is culturally- and linguistically-competent, who communicates and educates in
culturally-congruent ways, and who works in collaboration with the client’s team. The
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RD must demonstrate cultural sensitivity and linguistic competency specifically in the
services provided. The RD must also demonstrate cultural sensitivity and linguistic
competency with the target population receiving the services (see “The Provider’s Guide
to Quality and Culture”: http://bphc.hrsa.gov/quality/Cultural.htm).
Translation/Language Interpreter’s federal and state language access laws (Title VI of the
Civil Rights Act of 1964 and California’s 1973 Dymally-Alatorre Bilingual Services Act)
require health care facilities that receive federal or state funding to provide competent
interpretation services to Limited English Proficiency (LEP) patients at no cost, in order
to ensure equal and meaningful access to health care services.

National Standards for Culturally- and Linguistically-Appropriate
Services in Health Care
http://www.omhrc.gov/clas/finalcultural1a.htm

Documentation: Provider agencies providing Medical Nutrition Therapy are required
to meet all expectations for client and service delivery contract reporting and
documentation. Provider agencies must utilize the County of Los Angeles’ “Casewatch”
system to register the client’s eligibility data, demographic/resource data, enter service
utilization data, medical and support service outcomes, and to record linkages/referrals to
other service providers and/or systems of care.
For clients not receiving Medi-Cal benefits, providers are required to document if a client
was referred to apply for Medi-cal, if recently applied for Medi-Cal, date/ applied,
application status, and if not referred, must document why the client was not referred.
The “Casewatch” system must be used to invoice for all delivered services, to
standardized reporting, to import efficiency of billing, to support program evaluation
processes, and to provide OAPP and participating contractors with information relative to
the HIV/AIDS epidemic in the County of Los Angeles. Provider agencies must ensure
data quality and compliance with all data submission requirements.
DEFINITION OF ENCOUNTER
The US Department of Health and Human Services/Health Resources and Services
Administration (HRSA) publishes the Uniform Data System (UDS) Reporting
Instructions for Section 330 Grantees (last updated in 2006). The definition of an
encounter is:
“Encounters are Documented, face-to-face contact between a patient and
a provider who exercises independent professional judgment in the
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provision of services to the individual. To be included as an encounter,
services must be documented.” (Page 5)
Additional guidance relative to encounters includes:
1.

To meet the criterion for "independent judgment," the provider must be acting on
his/her own when serving the patient and not assisting another provider. For
example, a nurse assisting a physician during a physical examination by taking vital
signs, taking a history or drawing a blood sample is not credited with a separate
encounter. Independent judgment implies the use of the professional skills
associated with profession of the individual being credited with the encounter and
unique to that provider or other similarly or more intensively trained providers.

2.

To meet the criterion for "documentation," the service (and associated patient
information) must be recorded in written or electronic form. The patient record does
not have to be a full and complete health record in order to meet this criterion. For
example, if an individual receives services on an emergency basis and these
services are documented, the documentation criterion is met even though a
complete health record is not created. Screenings at health fairs, immunization
drives for children or the elderly and similar public health efforts do not result in
encounters.

4.

Such services as drawing blood, collecting urine specimens, performing laboratory
tests, taking X-rays, giving immunizations, and filling/dispensing prescriptions do
not constitute encounters.

5.

A provider may be credited with no more than one encounter with a given patient in
a single day, regardless of the types or number of services provided.

6.

The encounter criteria are not met in the following circumstances:
 When a provider participates in a community meeting or group session that is
not designed to provide clinical services. Examples of such activities include
information sessions for prospective patients, health presentations to
community groups (high school classes, PTA, etc.), and information
presentations about available health services at the center.
 When the only health service provided is part of a large-scale effort, such as a
mass immunization program, screening program, or community-wide service
program (e.g., a health fair).
 When a provider is primarily conducting outreach and/or group education
sessions, not providing direct services.
 When the only services provided are lab tests, x-rays, immunizations, TB tests
and/or prescription refills.
 Services performed under the auspices of a WIC program or a WIC contract.
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Specific guidance on encounters related to Medical Nutrition Therapy includes the
following:





An initial assessment defined by the Commission on HIV Standard of Care, is
estimated at one hour.
A continuing visit, designed to meet the needs identified in the assessment, is
estimated at 20 minutes.
Providers should request reimbursement for an initial assessment with a client only
when the assessment took approximately one hour or more.
Providers should request reimbursement for a continuing visit with a client only when
the continuing visit took approximately 20 minutes or more.

REQUIRED STAFFING
Medical Nutrition Therapy must be provided by a RD. Qualifications of RDs are
provided in the Los Angeles County Commission on HIV Standards of Care for Medical
Nutrition Therapy as follows.





The RD must have completed a Bachelors, Masters, and/or Doctorate degree in
nutrition and related sciences.
The RD must have completed a supervised internship or equivalent.
The RD must pass a national exam which credentials her/him as a Registered
Dietitian by the Commission on Dietetic Registration.
Continuing education is required to maintain certification.
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F
Data Request and ESIS Form (January 2008)
OAPP sent the data request, reproduced below, to providers in January, 2008.

From: Monique Collins [mailto:mcollins@ph.lacounty.gov]
Sent: Monday, January 07, 2008 3:33 PM
To: OBrien, Quentin
Cc: Michael Green
Subject: MOP Data Request
Hi QuentinAs requested, I am sending you the data request by Mercer for the MOP Rate Study. Please send
out to all MOP Caucus representatives for their review and response. If possible I would like to
get the data back by Friday, January 18, 2008. This information will help Mercer in their analysis
to capture true costs across providers. We hope to get a broader response from providers.
(Below Mercer Instructions)
1. General Ledgers in Excel
Please provide a General Ledger. Our preference is for providers to submit a General Ledger for
the time period March 1, 2005 through February 28, 2006 (Year 15) and (separately) for March 1,
2006 through February 28, 2007 for Ryan White Care Act (RWCA) funds for ambulatory
outpatient services only. Alternatively, providers may provide a General Ledger for a different
time period that covers at least six months in duration with a start date that begins January 1,
2005 or later. We recognize that not all providers may keep RWCA funding and/or ambulatory
outpatient care services separate from other fund sources and service provision in their General
Ledgers. Please provide whatever information you have. However, please identify the fund
sources captured, the time period covered, and the services covered in the General Ledger(s) in
the cover e-mail when you send the General Ledger(s) to OAPP. Any submission not provided in
Microsoft Excel will not be considered. Any submission that does not identify in the cover e-mail
the fund sources, time period, and services included will not be considered.
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2. Encounter and Staffing Information on attached Excel Spreadsheet
Please complete the attached Excel spreadsheet titled Encounter and Staffing.xls. Use
information from your General Ledger and any back-up detail you may have. As you scroll over
Columns B, C, and F on the attached spreadsheet to input your organization's information, "pop
up" boxes provide instructions. Boxes highlighted in yellow should be completed.
The most important thing about this spreadsheet is to make sure the funding information reported
in the General Ledger(s), and now reiterated in the spreadsheet (Rows 6 through 8 and Rows 13
through 19), relates directly to the number of encounters reported (Rows 9 and 10). The
expenses reported for staffing (Column B, beginning on Row 13 on the attached spreadsheet, as
well as Column F, beginning on Row 13, if your organization submitted a second General Ledger
for a separate time period) must tie directly to the staffing expenses identified in the
General Ledger(s) submitted. Any submission that does not clearly tie the expenses reported for
staffing to the General Ledger will not be considered. In short, the attached spreadsheet is asking
for information on encounters as these are not provided in the General Ledgers as well as more
specific information on staffing that is not provided on some presentations of the General
Ledgers. The information
is not meaningful, however, unless the number of encounters as well as dollar amount expended
and number of specific staff all relates directly to the General Ledger information provided.

3. Staffing Ratios Information
At the presentation on October 31, 2007, some providers indicated they were aware of published
studies related specifically to staffing HIV/AIDS clinics. If you have succinct empirical information
(internal studies, peer-reviewed professional studies, literature review information) about the
number of annual encounters typically provided by an outpatient clinic, please provide the actual
study or a direct website link.

All information is requested to be sent electronically by Friday, January 18, 2007 5:00 p.m. to
Monique Collins at mcollins@ph.lacounty.gov.
Monique Collins, MPH, CHES
State Grant Manager
Planning and Research Division
Office of AIDS Programs and Policy
(213) 351-8084
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Provider Name:
Contact Person's Name:
Contact Person's Telephone:
Contact Person's E-mail:

Time Period General Ledger 1 Covers
Fund Sources General Ledger 1
Covers
Total Funding (i.e., expenditures)
Identified on General Ledger 1

Time Period General Ledger 2
Covers
Fund Sources General Ledger 2
Covers
Total Funding (i.e., expenditures)
Identified on General Ledger 2

00/00/00 - 00/00/00

$

-

Number of Encounters Delivered

Number of Encounters Delivered

Actual or Estimated Encounters?

Actual or Estimated Encounters?

General Ledger Salary Amount:
- Physicians
- Physician Assistants
- Nurse Practitioners
- Registered Nurses
- Nurse (Other than RN)
- Other Direct Care Professional Staff
- Other Non-Direct Care Staff

Staffing in Dollars
$
$
$
$
$
$
$
$
Note: The dollar amount in
Row 20, Column B should
directly correlate to the
General Ledger line item(s)
for salary. If it does NOT,
please explain why below:

Mercer Government Human Services Consulting

Staffing in FTE
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

General Ledger Salary Amount:
- Physicians
- Physician Assistants
- Nurse Practitioners
- Registered Nurses
- Nurse (Other than RN)
- Other Direct Care Professional Staff
- Other Non-Direct Care Staff

00/00/00 - 00/00/00

$

-

Staffing in Dollars
$
$
$
$
$
$
$
$
Note: The dollar amount in
Row 20, Column F should
directly correlate to the
General Ledger line item(s)
for salary. If it does NOT,
please explain why below:

Staffing in FTE
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
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MEMO
To:

Charles L. Henry, Director
County of Los Angels, Office of AIDS Programs and Policy

Date:
From:

April 7, 2005 (with revisions)
Mercer Human Resource Consulting (Melanie L. Sovine, Ph.D., Terri Goens, John
Villegas-Grubbs)
Medi-Cal Rate Comparisons

Subject:

Introduction
Mercer Government Human Services Consulting (Mercer) has delivered recommended
fee-for-service reimbursement rates for services identified as part of medical services
under Work Order No. 6-49. Following the pattern from the prior Mercer rate study on
substance abuse and residential services, a comparison with Medi-Cal rates was requested
by the Office of AIDS Programs and Policy (OAPP). Mercer completed that comparison,
and this memo relays the resulting information to OAPP.

Findings
1. Eligibility, Education and Enrollment Services for ADAP: The service components in
this service description are defined and specified by the Office of AIDS, California
Department of Public Health, and they are distinctive to how the Ryan White Care
Act (RWCA), Part B, AIDS Drug Assistance Program is implemented in California.
There is no comparable Medi-Cal program with which to compare rates of
reimbursement for this service.
2. Drug Resistance Testing: The rate of reimbursement for this service description is for
the blood draw and both the pre-/post-test counseling sessions. The Mercer rate does
not reimburse costs for the actual blood laboratory analysis. The costs for resistance
analysis are processed through a separate voucher system; vouchers are submitted
with the sample to the County of Los Angeles, DHS, Public Health Laboratory.
Medi-Cal rates for resistance testing are available; however, these rates cover the
costs for blood draw and actual laboratory analysis of the blood sample, and these
rates do not reimburse for counseling. Therefore, the Medi-Cal rates do not reimburse
for costs comparable to the costs reimbursed by the Mercer rate.
Mercer did attempt to identify a similar service from other programs (e.g., STDs,
genetic testing, diabetes) where education-counseling and blood draws prior to
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treatment regimen initiation/changes are common. There were no Medi-Cal rates
based on a service bundle matching OAPP’s Drug Resistance Testing.
3. Referral to Medical Specialty Services: The service description reimburses for the
medical examination required to determine the appropriate referral(s) and the referral,
itself. The Mercer rate does not reimburse for the cost of the actual medical specialty
service. 6
Medi-Cal, at one time, reimbursed for a similar7 service through the “Fee-for-Service
Managed Care” model. In this delivery model Medi-Cal beneficiaries were assigned a
primary care provider for what was called “medical case management”. The primary
care provider acted as a gatekeeper for specialty services. These providers were paid
on a fee-for-service basis. Phased-out in June 2003, the model no longer operates in
California. There is no comparable Medi-Cal model for this OAPP service
description.8
4. Nutritional Counseling (Medical Nutritional Therapy): There is a Medi-Cal
reimbursement rate for Medical Nutritional Therapy; however, this rate was
established January 1, 1993 for the AIDS Medi-Cal Waiver Program (MCWP). The
development of AIDS Waiver Programs preceded advances in health outcomes as a
result of HIV-related pharmaceuticals, and State health financing departments
established them as a way to keep AIDS patients out of expensive hospital and/or
nursing home care.
The Medi-Cal rate is: Nutritional Counseling…..………

$33.48/hour9

The OAPP service description and corresponding reimbursement rate currently does
not include the costs for nutritional supplements, and neither does the above Medi-Cal

6

There are local medical specialty providers who negotiate a reimbursement rate for their services that are not reflective
of the actual costs of the service. Providers have been willing to do this as a way to help meet the medical needs of
those who have no or limited resources to pay for the services. The Mercer rate setting architecture cannot take into
consideration the “charity” implicit in these negotiated medical specialty rates.
7

Because a description of the actual service components is no longer available, the referenced Medi-Cal model is
qualified as “similar”, but not necessarily “comparable”, to the OAPP service description for Referral to Medical
Specialty Services.
8

This service description is under discussion for continuance in the rate study. This discussion has largely been carried
out through Mercer-OAPP shared conference calls and no decision has been made as of the date of this Memo. The
discussion stems from the fact that this service (medical exam for needed referral and making of referral) is actually a
required and routine service component in the HIV/AIDS Ambulatory/Outpatient Medical Care Services service
description, and therefore may be redundant.
9

There also is an allowance for travel time (billing up to one additional hour) under strict guidelines in the MCWP (see,
“AIDS Waiver Program Billing Codes and Rates”, October 2004 Provider Manual, Medi-Cal Publications,
http://files.medi-cal.ca.gov).
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rate. In the MCWP, “Nutritional Supplements/Home Delivered Meals” are capped at
$150.00 per client per month. This cap also was established January 1, 1993.
The Mercer rate study uses current, geographically relevant Bureau of Labor Statistics
data as an indicator of actual personnel hiring costs, and then factors these costs with
other real-time program and administrative costs derived from actual agency cost
reports. Therefore, the Mercer rate of reimbursement ($57.85) is a more realistic
reimbursement rate for this service in 2005. 10
A Note from Medicare/Medicaid: The American Dietetic Association (ADA)
proactively works to assist Registered Dietitians in understanding billing procedures
and actively describes appropriate billing codes. There are Medicare/Medicaid CPT
codes for Medical Nutritional Therapy released by the Centers for Medicare and
Medicaid Services (CMS) and included in the American Medical Association’s
(AMA) Current Procedural Terminology CPT 2001 book. Medi-Cal has not adopted
these codes for reimbursement.
Nutritional Supplements: As for the costs of nutritional supplements, OAPP is
currently engaged in internal discussions as to whether to include this cost in the
actual reimbursement rate or to retain this cost as a separate line-item in an agency
contract budget. Mercer will revise the rate, if needed, and in response to OAPP’s
final policy decision.
5. Medical Case Management: The OAPP service description for Medical Case
Management is based on a specific theoretical framework developed by Sr. Callista
Roy, PhD, RN, i.e., the “Roy Adaptation Model.” This is a decidedly professional
nursing model that results in a “nursing diagnosis” and treatment plan that is
implemented and monitored within a multidisciplinary health care team. There are no
Medi-Cal medical case management programs (or codes) that correspond to the Roy
model as employed in the OAPP service description.
There is a further consideration: at this time, OAPP is phasing in this model of RNdelivered Medical Case Management services due to limited funding. The Mercer rate
is based on one FTE clinical nurse using 30% time in medical case management
[patient care coordination] with a caseload of no more than 30 unduplicated clients at
any one point in time. The Mercer rate reimburses according to days of enrollment;
Medi-Cal rates are based on actual service encounters (e.g., evaluations, hourly visits
and/or timed encounters [e.g., per quarter hour]) and therefore are not comparable.
6. HIV/AIDS Ambulatory/Outpatient Medical Care Services: This service description
has two new aspects that are not paralleled in the service model underlying current
Medi-Cal rates. First, the service description includes new service components,
implemented in the routine medical encounter, that are based on the PHS guidelines’
10
There is anecdotal evidence that a decision to forego Medical Nutrition Therapy is made in favor of other needed
Waiver services because of the $13,209.00 cap per client per year for Medi-Cal Waiver services. Medical Nutrition
Therapy is a requirement in the current HIV/AIDS PHS Guidelines.
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recent emphasis on the integration of HIV prevention within primary medical care,
the significance of treatment adherence services, and the essential attention to
nutrition. These requirements expand the scope and duration of the routine medical
encounter, and define enhanced areas of expertise needed by the primary care
provider in each routine medical encounter.11
Second, the service description (and corresponding rate of reimbursement) is based on
a specific personnel model [1 FTE physician (or midlevel) to 2 clinical support
nurses]. This “medical support team” model is derived from the PHS Section 330
Community Health Center Program’s utilization statistics (Region 9), and is used in
the OAPP service description as a way of assuring adequate provider support for the
new standards of care in HIV/AIDS primary health care.
As a result the Mercer rate of reimbursement incorporating these features is not
comparable with current Medi-Cal fee-for-service (FFS) rates of reimbursement nor
with the service model on which the Medi-Cal rates are based.12
Conclusion
The Ryan White CARE Act has funded the planning and the development of a
substantial, yet politically fragile, HIV/AIDS service delivery system. Federal allocations
to the RWCA are made annually. The funding allocation, particularly the level of funding
each year, is not guaranteed. Because the RWCA is not considered to be the sole, indeed
not even the primary, source of funding to meet HIV/AIDS needs, HIV/AIDS providers
must depend on other public and private sector providers to complete the HIV/AIDS
service delivery system. Unchecked competition among providers for limited financial
resources is a potentially destructive force in the HIV/AIDS service system, and
competition can inadvertently be introduced into the service environment through varying
rates of reimbursement.

11

To clarify, Medicaid (and therefore Medi-Cal), HIV/AIDS primary care services are subject to the same PHS
HIV/AIDS Guidelines. Mercer is not adding additional requirements in the service descriptions and thereby
confounding comparisons, rather Mercer is updating the rates of reimbursement based on the same, shared HIV/AIDS
Guidelines and Mercer is not aware of Medi-Cal review and revision of rates of reimbursement based on the new
requirements.
12

Mercer identified many fee-for-service Medi-Cal rates for general outpatient medical care. These rates
vary according to the type of single professional delivering the care (physician only, nurse, etc. vs. a
medical team model) as well as by level of office visit (new vs. established, levels1-5). For some of these
rates, there are rate augmentations for care provided to children and for care provided in emergency rooms.
The FFS rates range from $12.00 (office visit, level 1, established patient) to $82.70 (office visit, level 5,
new patient…$57.20 level 5, established patient). For children and emergency room visits, the ranges are
$13.09 (office visit, level 1, established patient) to $62.41 (office visit, level 5, established patient), and in
the ER $12.00 (level 1, established patient and $28.44 new patient) to $102.71 (level 5, new patient and
$71.04 established patient). The Mercer rates are not based on visit type nor are they based on differences in
service delivery settings.
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Typically, a comparison with Medicaid is completed as a way of assuring reimbursement
rates are within an acceptable public sector range. In the RWCA programs, conceding to
the Medicaid reimbursement rate is also an established way for meeting a legislated
administrative management requirement for using costs-per-unit of service in
subcontracting for service provision.13 And, reimbursing for services (and accepting
reimbursements) within the range of Medicaid reimbursement rates has also helped to
build the much needed collaborative public-private provider relationships.
In this set of six medical services, however, comparisons with the Medi-Cal rates were
not helpful. This is because of the particular approach used by OAPP in the delivery of a
service and/or because of the recent revisions to PHS guidelines that are changing
HIV/AIDS medical service delivery. The Mercer service descriptions were carefully
based on the service delivery approaches discussed and consensed with OAPP,14 and the
Mercer rate setting architecture is a method that weds reimbursement rates with the most
current standards of care. Therefore, the Mercer rates are not comparable to Medi-Cal
rates.
13
As a result, some may ask why not use the Medicaid service components and corresponding rates as compared to
establishing new service descriptions and rates. As can be seen from the Memo, OAPP contracts for services that are
distinct from Medicaid approaches to HIV/AIDS services. While Medicaid reimbursement rates have been a place of
“common ground” financially, routine Medicaid services have rarely been seen as model approaches for HIV/AIDS
care. This, then, is the point of departure: no longer conceding to the Medicaid rates before financially reviewing
whether the published rates fully “cover” the ever-updating HIV/AIDS standards of care.
14
Mercer and OAPP worked collaboratively to best define all service descriptions. This statement pertains to external
requirements imposed on OAPP in certain circumstances, such as the requirements for assessing eligibility for ADAP
directed by the CA Office of AIDS, appropriately adopted in the service descriptions regardless of their comparability
to Medi-Cal services.
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Effective March 1, 2014

RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Food Bank

Food Bank
Occurrence

Dollars per Food Bank
Occurrence (weekly bag
of groceries, including
personal hygiene
products),
Plus a Dispensing Rate

Food Bank Services may
be accessed on an
emergency basis ONLY.

250%

I, II, III
Client eligibility
for this service
must be certified
by the Medical
Case Manager

Yes

Providers will also submit
a quarterly reconciliation
of actual expenditures for
food costs, staffing, and
other line items listed on
the approved budget.

The provision of this
service will be limited to
twelve (12) occurrences in
a Ryan White Program Part
A fiscal year. One (1)
occurrence is defined as all
food bank services
provided within one (1)
calendar week.

Medical Case
Management
Referral and has
applied for Food
Stamps, as
appropriate.

General Provision:
Groceries, including
personal hygiene products
when available, can be
picked up on a weekly or
monthly basis.

A Ryan White
Program
Certified
Referral, or an
Out-of-Network
Referral
including
appropriate
backup
documentation,
is required for
this service.

Weekly client limit =
$50.00 per week at
each pickup.
Monthly client limit =
$50.00 per week multiplied
by the number of times the
original day of pick-up
occurs in the month.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Food Bank
(continued)

Additional Food
Bank Occurrence

Dollars per Food Bank
Occurrence (weekly bag
of groceries, including
personal hygiene
products),
Plus a Dispensing Rate

Additional Occurrences:
A severe change to the
person’s medical
condition (i.e., new HIVrelated diagnosis/
symptom, wasting
syndrome, protein
imbalance, recent
chemotherapy, etc.) may
also warrant additional
occurrences of food bank
services.

250%

The client must be
reassessed for the
“warranting”
medical condition
every three (3)
months.

Yes

Provision for Families:
Each additional adult who
is HIV+ and lives in the
same household is eligible
to receive an additional
$50 per week in groceries,
subject to the same
general provisions above.
Each dependent (i.e.,
minors under 18 years of
age and living in the same
household as the client
who is HIV+) is also
eligible to receive $20 per
week, subject to the same
general provisions above.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)

Additional
occurrences
require a Ryan
White Program
Nutritional
Assessment Letter
for Food Bank
Services to be
completed by an
independent
physician or
registered dietician
not associated with
the Part A food
bank provider.

A Ryan White
Program
Certified
Referral, or an
Out-of-Network
Referral
including
appropriate
backup
documentation,
is required for
this service.

For Families:
The client must
provide
documentation to
prove the
dependent’s age
and place of
residence.

Section II, Page 3 of 22

Page 2 of 21
Rev. 2/13/2014

Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Insurance
Services
[ADAP Premium
Plus Insurance
Program/AIDS
Insurance
Continuation
Program
(ADAP/APPI)]

Number of
ADAP/APPI
premium
payments made
on behalf of a
Ryan White
Program Client,
Dollars per
Insurance
Premium,
Unduplicated #
of Clients
Served,
and
Dollars
Expended per
Client

Number of ADAP/APPI
premium payments made
on behalf of a Ryan White
Program Client, Dollars
Expended per Insurance
Premium per Client

Reimbursement will be
based on documentation
of the cost of each
insurance premium.

400%

I, II, III

Yes

(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

Note: additional rules for
reimbursement are
pending negotiations
between the County and
the service provider

Maximum amount of
assistance a client may
receive on a monthly
basis is $750.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)

Client must have
insurance under
a group,
individual, or
COBRA policy.
Client must be
willing to sign
all required
forms and to
provide
eligibility
information.
A complete
financial
assessment and
disclosure are
required.
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Insurance
Services
(Insurance
Deductibles)

Number of
Insurance
Deductible
payments made
on behalf of
Ryan White
Program Clients,
Dollars per
Deductible,
Unduplicated #
of Clients
Served,
and
Dollars
Expended per
Client

Number of Insurance
Deductible payments
made on behalf of Ryan
White Program Clients,
Dollars Expended per
Client per Deductible

Reimbursement will be
based on documentation
of dollars expended per
deductible.

400%

I, II, III

Yes

(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

Note: additional rules for
reimbursement are
pending negotiations
between the County and
the service provider

A complete
financial
assessment and
disclosure are
required.

Maximum amount of
assistance a client may
receive on an annual
basis is $2,500.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Insurance
Services
(Co-payments &
Co-insurance for
medical visits,
labs, diagnostics,
and prescription
drugs)

Dollars per Copayment/CoInsurance
Encounter,
Unduplicated #
of Clients Served
and
Dollars per
Client

Dollars Expended
per Co-payment/CoInsurance Encounter

Reimbursement will be
based on documentation
of dollars expended per
co-payment/co-insurance
encounter.

400%

I, II, III
Physician’s
Prescription

Yes

(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

Note: additional rules for
reimbursement are
pending negotiations
between the County and
the service provider

Assistance is restricted to
those medications listed
on the most current
approved Ryan White
Program Prescription
Drug Formulary

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Insurance
Services
(Monthly
Premium
Payments for
Enrollment in
Federal Health
Insurance
Exchange
Programs)

Number of
Health Insurance
Exchange
premium
payments made
on behalf of a
Ryan White
Program Client,
Dollars per
Insurance
Premium,
Unduplicated #
of Clients
Served,
and
Dollars
Expended per
Client

Number of Health
Insurance Exchange
premium payments made
on behalf of a Ryan White
Program Client, Dollars
Expended per Insurance
Premium per Client

Reimbursement will be
based on documentation
of the cost of each
insurance premium.

400%

I, II, III

Yes

(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

Note: additional rules for
reimbursement are
pending negotiations
between the County and
the service provider

Client must have
active health
insurance under
a group or
individual plan
that has, at a
minimum, all
medications on
the most recent
Florida AIDS
Drug Assistance
Program
Formulary.

Maximum amount of
assistance a client may
receive on a monthly
basis is $750. This
amount is subject to
change.

Client must be
willing to sign
all required
forms and to
provide
eligibility
information.
A complete
financial
assessment and
disclosure are
required.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Legal Assistance

Hour of legal
consultation
and/or advocacy
provided by an
attorney or
paralegal

Cost of one
hour of legal consultation
and/or advocacy provided
by an attorney or
paralegal

$90.00 per Hour

200%

I, II, III

Yes

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)

A Ryan White
Program
Certified
Referral, or an
Out-of-Network
Referral
including
appropriate
backup
documentation,
is required for
this service.
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Medical Case
Management
(including MAI)

Type of OneMinute Activity
with or on behalf
of Client
(Face-to-Face or
Other)
and
Unduplicated #
of Clients Served

One unit equals one
minute of actual time

$1.00 / Minute

400%

I, II, III

Yes

One unit equals one
minute of actual time

$0.50 / Minute

400%

I, II, III

Yes

OR
Type of OneMinute Activity
Performed by a
Case
Management
Supervisor (chart
review,
consultation,
etc.)
Medical Case
Management:
Peer Education
and Support
Network
(PESN)
(including MAI)

Type of OneMinute Activity
with or on behalf
of Client (Faceto-Face or Other)
and
Unduplicated #
of Clients Served

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Mental Health
Therapy/
Counseling
(Level I)
Individual and
Group

½ Hour
Counseling
Session and
Unduplicated #
of Clients Served

Individual:
½ Hour Counseling
Session
per Client

Individual:
$32.50 per unit

400%

I, II, III

Yes

400%

I, II, III

Yes

(PhD, EdD, or
PsyD; and
licensed by the
State of Florida
as a Licensed
Clinical
Psychologist,
LCSW, LMHC,
or LMFT)
Mental Health
Therapy/
Counseling
(Level II)
Individual and
Group
(MS, MA,
MSW, or MEd;
and licensed by
the State of
Florida as a
LCSW, LMHC,
or LMFT)

½ Hour
Counseling
Session and
Unduplicated #
of Clients Served

(MAX: 32 encounters per
fiscal year and 5 units or 2
½ hours per session; 1
encounter = 1 day of
service)

Group:
½ Hour Counseling
Session
per Counselor

Group:
$35.00 per unit
(minimum of 3 Ryan
White clients to
maximum of 15 total
clients)

Individual:
½ Hour Counseling
Session
per Client

Individual:
$32.50 per unit
(MAX: 32 encounters per
fiscal year and 5 units or 2
½ hours per session; 1
encounter = 1 day of
service)

Group:
½ Hour Counseling
Session
per Counselor

Group:
$35.00 per unit
(minimum of 3 Ryan
White clients to
maximum of 15 total
clients)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Oral Health Care

Client Office
Visit, Oral
Health Care
Procedure
Provided,
and
Unduplicated #
of Clients Served

Multiplier applied to
procedure rate listed in
the State of Florida
Medicaid Dental Services
Fee Schedule, revised for
January 1, 2014;
reimbursement rates
based on the American
Dental Association’s
2014 Current Dental
Terminology (CDT
2014), codes for dental
procedures

Maximum Multiplier
Rate of 3.0

400%

I, II, III

Yes

Maximum Annual Limit
(Ryan White Part A
Program Fiscal Year) for
Oral Health Care
Services: $3,000 per
client
Very limited exceptions
to the annual cap may be
approved by the County,
with consultation from the
Miami-Dade HIV/AIDS
Partnership’s Oral Health
Care Subcommittee as
needed, on a case-by-case
basis for the provision of
preventative oral health
care services only.
(NOTE: This service is
limited to procedures
found on the most current
Ryan White Program Oral
Health Care Formulary.)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Outpatient
Medical Care
[including
Minority AIDS
Initiative (MAI)]

Client
Medical Visit
and
Unduplicated #
of Clients Served

Multiplier applied to
reimbursable procedure
rate listed in the Year
2014 Florida Medicare
Part B Physician Fee
Schedule (Participating,
Locality/Area 04), file
dated December 31, 2013
revised, for Evaluation
and Management (E&M)
codes for outpatient
medical care and
psychiatric visits only.
Inpatient and emergency
room services are not
covered.

Maximum multiplier rate
of 1.50 will be applied to
Medicare reimbursable
rates for Evaluation and
Management codes for
outpatient medical care
and psychiatric visits
only.

400%

I, II, III
Referral from a
primary care
physician is
required for
outpatient specialty
care, except for
psychiatric services
which may be
requested by a
mental health care
professional

Yes

All other non-E&M
procedures will be
reimbursed at the 2014
applicable Medicare rate
as referenced in this
outpatient medical care
section.

No multiplier will be
applied to non-E&M
procedures.

(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Outpatient
Medical Care
(including MAI)

(see previous
page)

Medical Procedures
performed at Ambulatory
Surgical Centers (ASCs)
will be reimbursed at rates
found in the 2014 Florida
Medicare ASC Fee
Schedule, by HCPCS
Codes and Payment
Rates, for Core Based
Statistical Area (CBSA)
Miami (33124), modified
January 8, 2014. (Update
pending)

No multiplier will be
applied to the Medicare
ASC Reimbursement
Rates. Billing is
restricted to organizations
with on-site or affiliated
ASCs only.

400%

I, II, III
Referral from a
primary care
physician is
required for
outpatient specialty
care, except for
psychiatric services
which may be
requested by a
mental health care
professional

Yes

Medical Procedures
performed at Outpatient
Hospital centers will be
reimbursed at rates found
in the approved Medicare
Addendum B Outpatient
Prospective Payment
System (OPPS) by
HCPCS Code for CY
2014 Fee Schedule
(January 2014), dated
December 19, 2013.

No multiplier will be
applied to the Medicare
OPPS Reimbursement
Rates. Billing is
restricted to organizations
with on-site or affiliated
outpatient hospital centers
only.

(cont’d)
(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)

Any referral to
specialty medical
care and outpatient
hospital or
ambulatory
surgical centers on
behalf of a Ryan
White Program
client must include
documentation or a
notation that the
service requested is
a Ryan White
Program-allowable
condition (i.e., is in
relation to a
client’s HIV
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Outpatient
Medical Care
(including MAI)

(see previous
page)

(see previous page)

(see previous page)

(see previous
page)

diagnosis, a related
co-morbidity, a
condition
aggravated or
exacerbated by
HIV, or a
complication of
HIV treatment).
Please refer to the
OMB-GC/RW’s
clarification letter
dated December
20, 2013, and the
accompanying list
of Sample
Conditions.

(see previous
page)

(cont’d)
(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Outpatient
Medical Care
(including MAI)

(see previous
page)

Laboratory procedures
will be reimbursed at rates
included in the 2014
Medicare Clinical
Diagnostic Laboratory
Fee Schedule, for Florida
(FL), revised for January
2014.

No multiplier will be
applied to laboratory fees.

400%

Yes

Injectables will be
reimbursed at rates
included in the 2014
Medicare Part B Drug
Average Sales Price
(ASP) Drug Pricing Files,
Payment Allowance
Limits for Medicare Part
B Drugs, dated December
17, 2013.

No multiplier will be
applied to injectable fees.

I, II, III
Referral from a
primary care
physician is
required for
outpatient specialty
care, except for
psychiatric services
which may be
requested by a
mental health care
professional

(cont’d)
Labs /
Injectables
(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Outpatient
Medical Care
(including MAI)

Number of
Clients Served,
Consumable
Medical Supply
Distributions per
Client (for
Administering
Prescribed
Medications
Only),
and
Dollar Amount
Spent per Client

Allowable flat rate listed
in the Medicare Durable
Medical Equipment and
Supplies Fee Schedule,
for Florida (FL), revised
for January 2014.

No multiplier will be
applied to DME fees.

400%

I, II, III
Referral from a
primary care
physician is
required for
outpatient specialty
care, except for
psychiatric services
which may be
requested by a
mental health care
professional

Yes

(cont’d)

Consumable
Medical Supplies
(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

If no Medicare Rate is
available for approved
DME and consumable
medical supplies,
providers will be
reimbursed at the
Medicaid DME for
Recipients of All Ages fee
schedule rates, dated
December 2013. In such
case, providers must
submit a request to the
County for a
Supplemental
Reimbursement Rate.
Allowable items are
limited.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

Outreach
Services
(including MAI)

Type of 15Minute Outreach
Encounter
[Face-to-Face or
Other (i.e.,
Telephone
Contact, Referral
Activity, etc.)]
and
Unduplicated #
of Clients Served

Line Item Budget

See the full
Service
Definition for
details regarding
the minimum
required new
connections
(50%), and the
re-connections
(50%), to
outpatient
medical care
and/or medical
case
management

REIMBURSEMENT
CAP

Outreach services will be
paid based on full-time
Reimbursement will be
equivalent (FTE)
based on a line item
employees providing
budget (for actual expenses direct services as outlined
incurred per month by the
in the corresponding
outreach service provider). service definition, as well
as on the basis of other
allowable direct and
administrative costs.

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

N/A

I, II, III

Yes

Reimbursement of
salaries will be based on
the approved budget and
productivity as recorded
by hours spent doing
allowable outreach
activities, HIV+ people
contacted, their risk
factors, and the # of HIV+
people connected to care.
All administrative and/or
indirect expenses (other
than those associated with
the delivery of outreach
services) are capped at
10% of the total award for
the service category.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Prescription
Drugs
(including MAI
for all
components)

Individual Drugs
Dispensed, # of
Filled
Prescriptions, $
Spent per Drug,
and
Unduplicated #
of Clients Served

PHS of Injectable/
Non-Injectable
Medication Plus Flat Rate
Dispensing Fee

PHS Price Plus Flat Rate
Dispensing Fee

400%

Yes

OR

OR

AWP of Injectable/
Non-Injectable
Medication Minus
Discount Rate

AWP Minus Applied
Discount Rate of No Less
Than 10%

I, II, III
and
Physician’s
Referral or
Prescription, with
Letter of Medical
Necessity or Prior
Authorization
Form, if applicable

(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

(NOTE: This service is
limited to medications
found on the most current
Ryan White Program
Prescription Drug
Formulary. Prescription
drug providers should use
the most cost-effective
product, either brand or
generic, whichever is less
expensive at the time of
dispensing.)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Prescription
Drugs:
Consumable
Medical Supplies
(for
Administering
Prescribed
Medications
only)

Number of
Clients Served,
Consumable
Medical Supply
Distributions per
Client (for
Administering
Prescribed
Medications
Only),
and
Dollar Amount
Spent per Client

Allowable flat rate listed
in the Medicare Durable
Medical Equipment and
Supplies Fee Schedule,
for Florida (FL), revised
for January 2014.

No multiplier will be
applied to approved DME
or consumable medical
supplies.

400%

I, II, III
and
Physician’s
Referral or
Prescription, with
Letter of Medical
Necessity, if
Applicable

Yes

(NOTE: THIS
INFORMATION IS
SUBJECT TO
CHANGE
UPON
FURTHER
GUIDANCE
RELATED TO
IMPLEMENTA
-TION OF THE
AFFORDABLE
CARE ACT.)

If no Medicare Rate is
available for approved
DME and consumable
medical supplies,
providers will be
reimbursed at the
Medicaid DME for
Recipients of All Ages fee
schedule rates, dated
December 2013. In such
case, providers must
submit a request to the
County for a
Supplemental
Reimbursement Rate.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Substance Abuse
Counseling –
Outpatient
(Level I)
Individual and
Group

½ Hour
Counseling
Session and
Unduplicated #
of Clients Served

Individual:
½ Hour Counseling
Session
per Client & Family
Member

Individual:
$30.00 per unit

400%

I, II, III

Yes

Group:
½ Hour Counseling
Session
per Counselor

Group:
$34.00 per unit

400%

I, II, III

Yes

Substance Abuse
Counseling –
Outpatient
(Level II)
Individual and
Group

½ Hour
Counseling
Session and
Unduplicated #
of Clients Served

(minimum of 3 Ryan
White clients to
maximum of 15 total
clients)

Individual:
½ Hour Counseling
Session
per Client and/or Family
Member, as appropriate

Individual:
$27.00 per unit

Group:
½ Hour Counseling
Session
per Counselor

Group:
$30.00 per unit
(minimum of 3 Ryan
White clients to
maximum of 15 total
clients)

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Substance Abuse
Counseling –
Residential
(including MAI)

# of Days of
Residential
Substance Abuse
Treatment
per Client
and
Unduplicated #
of Clients Served

Cost of One Day of
Residential Counseling
Treatment Per Client

$125.00 per client day

300%

I, II, III

Yes

[up to a maximum of 120
days within a 12-month
period; 12-months begins
on the 1st day of client’s
residential treatment
regardless of Part A /
MAI provider]
[includes the cost of
family member(s)
participating in the
substance abuse
counseling session
provided during day of
treatment]

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)

A Ryan White
Program
Certified
Referral, or an
Out-of-Network
Referral
including
appropriate
backup
documentation,
is required for
this service.
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Effective March 1, 2014
RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)
IMPORTANT: To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements.
SERVICE
CATEGORY
(listed in
alphabetical
order)

REPORTING
UNIT

REIMBURSEMENT
UNIT

REIMBURSEMENT
CAP

MAXIMUM %
OF 2014
FEDERAL
POVERTY
LEVEL

ELIGIBLE HIV
STATUS*

REQUIRED
MEDICAID/
OTHER
SCREENING

Transportation
Vouchers
(Discounted
EASY Tickets)

Dollars per
Voucher,
# of Vouchers,
and
Unduplicated #
of Clients Served

Dollars per Voucher
Plus a Dispensing Rate
Not to Exceed 15%

Cost of Vouchers
Plus Dispensing Rate
Not to Exceed 15%

150%

I, II, III
Medical Case
Management
Referral

Yes

Case Manager recertification
required every 6
months.

Clients must be
screened for
eligibility of
Miami-Dade
County Golden
Pass Program,
Special
Transportation
Services (STS),
Miami-Dade
Transit
Transportation
Disadvantaged
Program,
Medicaid, etc.
--------

A Ryan White
Program
Certified
Referral, or an
Out-of-Network
Referral
including
appropriate
backup
documentation,
is required for
this service.

*LEGEND: I = HIV+ Asymptomatic, II = HIV+ Symptomatic, III = AIDS (As Defined by the CDC)
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Performance-based reimbursement
Public Health Solutions’ reimbursement approach aligns contractor payment with performance. We do
this in four ways:
Per Member, Per Day (Care Coordination) – see attached (21% of the value of our portfolio)
Fee-for-Service (41% of the value of our portfolio)
Deliverables-Based (6% of the value of our portfolio)
Hourly (4% of the value of our portfolio in dollars)
Regardless of reimbursement model, all contracts must complete a line-item budget which is reviewed
for cost allowability and reasonability; service projections, which must demonstrate reasonable staff
effort and caseloads; a scope of work, which clearly outlines project expectations, with staff
responsibility; and a general contract agreement which lays out all relevant requirements and
regulations governing the contract.
Fee-for-Service
Overview: Services are associated with reimbursement rates, payable based on reporting of client-level
data in eSHARE, the EMA’s client-level data system. Each month we analyze eSHARE data to process
payment. The product of reported billable services for the month and their associated reimbursement
rates is our payment to contractors. Projected services multiplied by their associated reimbursement
rates equals the total contract award.
Mechanics: Each month contractors enter service data into eSHARE. eSHARE data are extracted and
transferred to Public Health Solutions’ payment system, which organizes them for payment, multiplying
services by reimbursement rate and subjecting data to certain payment rules (see below). Ultimately,
the system generates a payment which is reviewed by a Contract Manager and a supervisor before
being processed.
Contractors receive a monthly report called the Master Itemization Report (MIR), which lists and
summarizes services recognized by our system. Potentially disallowable services (e.g., duplicate
services, violations of frequency limits, and problems identified through site visits) are flagged for
possible recoupment. Contractors reconcile the MIR against their own records.
Rate development: Some rates are negotiated with individual contractors. In that case, we establish a
ceiling rate for each service type. More commonly, we compute rates and publish them in Requests for
Proposals so that prospective applicants can determine whether they wish to apply for funding. Most
payment points are outputs (e.g., counseling sessions, HIV tests, meals served); others are short-term
outcomes (e.g., linkages to care, housing placement, workshop completion). In general, calculated rates
and rate ceilings reflect the following inputs:

Expenses: Salary (at levels/job titles we deem reasonable and appropriate), fringe benefits (average
nonprofit rate), OTPS (with allowances for special services such as food for food and nutrition programs
or rent for housing assistance programs), administration (we allow 12% because several large contracts
in the EMA have very low administrative spending, keeping us below 10% in the aggregate).
Service time: We make assumptions about how long a service should take (including preparation,
charting and data entry), and thus how productive we expect a worker and program to be. We
understand that some clients do not show for scheduled appointments despite the program’s
mobilization to serve them, and build in a no-show allowance in our rate calculations.
Outcomes and incentive payments: Some of our reimbursement points are culminating events such as
linkage to care, graduation and housing placement. We assign rates to these events using a
combination of benchmarking and programmatic knowledge, since their inputs (time and human
resources) vary significantly among programs.
We review and, as indicated, adjust reimbursement rates approximately every two to three years based
on analysis of service intensity, time and costs. When funding permits, we sometimes provide modest
increases to reflect rises in the cost of living.
Rules: Some services have supplemental payment rules specific to the service category. For example,
HIV testing, mental health counseling services and housing placement have frequency caps. Group
services have minimum group sizes. Some services, like HIV confirmatory testing and Transitional Care
Coordination graduation, have service prerequisites. Other services, like outreach activities in a
homeless youth initiative, are capped as a percentage of the overall contract amount.
Monitoring:
Programmatic: On-site visits include a retrospective review of documentation of service provision,
client eligibility, provider eligibility and adherence to service models and funding guidelines. Deficient
documentation and failure to adhere to client and/or provider eligibility and service model
requirements can result in recoupment. Monitoring staff also review monthly narrative reports
highlighting achievements and challenges.
Fiscal: Audit packages (financial statements, A-133, management letters) are reviewed annually, with
any relevant findings pursued with senior fiscal staff. At the end of the year, we request a line-item
expense report by “service family” (a cluster of services usually sharing a reimbursement rate), which is
used to inform future rate adjustments.
Spending Management: Several times during the year we analyze spending to determine whether
contracts are on track to spend their full award. Using established criteria, we “take down,” or reduce,
low-performing contracts and redirect that funding to contractors who are exceeding their prorated
targets. Contractors with “takedowns” can appeal our decision. We rescind takedowns in
approximately 30% of appeals. Contractors have an incentive to overperform since, pending availability
2

of funds, we can pay them for exceeding their contract award amounts. As a result of our aggressive
spending management, we spend almost 100% of program funds.
Deliverables
Some programs are reimbursed on completion of program deliverables. We often employ this approach
during programs’ start-up periods, when deliverables include activities such as staff training, space
rental, establishment of a Consumer Advisory Board and completion of policies and procedures. Some
services have very challenging and/or delayed fee-for-service outcomes, so we reserve a portion of the
contract award for draw-down through completion of regular deliverables such as programmatic reports
or training. Such contracts have a hybrid reimbursement model, with some deliverables and some feefor-service.
Hourly
Our EMA reimburses legal services providers on an hourly basis – the recording methodology to which
attorneys are accustomed. Hourly rates are capped based on reasonableness and average costs.
________________________________
Reflections
A recent survey of service providers indicates that after seven years, almost 60% think that on balance,
the benefits of performance-based reimbursement outweigh its challenges. Benefits include the ability
to earn more for exceeding targets and to modify their budgets as they deem necessary, without the
need for funder approval. The challenges are emphatically financial: lower-than-projected performance
means they may not cover their fixed costs. Performance deficiencies can come about as the result of
staff vacancies, damage to facilities which compromises service capacity, difficulty recruiting clients and
client no-shows. In addition, during the transition to performance-based reimbursement, program
administrators have described the need to employ program and clinical staff who are data-oriented,
that is, who are able and willing to project, track and analyze service revenue at the caseload and
program level. In addition, quality management for data processing has emerged as critical, so that
providers develop the understanding of their client-level data entry as billing vouchers or accounts
receivable.
From the EMA’s perspective, information systems have been the key to the success of our system,
translating client-level data entry into program payments. We work with numerous systems: eSHARE,
the repository of client information (enrollment, demographics and services) used by service providers;
a contract management system developed and used by Public Health Solutions for contracting and
payment, the Master Contractor for DOHMH; and a “bridge” system that allows us to import data from
eSHARE into our contract management system, applying program rules to correctly calculate payments
and highlight potentially unallowable items. The contract management system, known as MAPS,
generates reports for contractors and EMA staff to ensure accurate payment and reporting (both at the
contract level and the aggregate grant level) and to support operational management and improvement.
3

Public Health Solutions’ contract management staff are responsible for programmatic and fiscal
operations, which requires a level of program and fiscal analysis capacity not assumed in a more
conventional line-item budget contract (where fiscal staff manage budgets and billing and program staff
monitor program deliverables). DOHMH staff provide technical assistance on program models, eSHARE
and quality management.

4
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Updated April 13, 2012

New York City Department of Health & Mental Hygiene
Bureau of HIV/AIDS Prevention & Control
Reimbursement Plan for Ryan White Care Coordination (RWCC)
Overview

Beginning in March 2012, Ryan White Care Coordination (RWCC) reimbursement has a three-part structure:
(1) Per-member-per-day payments for enrollment in the various tracks
(2) Milestone payments for transitions that step a patient down to a lower intensity track
(3) Fee-for-service for Directly Observed Therapy (DOT) and Outpatient Bridge Medical Care (OBMC)
This document describes the method by which RWCC costs were determined and used to generate the rates for
payment.

Cost calculation

RWCC- specific inputs and assumptions include:
Table 1: Inputs and assumptions for unit service costs
Salary information was culled from contract review and other contractor solicited input
in 2008 and reflect recommended staffing credentials from the RWCC RFP and protocol.
Annual salary of a Navigator
$35,000.00
Annual salary of a Care Coordinator
$50,000.00
Annual salary for field DOT
$30,000.00
Annual salary for center DOT*
$50,000.00
Other inputs and assumptions
Field travel time (per event)
30 min (used for field DOT)
Markups: Indirect personnel**; OTPS; Fringe; Admin
20%; 25%; 30%; 12%
Medical care in low intensity
1 visit/4 months
Medical care in high intensity
3 visits/2 months
Service frequencies are dictated by the Care Coordination Protocol
*Salary is for a licensed practical nurse (LPN)
**The markup is defined as a percent added to the base direct service salary to account for indirect personnel time (e.g. the
time it takes for a supervisor to oversee the work done)

Reimbursement Rate Calculation

(1) Per-member-per-day (PMPD) payments for enrollment in the various tracks.

A) Base PMPD Rates
Base PMPD payment calculations were originally set in 2011 using a method of assembling service costs
within program tracks. The time period for calculation was set at one day to obviate the need for
prorating or complex rules for track assignation for payment. A month was considered to have 30.42 days
on average.
B) Adjusting PMPD rates by carving out DOT as an activity reimbursed on a fee-for-service (FFS) basis
DOT when administered as a daily service added complexity and uncertainty to our rules for making
payments on a PMPD basis. Because of the nature of the service it is not prone to overuse and
consequent cost inflation, it is therefore amenable to FFS payment with a few simple controls (e.g. limit
one per day).
Page 1 of 4
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C) Adjusting for Medicaid Community Follow-up Program (CFP)
Based on conversations with the New York State Department of Health AIDS Institute, the following
services are reimbursable under the COBRA Community Follow Up Program (CFP): Plan development;
Appointment assistance (excluding Accompaniment); Accompaniment; Benefits assessments. The
following services are not reimbursable under the CFP: Health Promotion (Basic, Quarterly, Monthly,
Weekly – including Adherence Education); DOT. This identified the need for integration and therefore cost
adjustments for enrollees receiving services from both the CFP and RWCC.
Table 2: Net rates after adjusting for DOT, and CFP
Track
Expected #
Base (Unadjusted)
Final PMPD after DOT
Mos. In
PMPD
Carve-out
Track
A
12
$1.07
$1.07
B
3
$1.68
$1.68
C1
6
$14.86
$14.86
C2
7.5
$22.98
$22.98
D
6
$32.80/$49.76*
$22.98
*Clinic-based vs. field-based DOT before DOT carve out.

Final PMPD w/CFP
Adjustment
$0.58
$0.91
$8.02
$12.41
$12.41

PMPD Payment Rules
The payability of each day’s enrollment will be validated on the basis of a threshold (T) of services provided during
the preceding time period (P).
For clients enrolled in CFP, Health education/promotion services are the only services that count toward
validation.
For clients enrolled in Ryan White only, services which count toward validation include the following: Case finding,
Intake assessment, Medical assessment/reassessment, Other assessment/reassessment, Care plan/service plan,
Case conference, Accompaniment, Assistance with entitlements and benefits, Assistance with health care,
Assistance with housing, Assistance with social services, and Health education/promotion. (Note that services
must be face-to-face; those performed over the phone do not count toward validation.)
Table 3: PMPD payment rules
Expected
Look Back
frequency
Period
(P)

Payment
Threshold
(T)

Rule

If actual units of services
over previous P days >= T, pay
PMPD for today, IF NOT do not pay
“
“
“
“

Track D

4.345

30

2

Track C2
Track C1
Track B
Track A

4.345
3
2
2

30
92
183
183

2
2
1
1

In addition to the provision of these services according to the timeframes specified, for clients enrolled in Ryan
White only there is another way a day may be validly payable: by having an Outreach for patient re-engagement
service within a 7-day look back period. This method of validating payment is only permitted for a 60 day period
beginning with the last recorded face-to-face service.
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These payment rules were implemented in month ten of the new reimbursement model (December 2011). The
tracks and threshold value for payment are shown in Table 3. (It is anticipated that sometime in 2012, these
payment rules may be expanded to require periodic adherence assessments for all tracks except A.)

(3) Milestone payments for transitions that step a patient down to a lower intensity track

The RWCC model is based on the idea that intensive navigation-type case management can stabilize even some of
the most complex cases, that health behavior skills can be augmented over time, and that service delivery,
therefore, should be tailored to individual need and intensification or scale back of services implemented as
warranted. Milestone payments are used in order to promote provider attention to patient movement through
the program. A milestone is defined as an allowed transition from a track of higher intensity to one of lower
intensity that lasts for 60 days or longer without regression to a higher intensity track in that period.
Milestone payments are set to be equal to one month (i.e. 30.42 days) of the capitated rate of the track exited
from (after calculating those rates net the milestone amount). Exceptions: Both the A and B track (graduation)
milestones would have excessively low values by this method and are set at $75. There is no hard data behind
determining the size of the milestone payment. Rather, we chose a reasonable starting point relative to the basis
– PMPD – with the idea that it can be adjusted in following years depending on the degree to which it incentivizes
the desired outcome. Milestone payments were calculated based solely on unblended RW funds because CFP
funds could only be attributed to a part of PMPD payment and were adjusted for DBR carve out.
Table 4: Milestone payment amounts
Transition
ID
Milestone payment
1
$75.00
2
$75.00
3
$290.60
4
$753.20
5
$462.61
6
$449.39
*The valuation

is equivalent to that of the stepwise progression

Milestone payment rules
For any enrollment, a provider may be paid either the set of milestones {3,5} or else {4}.
Only transitions that represent clinical progress are payable; those initiated by patient request or refusal
of higher level service are not payable.
Each milestone may be paid only once over the course of a patient enrollment. Some transitions will
naturally be repeated due to regression, but only the first within an enrollment will be payable as a
milestone.
In order to limit circumvention of the above rule no client may be formally dis-enrolled until 60 days after
loss of contact or end of participation. Any return of the enrollee to service during the 60 day window
constitutes a continuation of the prior enrollment.
A milestone can only be paid 60 days or more after the transition occurred to ensure the definition of a
milestone was met.

(4) Fee-for-service for DOT and OBMC services.

Incorporation of DOT service costs added unwarranted complexity to PMPD rate setting. Both home and centerbased DOT service were, therefore, carved out of the capitated rate to be reimbursed separately on a fee-forservice basis. OBMC services were always set to be reimbursed separately on a fee-for-service basis and were
never part of the PMPD rate setting process; OBMC has been fee-for-service since December 2009.
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Table 5: Fee-for-service DOT and OBMC rates
Rate
Cost per unit of center-based DOT
$9.82
Cost per unit of field-based DOT
$26.78
OBMC Initial visit with labs
$300
OBMC medical visit
$175
OBMC Navigator visit
$100
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